Closure device and methods for making and using them

Description

BACKGROUND OF THE INVENTION

1. The Field of the Invention

The present invention relates generally to apparatus and methods for engaging tissue and/or closing openings through tissue, and more particularly to devices for closing a puncture in a blood vessel or other body lumen formed during a diagnostic or therapeutic procedure, and to methods for making and using such devices.

2. The Relevant Technology

Catheterization and interventional procedures, such as angioplasty or stenting, generally are performed by inserting a hollow needle through a patient's skin and intervening tissue into the vascular system. A guide wire may then be passed through the needle lumen into the patient's blood vessel accessed by the needle. The needle may be removed, and an introducer sheath may be advanced over the guide wire into the vessel, e.g., in conjunction with or subsequent to a dilator. A catheter or other device may then be advanced through a lumen of the introducer sheath and over the guide wire into a position for performing a medical procedure. Thus, the introducer sheath may facilitate introduction of various devices into the vessel, while minimizing trauma to the vessel wall and/or minimizing blood loss during a procedure.

Upon completion of the procedure, the devices and introducer sheath may be removed, leaving a puncture site in the vessel wall. External pressure may be applied to the puncture site until clotting and wound sealing occur. This procedure, however, may be time consuming and expensive, requiring as much as an hour of a physician's or nurse's time. It is also uncomfortable for the patient, and requires that the patient remain immobilized in the operating room, catheter lab, or holding area. In addition, a risk of hematoma exists from bleeding before hemostasis occurs.

Various apparatus have been suggested for percutaneously sealing a vascular puncture by occluding the puncture site. For example, U.S. Pat. Nos. 5,192,302 and 5,222,974, issued to Kensey et al., describe the use of a biodegradable plug that may be delivered through an introducer sheath into a puncture site. When deployed, the plug may seal the vessel and provide hemostasis. Such devices, however, may be difficult to position properly with respect to the vessel, which may be particularly significant since it is generally undesirable to expose the plug material, e.g., collagen, within the bloodstream, where it may float downstream and risk causing an embolism.

Another technique has been suggested that involves percutaneously suturing the puncture site, such as that disclosed in U.S. Pat. No. 5,304,184, issued to Hathaway et al. Percutaneous suturing devices, however, may require significant skill by the user, and may be mechanically complex and expensive to manufacture.

U.S. Pat. No. 5,478,354, issued to Tovey et al., discloses a surgical fastener including an annular base having legs that, in a relaxed state, extend in a direction substantially perpendicular to a plane defined by the base and slightly inwards toward one another. During use, the fastener is fit around the outside of a cannula, thereby deflecting the legs outward. The cannula is placed in an incision, and the fastener is slid along the cannula until the legs pierce into skin tissue. When the cannula is withdrawn, the legs move towards one another back to the relaxed state to close the incision.

U.S. Pat. Nos. 5,007,921 and 5,026,390, issued to Brown, disclose staples that may be used to close a wound or incision. In one embodiment, an “S” shaped staple is disclosed that includes barbs that may be engaged into tissue on either side of the wound. In another embodiment, a ring-shaped staple is disclosed that includes barbs that project from the ring. Sides of the ring may be squeezed to separate the barbs further, and the barbs may be engaged into tissue on either side of a wound. The sides may then be released, causing the barbs to return closer together, and thereby pulling the tissue closed over the wound. These staples, however, have a large cross-sectional profile and therefore may not be easy to deliver through a percutaneous site to close an opening in a vessel wall.

Accordingly, devices for engaging tissue, e.g., to close a vascular puncture site, would be considered useful.

BRIEF SUMMARY OF THE INVENTION

The present invention is directed to devices and methods for engaging tissue, e.g., to connect tissue segments together or to close and/or seal openings through tissue, such as in a wall of a body lumen. More particularly, the present invention is directed to vascular closure devices or clips for closing a puncture in a wall of a blood vessel formed during a diagnostic or therapeutic procedure, and to methods for making and using such devices.

In accordance with one aspect of the present invention, a device for closing an opening in a body lumen is provided that includes a generally annular-shaped body defining a plane, and a plurality of tissue engaging portions extending from the annular-shaped body substantially transversely with respect to the plane. In this embodiment, opposing tissue engaging portions, e.g., tines, are biased towards a substantially planar configuration lying in the plane. In one embodiment, the tissue engaging portions are biased towards one another, e.g., to close a puncture site or other opening through tissue. Alternatively, the tissue engaging portions may be biased away from one another.

In accordance with one aspect, the tissue engaging portions are integrally formed with the annular-shaped body, e.g., from a sheet of material, such as Nitinol or other superelastic alloy. The tissue engaging portions may be formed with the sheet of material in the substantially planar configuration. The tissue engaging portions may be deflected substantially transversely with respect to the plane to define a substantially transverse configuration. Alternatively, the device may be formed from an elongate wire or tube that may be wound to form an enclosed body.

In accordance with another aspect, the tissue engaging portions, e.g., tines, optionally including barbs, for penetrating tissue, may be disposed substantially symmetrically about a central axis. Alternatively, the tissue engaging portions may be disposed in opposing sets along a linear axis.

In accordance with another aspect of the present invention, a device for engaging tissue, e.g., to close an opening in a body lumen, is provided that includes a generally annular-shaped body defining a plane. A plurality of tissue engaging portions extend from the annular-shaped body substantially transversely with respect to the plane. In one embodiment, opposing tissue engaging portions of the device are biased towards a substantially planar configuration lying in the plane, as described above.

One or more expandable elements are disposed along a periphery of the annular-shaped body. The expandable elements are expandable between expanded and compressed states for increasing and reducing a peripheral dimension of the annular-shaped body, respectively. In one embodiment, the expandable elements may be an enclosed cell, e.g. a diamond-shaped cell, having a first width in the expanded state and a second width in the compressed state that is smaller than the first width. Alternatively, the expandable elements may be a zig-zag element or an arcuate element. The expandable elements can be biased to the expanded state, e.g., by appropriate heat treating of the expandable elements. Alternatively, the expandable elements may be biased to the compressed state.

In accordance with yet another aspect of the present invention, a clip, such as those described above, may be loaded on a delivery apparatus and used to close and/or seal an opening in a wall of a body lumen. The apparatus generally includes a sheath including proximal and distal ends defining a longitudinal axis there between. A housing is slidably disposed on the sheath, the housing including an annular cavity therein. A clip, such as those described above, is disposed within the cavity with the tissue engaging portions disposed substantially distally.

The housing can be actuable for advancing the clip distally towards the distal end of the sheath, e.g., to deploy the clip from the cavity. For example, the apparatus may include an actuator coupled to the housing, the actuator configured for advancing the housing distally to deploy the clip. The actuator includes a spring mechanism for biasing the housing distally upon activation of the actuator. In addition, the apparatus may include a locator element for positioning the distal end of the sheath, such as a bleed back lumen or a mechanical locator.

During use, the distal end of the sheath, with the housing and clip near its proximal end, may be positioned through a patient's skin along a passage and into a body lumen via an opening in the wall of the body lumen. One or more instruments may be introduced through the lumen of the sheath into the body lumen. A diagnostic or therapeutic procedure may be performed using the instruments at a location accessed via the body lumen. For example, the body lumen is a peripheral blood vessel, such as a femoral artery, and the procedure may include angioplasty, atherectomy, stent delivery, delivery of a therapeutic agent, and/or tissue ablation.

The sheath may be manipulated, for example, with the aid of a locator element, to position the distal end with respect to the opening, e.g., to ensure that the clip engages a wall of the body lumen or other tissue proximal to the opening and is not advanced into the body lumen itself. The housing is advanced distally into the passage, e.g., until the tissue engaging portions of the clip substantially engage the wall of the body lumen or other tissue proximal to the opening in the wall of the body lumen. In addition, or alternatively, the clip may be deployed from the housing, for example, by an ejector within the housing. The sheath may then be withdrawn from the body lumen and passage, leaving the clip in the passage. As the distal end of the sheath is withdrawn through the clip, the tissue engaging portions automatically at least partially move towards the planar configuration to pull the engaged tissue together and substantially close the opening.

In one embodiment, the clip automatically expands to an enlarged cross-section when the clip is deployed from the housing. Thus, the clip may be compressed to facilitate loading into the housing, and thereby provide a reduced profile for the clip. This may be useful to allow the clip to be delivered through a smaller puncture.

A method according to the present invention may include causing a clip or other closure element to engage tissue, e.g., muscle, fat, fascia, and the like, that is proximal to the body lumen. Thus, unlike previously known methods, which are directed to closing the wall of a blood vessel using clips or sutures, the present invention may include deploying a closure element in the passage to cause it to engage intermediate tissue between the patient's skin and the wall of the body lumen. When performed in this manner, the need to precisely position a closure element may be avoided as is required when engaging the wall of a vessel. Instead, the closure element may be located and delivered at a range of locations along the length of the passage yet still close and/or seal the passage. In effect, extra-vascular tissue is engaged to close the passage and thereby cause sealing of the wound. When the closure element is deployed, it can be planar, e.g., extending substantially parallel to the surface of the patient's skin, although not necessarily so.

In one aspect of the present invention, a device for engaging tissue includes a generally annular-shaped body defining a plane and disposed about a central axis extending substantially normal to the plane. The body may be movable from a substantially planar configuration lying generally in the plane towards a transverse configuration extending out of the plane. The body may also include a plurality of looped elements including alternating first and second curved regions that define an inner and outer periphery of the body, respectively, in the planar configuration. A plurality of tines or other tissue-engaging elements may extend from the first curved regions, and may be oriented towards the central axis in the planar configuration, and substantially parallel to the central axis in the transverse configuration. The device may be biased towards the planar configuration, e.g., to bias the tines towards the central axis.

The looped elements of the device may generally define an endless zigzag pattern, e.g., a sinusoidal pattern, extending about the central axis. The looped elements may facilitating deforming the device between the planar and transverse configurations, e.g., by distributing stresses through the device and minimizing localized stresses in the curved regions. In addition, the looped elements may be expandable between expanded and compressed states for increasing and reducing a periphery of the body in the transverse orientation, respectively. The looped elements may be biased towards one of the compressed and expanded states.

Adjacent tines of the device may have a first curved region disposed between them. The first curved region between adjacent tines may include a substantially blunt element extending towards the central axis. The blunt element may have a length shorter than lengths of the adjacent tines.

In addition or alternatively, the tines of the device may include first and second primary tines, having a first length and a second length, respectively, which may be the same as or different than one another. The first and second primary tines may be disposed on opposing first curved regions, and may be oriented substantially towards each other in the planar configuration. In the planar configuration, the first and second primary tines may at least partially overlap. The tines may also include one or more secondary tines having a length substantially shorter than the first and second lengths of the primary tines. The secondary tines may be disposed on either side of the first and second primary tines.

In another aspect of the present invention, a device for engaging tissue includes a generally annular-shaped body defining a plane and disposed about a central axis extending substantially normal to the plane. The body may be movable from a substantially planar configuration lying generally in the plane towards a transverse configuration extending out of the plane. A first primary tine, having a first length, may extend from the body towards the central axis in the planar configuration, and may be deflectable out of the plane when the body is moved towards the transverse configuration. A second primary tine, having a second length, may extend from the body towards the first tine when the body is in the planar configuration, and may be deflectable out of the plane when the body is moved towards the transverse configuration. The lengths of the first and second primary tines may cause the primary tines to at least partially overlap in the planar configuration. The body may be biased towards the planar configuration to bias the tines generally towards the central axis.

The device may include a set of secondary tines having a length shorter than the first and second lengths. The secondary tines may extend from the body towards the central axis in the planar configuration, and may be deflectable out of the plane when the body is moved towards the transverse configuration. In an exemplary embodiment, a secondary tine may be disposed on either side of the first primary tine, and a secondary tine may be disposed on either side of the second primary tine.

Optionally, adjacent tines may have a first curved region disposed between them. The first curved region between adjacent tines may include a substantially blunt element extending towards the central axis. The blunt element may have a length shorter than lengths of the adjacent tines.

Also, the device may include a plurality of looped elements disposed around a periphery of the body. The looped elements may generally define an endless zigzag pattern extending about the central axis. The first primary tine and the second primary tine may extend from looped elements disposed opposite one another. The looped elements may be expandable between expanded and compressed states for increasing and reducing a periphery of the body in the transverse orientation, respectively. The looped elements may be biased towards one of the compressed and expanded states.

In another aspect of the present invention, a method is provided for manufacturing a clip from an elastic material, such as a sheet of superelastic alloy, e.g., a nickel-titanium alloy (“Nitinol”). The components of the clip, e.g., a generally-annular body, optionally including looped elements, and/or tines, may be formed by removing portions from the sheet. The portions may be removed, e.g., by laser cutting, chemical etching, photo chemical etching, stamping, electrical discharge machining, and the like. The clip may be polished using one or more processes, such as electro-polishing, chemical etching, tumbling, sandblasting, sanding, and the like, and/or heat-treated to provide a desired finish and/or desired mechanical properties. Optionally, the body and tines may be coated with a therapeutic agent, e.g., a peptide coating and/or one or more clotting factors.

In addition or alternatively, the clip may be disposed in a planar configuration, e.g., upon forming the clip from the sheet, and heat treated to form a clip biased to the planar configuration. For example, the clip may be formed from a shape memory material, e.g., Nitinol, which may substantially recover the planar configuration when heated to a first predetermined temperature corresponding to an austenitic state, e.g., a temperature close to body temperature. The clip may be cooled to a second predetermined temperature corresponding to a martensitic state, e.g., a temperature at or below ambient temperature, and malleably manipulated. For example, the clip formed from the sheet may be deformed to a transverse configuration, such as that described above, e.g., by loading the clip onto a mandrel or directly onto a delivery device. If the clip includes looped elements formed from the body, the looped elements may be biased upon heat treatment towards an expanded state, but may be malleably deformed to a compressed state upon cooling, e.g., to facilitate loading onto the delivery device. Alternatively, the clip may be formed from a superelastic material, e.g., Nitinol, such that the clip may be resiliently deformed to the transverse configuration and/or compressed state, yet may automatically attempt to resume its planar configuration and/or expanded state upon release from external forces.

In still another aspect of the present invention, a method for closing an opening in a wall of a body lumen is provided. The distal end of an elongate member may be advanced through an opening in a patient's skin, along a passage through tissue, and into the body lumen. A distal portion of an obturator may be positioned distally beyond the distal end of the elongate member along the passage within the body lumen. One or more expandable elements on the distal portion of the obturator may be expanded transversely. The obturator may be withdrawn from the passage until the expandable elements contact the wall of the body lumen, thereby providing a tactile indication of a location of the wall of the body lumen between the elongate member and the plurality of expandable elements of the obturator.

The tines of the clip may include primary tines and secondary tines. Here, advancing the clip may include puncturing the wall of the body lumen with the primary tines until tips of the primary tines enter the body lumen, and puncturing the wall of the body lumen with the secondary tines. The primary tines and the secondary tines may puncture the walls without contacting the expandable elements of the obturator.

The present invention is also directed to methods for manufacturing tissue engaging clips in a manner in which a clip-precursor is first formed and such precursor is then reconfigured into the final shape of the clip. In one embodiment of the invention, a clip having an annular or hoop-shaped generally planar configuration with radially inwardly extending tines is manufactured by first forming a precursor with the tines extending radially outward and then reconfigured by inserting the precursor to its final shape with the tines extending radially inward and then heat setting the clip in this configuration. This permits the tines to be packed more closely together which enhances the sealing function of the clip and reduces the size of the clip's footprint. As will be explained in more detail herein, this manufacturing method overcomes the limitations of conventional methods in which the clip is manufactured in its final configuration.

In another embodiment, an annular or hoop-shaped planar clip precursor with radially inwardly extending tines is first manufactured in an oversize configuration and then has its lateral dimensions reduced to pack the tines closer together and to reduce the footprint of the clip and then heat set in that configuration.

The present invention is directed to vascular closure devices or clips having a design particularly suitable for closing a puncture in a wall of a blood vessel formed during a diagnostic or therapeutic procedure. According to the present invention, a device for engaging tissue includes a generally annular-shaped body defining a plane and disposed about a central axis extending substantially normal to the plane. The body may be movable from a substantially planar configuration lying generally in the plane towards a transverse configuration extending out of the plane. The body also includes a plurality of looped elements including alternating first and second curved regions that define an inner and outer periphery of the body, respectively, in the planar configuration. A plurality of tines or other tissue-engaging elements extend from the first curved regions, and are oriented towards the central axis in the planar configuration, and substantially parallel to the central axis in the transverse configuration. The device may be biased towards the planar configuration, e.g., to bias the tines towards the central axis.

The tines of the device may include first and second primary tines, having a first length and a second length, respectively, which may be the same as or different than one another. The first and second primary tines may be disposed on opposing first curved regions, and may be oriented substantially towards each other in the planar configuration. In the planar configuration, the first and second primary tines may at least partially overlap the body or each other. The tines may also include one or more secondary tines having a length substantially shorter than the first and second lengths of the primary tines. The secondary tines may be disposed on either side of the first and second primary tines.

A first primary tine, having a first length, may extend from the body towards the central axis in the planar configuration, and may be deflectable out of the plane when the body is moved towards the transverse configuration. A second primary tine, having a second length, may extend from the body towards the first tine when the body is in the planar configuration, and may be deflectable out of the plane when the body is moved towards the transverse configuration. The lengths of the first and second primary tines may cause the primary tines to at least partially overlap in the planar configuration. The body may be biased towards the planar configuration to bias the tines generally towards the central axis.

In any event, the primary tines of the clips of the present invention will be offset from the axis of symmetry of the loop from which they extend. The offsetting of the primary tines is achieved by simply relocating the primary tines which are directly attached to the loop to a location which is not on the axis of symmetry of the loop or providing an intermediate connecting element between the tines and the axis of symmetry of the curved region of the loop from which the tine extends. This connecting element is straight or linear, but may also be curved. The connecting element can be connected to a point or region on the axis of symmetry of the loop to enhance consistency of performance of the clip during deployment. The offsetting of the tines is believed to reduce any tendency to wander during deployment, which the tines might otherwise have.

In another aspect of the present invention, a method is provided for manufacturing a clip from an elastic material, such as a sheet of superelastic alloy, e.g., a nickel-titanium alloy (“Nitinol”). The components of the clip, e.g., a generally-annular body, optionally including looped elements, and/or tines, may be formed by removing portions from the sheet. The portions may be removed, e.g., by laser cutting, chemical etching, photo chemical etching, stamping, electrical discharge machining, and the like, or by the method disclosed in one or more of the incorporated by reference patents or patent applications. The clip may be polished using one or more processes, such as electro-polishing, chemical etching, tumbling, sandblasting, sanding, and the like, and/or heat-treated to provide a desired finish and/or desired mechanical properties. Optionally, the body and tines may be coated with a therapeutic agent, e.g., a peptide coating and/or one or more clotting factors.

For example, the clip formed from the sheet may be deformed to a transverse configuration, such as that described above, e.g., by loading the clip onto a mandrel or directly onto a delivery device. If the clip includes looped elements formed from the body, the looped elements may be biased upon heat treatment towards an expanded state, but may be malleably deformed to a compressed state upon cooling, e.g., to facilitate loading onto the delivery device. Alternatively, the clip may be formed from a superelastic material, e.g., Nitinol, such that the clip may be resiliently deformed to the transverse configuration and/or compressed state, yet may automatically attempt to resume its planar configuration and/or expanded state upon release from external forces.

A clip may be advanced into the passage over the elongate member until tines of the clip penetrate the wall of the body lumen, the tines and the expandable elements on the obturator being angularly offset from one another such that the tines penetrate the wall at locations between the expandable elements. The obturator may be collapsed, and the elongate member and/or obturator may be withdrawn from the body lumen and passage, leaving the clip to substantially close the opening in the wall of the body lumen. When the elongate member is withdrawn, the tines may automatically at least partially move towards a planar configuration to substantially close the opening. The clip may also be delivered to the desired site by using the apparatus and methods disclosed in U.S. patent application Ser. No. 10/356,214, filed Jan. 30, 2003 and Ser. No. 10/638,115, filed Aug. 8, 2003. The clip may also be manufactured according to the method set forth in U.S. patent application Ser. No. 10/335,075, filed Dec. 31, 2002.

Advancing the clip may include puncturing the wall of the body lumen with the primary tines until tips of the primary tines enter the body lumen, and puncturing the wall of the body lumen with the secondary tines. The primary tines and the secondary tines may puncture the walls without contacting the expandable elements of the obturator.

The present invention also relates to a method for closing an opening in a wall of a body lumen. The method can include advancing a distal end of an elongate member within the body lumen, the elongate member having a distal portion that assists in presenting the wall for receiving a clip having a plurality of tissue engaging portions having tips that point generally toward a central axis of the clip. Further, the method can include advancing the clip relative to the elongate member and the wall of the body lumen until the plurality of tissue engaging portions penetrate the wall of the body lumen. Optionally, the clip can be advanced until a distal end of the plurality of tissue engagement portions penetrate the wall but do not enter the body lumen. Stated another way, the method can include stopping advancement of the clip before the distal end of the plurality of tissue engagement portions enter the body lumen. Once the clip penetrates the wall, the elongate member can be withdrawn from the body lumen, leaving the clip to substantially close the opening in the wall of the body lumen.

According to another aspect, the method can include advancing a second elongate member relative to the elongate member, the clip slidably cooperating with the second elongate member. Withdrawing the second elongate member relative to the elongate member following penetration of the plurality of tissue engaging portions into the wall of the body lumen can enable the plurality of tissue engaging portions to automatically at least partially move towards a planar configuration to substantially close the opening.

The method can also related to closing a opening in a wall of a body lumen by (i) advancing a distal end of a first elongate member within the body lumen, the elongate member having a distal portion that assists in presenting the wall for receiving a clip having a plurality of tissue engaging portions symmetrically disposed about the clip, (ii) advancing the clip relative to the elongate member and the wall of the body lumen, as the distal portion of the elongate member assists with presenting the wall for receiving the clip, until the plurality of tissue engaging portions penetrate the wall of the body lumen, the tissue engaging portions and the distal portion of the elongate member being angularly offset from one another; and (iii) withdrawing the elongate member from the body lumen, leaving the clip to substantially close the opening in the wall of the body lumen.

To aid with positioning the clip relative to the wall, the method can further include positioning the distal portion of the first elongate member relative to the wall to assist in presenting the wall for receiving the clip to close the opening. In addition, the method can include moving the clip within a carrier assembly that moves relative to a second elongate member, toward the distal portion of the first elongate member until the clip deploys from within the carrier assembly.

Still another method of closing an opening in a wall of a body lumen can include advancing a distal end of a first elongate member within the body lumen, the elongate member having a distal portion that assists in presenting the wall for receiving a clip having a plurality of tissue engaging portions symmetrically disposed about the clip. The method can further include positioning a distal end of a second elongate member relative to the first elongate member, the second elongate member having a carrier assembly that receives the clip, and advancing the clip relative to the wall of the body lumen, as the distal portion of the first elongate member assists with presenting the wall for receiving the clip, until the plurality of tissue engaging portions penetrate the wall of the body lumen. Once the clip penetrates the wall, the method can include withdrawing the first elongate member and the second elongate member from the body lumen, leaving the clip to substantially close the opening in the wall of the body lumen.

These and other objects and features of the present invention will become more fully apparent from the following description and appended claims, or may be learned by the practice of the invention as set forth hereinafter.

BRIEF DESCRIPTION OF THE DRAWINGS

To further clarify the above and other advantages and features of the present invention, a more particular description of the invention will be rendered by reference to specific embodiments thereof which are illustrated in the appended drawings. It is appreciated that these drawings depict only typical embodiments of the invention and are therefore not to be considered limiting of its scope. The invention will be described and explained with additional specificity and detail through the use of the accompanying drawings in which:

FIG. 1A illustrates a top view of a first embodiment of a clip including a plurality of tissue engaging portions in a planar orientation, in accordance with the present invention.

FIGS. 1B and 1C illustrate side views of the clip of FIG. 1A, with the tissue engaging portions oriented substantially transversely from the planar orientation, in reduced and expanded diameters, respectively.

FIG. 1D illustrates a top view of the clip of FIG. 1A with the tines oriented substantially transversely from the planar orientation.

FIG. 2 illustrates a top view of another embodiment of a clip, in accordance with the present invention.

FIG. 3 illustrates a top view of another embodiment of a clip, in accordance with the present invention.

FIG. 4 illustrates a top view of another embodiment of a clip, in accordance with the present invention.

FIG. 5 illustrates a top view of another embodiment of a clip, in accordance with the present invention.

FIG. 6 illustrates a top view of the clip of FIG. 5 with the clip unwound from its annular shape.

FIGS. 7A and 7B illustrate top views of an alternative embodiment of the clip of FIG. 5, the clip shown unwound and including expandable elements shown in their expanded and compressed states, respectively.

FIGS. 8A and 8B illustrate top views of another alternative embodiment of the clip of FIG. 5, the clip shown unwound and including expandable cells shown in their expanded and compressed states, respectively.

FIG. 9 illustrates a side view of an apparatus for delivering a clip, including an introducer sheath and an actuator assembly, in accordance with the present invention.

FIGS. 10A-10D illustrates cross-sectional views of a blood vessel, showing a method for delivering a closure device into a passage communicating with the vessel such that the closure device engages the vessel wall.

FIGS. 11A-11D illustrate cross-sectional views of a blood vessel, showing another method for delivering a closure device into a passage communicating with the vessel such that the closure device engages extra-vascular tissue proximal to the vessel wall.

FIG. 12 illustrates a top view of an alternative embodiment of a clip, in accordance with the present invention.

FIGS. 13-15 illustrate top views of additional embodiments of a clip, in accordance with the present invention.

FIG. 16A illustrates a top view of another embodiment of a clip including a plurality of tines in a planar orientation, in accordance with the present invention.

FIGS. 16B and 16C illustrate side views of the clip of FIG. 16A, with the tines oriented substantially transversely from the planar orientation, in compressed and expanded states, respectively.

FIG. 17A illustrates a top view of yet another embodiment of a clip including a plurality of tines in a planar orientation, in accordance with the present invention.

FIGS. 17B and 17C illustrate side views of the clip of FIG. 17A, with the tines oriented substantially transversely from the planar orientation, in compressed and expanded states, respectively.

FIG. 18 illustrates a top view of another embodiment of a clip, in accordance with the present invention.

FIG. 19 illustrates a top view of an embodiment of a clip having radiopaque markers thereon.

FIG. 20 illustrates a top view of an embodiment of a clip having pockets for holding radiopaque markers therein.

FIG. 21 illustrates a top view of another embodiment of a clip including stop elements, in accordance with the present invention.

FIG. 22 illustrates a top view of yet another embodiment of a clip including stop elements, in accordance with the present invention.

FIG. 23 illustrates a top view of still another embodiment of a clip including stop elements, in accordance with the present invention.

FIG. 24 illustrates a side view of an apparatus, including an introducer sheath and an obturator, suitable for delivering a clip of the present invention.

FIGS. 25A-25D illustrate cross-sectional views of a blood vessel, showing a method for delivering a clip into a passage communicating with the vessel using the apparatus of FIG. 24.

FIG. 26A illustrates a top view of the blood vessel of FIGS. 25A-25D, showing the orientation of the expandable elements of the obturator and openings produced by primary tines of the clip relative to an arteriotomy in the vessel.

FIG. 26B illustrates Figure a top view of the blood vessel of FIG. 26A, showing the arteriotomy being closed by the clip.

FIG. 27 illustrates a top view of an embodiment of a clip having arcuate tines, in accordance with the present invention.

FIGS. 28A and 28B illustrate the before and after configuration of a clip manufactured according to one embodiment of this invention.

FIGS. 29A and 29B illustrate the before and after-configuration of a clip manufactured according to another embodiment of the invention.

FIGS. 30A-30C illustrate alternate before and after-configurations of clips manufactured according to the method of this invention.

FIG. 31 illustrates a clip which, while generally planar, has tines which extend radially inwardly at an angle to the plane defined by the body.

FIGS. 32 and 33 illustrate clip precursors in which radially opposed primary tines have different lengths.

FIG. 34 illustrates one relationship between the grain orientation of a Nitinol sheet and the primary tines of a clip precursor.

FIG. 35A illustrates a top view of a clip including a plurality of tines in a planar orientation, in which the primary tines are offset from the axis of symmetry of the loop from which they extend and are connected to a curved region of the loop by a straight connecting element in accordance with the present invention.

FIGS. 35B and 35C illustrate side views of the clip of FIG. 35A, with the tines oriented substantially transversely from the planar orientation, in compressed and expanded states, respectively.

FIG. 36 illustrates a clip according to the present invention in which the primary tines overlap with the body of the clip.

FIGS. 37A-37C illustrates top views of clips in which the primary tines are offset from the axis of symmetry of the loop from which they extend by a connecting element which is at least partially curved.

FIG. 38 illustrates a clip in which the primary tines have different lengths.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

Turning now to the drawings, FIGS. 1A-1D show a first embodiment of a closure device or clip 10 for closing an incision, puncture, or other passage communicating with a blood vessel or other body lumen (not shown). The clip 10 includes a peripheral body 12 and a plurality of tissue engaging portions 14. Each tissue engaging portion 14 includes a pair of legs 16 terminating in a tine 18 configured for penetrating or otherwise engaging tissue. The tines 18 may include a variety of known pointed tips, such as a bayonet tip, and/or may include barbs (not shown) along an edge or planar surface of the tine 18. The tissue engaging portions 14 are disposed substantially symmetrically about a central axis 24. The body 12 also can include a plurality of expandable cells 20 that are connected by hinged regions 22 that also connect adjacent tissue engaging portions 14.

In another embodiment, the body 12 and tissue engaging portions 14 are integrally formed from a single sheet of material, such as a superelastic alloy, such as a nickel-titanium (“Nitinol”) alloy. Portions of the sheet may be removed using conventional methods, such as laser cutting, chemical etching, and the like, to form the clip 10. FIG. 1A shows the clip 10 with the tissue engaging portions 14 in a substantially planar configuration lying in a plane defined by the sheet. The clip 10 may include one or more radiopaque markers or other markers visible using external imaging, such as fluoroscopy. For example, the entire clip 10 may be coated with radiopaque material, or one or more discrete markers may be provided at predetermined locations on the clip 10.

As shown in FIGS. 1B and 1D, the tissue engaging portions 14 may be deflected such that they extend from the body 12 substantially transversely with respect the plane defined by the sheet. The tissue engaging portions 14 can be oriented substantially parallel to the axis 24 to define a transverse configuration, as shown in FIG. 1B. Alternatively, the tissue engaging portions 14 may define an angle with respect to the axis 24, as shown in FIG. 1D. In the clip's transverse configuration, the body 12 has a generally annular shape, e.g., a hexagonal shape as shown in FIG. 1D. The body 12 is sufficiently flexible such that the clip 10 assumes a generally circular or elliptical shape (not shown), e.g., conforming to an exterior surface of a delivery device (not shown) used to delivery the clip 10.

The tissue engaging portions 14 can be biased from the transverse configuration towards one another, i.e., towards the planar configuration of FIG. 1A. Thus, with the tissue engaging portions 14 in the transverse configuration, the tines 18 may be engaged with tissue, e.g. adjacent to a puncture site. When the clip 10 is released, the tissue engage portions 14 may attempt to return to the planar configuration, thereby drawing the engaged tissue together and substantially closing and/or sealing the puncture site.

In addition, the expandable cells 20 may be expandable from a compressed state, shown in FIG. 1B, to an expanded state, shown in FIG. 1C. The expandable cells 20 can be biased to the expanded state, but may be compressed to the compressed state, e.g., by constraining the clip 10. In one embodiment, the clip 10 is formed with the expandable cells 20 in the expanded state. With the clip in its transverse configuration, the expandable cells 20 may be circumferentially and/or radially compressed to the compressed state such that the clip 10 defines a first diameter 26a, shown in FIG. 1B. The clip 10 may be constrained at the first diameter, e.g., by loading the clip 10 into a delivery device (not shown), as described further below. When released from the constraint, e.g., when deployed from the delivery device, the clip 10 may automatically expand to a second diameter 26b, shown in FIG. 1C. Thus, the expandable cells 20 may reduce the profile of the clip 10 during delivery, e.g., to facilitate introduction of the clip 10 through a smaller puncture or other passage.

In an alternative embodiment, the clip 10 may be formed from a shape memory alloy, e.g., Nitinol, with the expandable cells in the compressed state. With the clip 10 in the transverse configuration, the clip 10 may be expanded, e.g., by applying a force radially outwards against an inner surface of the clip 10, thereby expanding the expandable cells 20 to the expanded state and expanding the clip 10 to the second diameter 26b. The expandable cells 20 may then be heat treated to cause the expandable cells 20 to “remember” the expanded state, as is known to those skilled in the art. It may also be necessary to subsequently heat treat the clip 10 further, e.g. with the tissue engaging portions 14 in the planar configuration to cause the tissue engaging portions 14 to “remember” and be biased to the planar configuration, as is known to those skilled in the art.

Turning to FIG. 2, another embodiment of a clip 110 is shown that includes a peripheral body 112 and a plurality of tissue engaging portions 114. Each tissue engaging portion 114 includes a pair of legs 116 terminating in a tine 118. The tissue engaging portions 114 are disposed substantially symmetrically about a central axis 124. The body 112 also can include a plurality of expandable cells 120 that are connected by hinged regions 122 that also connect adjacent tissue engaging portions 114, similar to the first embodiment described above.

The tissue engaging portions 114 may be deflected such that they extend substantially transversely from the body 112 (not shown). The tissue engaging portions 114 may be oriented substantially parallel to the axis 124 to define a transverse configuration such that the body 112 has a generally annular shape. The tissue engaging portions 114 can be biased from the transverse configuration towards one another, i.e., towards the planar configuration of FIG. 2, similar to the previous embodiment.

The expandable cells 120 have a generally arcuate shape that may be expandable from a first width to a second wider width (not shown), behaving similarly to the diamond-shaped cells of the previous embodiment. Thus, the expandable cells 120 may be biased to the expanded state, but may be compressed to the compressed state, as described above.

Turning to FIG. 3, another embodiment of a clip 210 is shown that includes a peripheral body 212 including a plurality of arms 216 extending between tissue engaging portions or tines 214; expandable cells 220, and hinged regions 222. The clip 210 can be formed from a single sheet of material, similar to the embodiments described above, with the tines 214 biased to a planar configuration, as shown. The body 212 is deflectable to a transverse configuration (not shown) such that the tines 212 are oriented substantially transversely with respect to the plane of the sheet. The body 212, and particularly the arms 216, are sufficiently flexible such that the clip 210 may assume a generally annular shape in the transverse configuration, e.g., to facilitate loading of the clip 210 onto a delivery device (not shown).

The expandable cells 220 are substantially enclosed loops that may at least partially open from a compressed state (shown in FIG. 2), to an expanded state (not shown). The loops can be biased to the expanded state, similar to the embodiments described above, thereby allowing the clip 210 to assume a reduced diameter and an expanded diameter.

Turning to FIG. 4, another embodiment of a clip 310 is shown, that is similar to the embodiment shown in FIG. 3, except that the clip 310 includes only two expandable cells 320. The expandable cells 320 are still disposed in a substantially symmetrical arrangement to facilitate expansion of the clip 310 in a generally uniform manner. As will be appreciated by those skilled in the art, a clip in accordance with the present invention may have a variety of configurations, including two or more tissue engaging portions or tines, and including one or more expandable cells (or optionally no expandable cells). The tissue engaging portions and/or expandable cells can be arranged in a substantially symmetrical configuration, for example, about a central axis.

Turning to FIG. 5, another embodiment of a clip 410 is shown that includes a peripheral body 412 and a plurality of tissue engaging portions 414 terminating in tines 418. The clip 410 may be formed from a single sheet of material, such as Nitinol, similar to the embodiments described above.

Alternatively, as shown in FIG. 6, the clip 410 may be formed from an elongate wire 430, e.g., a solid rod or hollow tube, such as a length of hypotube. The tube 430 can be semi-rigid or flexible, thereby accommodating deflection of the clip 410 between its planar and transverse configurations, as described further below. The tube 430 may be bent and tines 418 may be formed therein using conventional methods. Alternatively, tines 418 may be formed separately and attached to the tube 430, for example, by welding. The tube 430 may then be wound into an enclosed loop and the ends 432, 434 may be connected together, e.g., by welding, to provide a clip 410, such as that shown in FIG. 5.

In this embodiment, the tissue engaging regions 414 are disposed in opposing sets along an axis of symmetry 424 extending between looped regions 426, defining a substantially planar configuration. The tissue engaging portions 414 may be directed substantially transversely with respect to a plane defined by the planar configuration, but can be biased to return towards the planar configuration, similar to the embodiments described above.

In an alternative embodiment, shown in FIGS. 7A and 7B, the regions 426′ between the tissue engaging portions 414 include expandable elements 420, having a zig-zag shape, that are expandable between a compressed state and an expanded state. Thus, when the tube 412′ is wound to form a clip (not shown), the zig-zag elements 420 are disposed at the looped regions 426′ of the clip. The zig-zag elements 420 have a first width w₂in the compressed state (FIG. 7B) and a second width w₂in the expanded state that is larger than the first width (FIG. 7A). In a further alternative embodiment, shown in FIGS. 8A and 8B, the expandable elements are substantially enclosed cells 420′, optionally having a diamond shape. Thus, similar to the embodiments described above, the expandable elements or cells allow the clip 410″ to assume first and second diameters.

Turning to FIG. 9, an apparatus 50 is shown that may be used to deliver a clip, such as any of the embodiments described above. Generally, the apparatus 50 includes an introducer sheath 52, and a housing 54 slidably disposed on the sheath 52. The sheath 52 includes a substantially flexible or semi-rigid tubular body 58 including a lumen 60 extending between its proximal and distal ends 62, 64. The distal end 64 has a size and shape to facilitate insertion into a blood vessel, e.g., having a tapered tip for facilitating substantially atraumatic introduction through the passage and at least partially into the vessel. The lumen 60 has a size for accommodating insertion of one or more devices therethrough, such as a catheter, guidewire, and the like (not shown). The sheath 52 also can include a seal (not shown), such as a hemostatic valve, within the lumen 60 at or near the proximal end 62 that provides a fluid-tight seal, yet accommodates insertion of one or more devices into the lumen 60 without fluid passing proximally from the sheath 52.

Optionally, the sheath 52 may include a side port 66 that communicates with the lumen 60, for example, to allow the infusion of fluids into the lumen 60, through the sheath 52. Alternatively, or in addition, the side port 66 may be used to provide a “bleed back” indicator, such as that disclosed in U.S. Pat. No. 6,626,918, entitled “Apparatus and Methods for Positioning a Vascular Sheath,” which is assigned to the assignee of the present invention, and the disclosures of which, and any references therein, are incorporated herein in their entirety by this reference. Alternatively, the apparatus 50 may include a mechanical locator (not shown), such as that disclosed in U.S. Pat. No. 6,780,197, filed on the same day with U.S. Pat. No. 6,719,777, entitled “Apparatus and Method for Delivering a Closure Device,” the disclosures of which, and any references therein, are incorporated herein in their entirety by this reference.

The housing 54 is slidably disposed on an exterior of the sheath 52, the housing 54 configured for releasably holding the clip 10, e.g., within an annular cavity therein (not shown). The housing may be substantially permanently attached to the sheath 52 or, alternatively, the housing 54 may be attachable to the sheath 52, e.g., using an outer sleeve (not shown). This outer sleeve may have the housing thereon, and the sleeve may be advanced over the sheath 52, and coupled thereto at any time during its use. Exemplary embodiments of a housing for use with an apparatus in accordance with the present invention are disclosed in U.S. Pat. Nos. 6,197,042, 6,461,364, and 6,391,048, the disclosures of which, and any references therein, are incorporated herein in their entirety by this reference.

The housing 54 is actuable from the proximal end 62 of the sheath 52, for example, by a housing actuator assembly (not shown), for advancing the clip 10 distally during deployment. A rod, cable, or other control wire (not shown) may couple the housing 54 to the actuator assembly. The housing actuator assembly may be detachable from the sheath 52, e.g., to facilitate introduction of devices into the lumen 60. In one embodiment, the actuator may be biased to advance the housing 54 upon activation. Thus, when activated, the housing 54 may be advanced towards the distal end of the sheath 52 to deploy the clip 10.

Turning to FIGS. 10A-10D, the apparatus 50 may be used to deliver a clip 10, e.g., to close and/or seal an incision, puncture, or other passage 92 that extends from a patient's skin 94 through intervening tissue 96, and a wall 98 of the vessel 90. Alternatively, the apparatus 50 may be used to deliver any of the clips disclosed herein to engage tissue in other procedures, e.g., to connect tissue segments together or otherwise to secure tissue structures engaged by the clip with respect to one another. For example, the apparatus and clip may be used to attach an anastomosis during a bypass procedure. It will be appreciated by those skilled in the art that a clip and/or apparatus in accordance with the present application may be useful in a variety of procedures, including tubal ligations, and the like.

Generally, the clip 10 is pre-loaded in the housing 54 before the procedure. The clip 10 may be constrained in its substantially transverse configuration and then introduced over the distal end 64 of the sheath 52 and into the cavity or otherwise loaded in the housing 54. Because the tissue engaging portions (not shown) of the clip 10 are biased to a planar configuration, they may engage an inner wall (not shown) of the housing 54 or an outer surface of the sheath 52, thereby constraining the clip 10 in its transverse configuration. Alternatively, the clip 10 may be directed over the distal end 64 of the sheath 62, thereby causing the tissue engaging portions to deflect transversely from the planar configuration towards a substantially axial or distal configuration.

As shown in FIG. 10A, the sheath 52 may be inserted or otherwise positioned within the blood vessel 90, i.e., through the passage 92. The sheath 52 can be provided with the housing 54 in its proximal position, e.g., without the housing actuator assembly (not shown) attached. Alternatively, the housing actuator assembly may be provided attached to the sheath 52 as long as the lumen 60 may be accessed. In a further alternative, the housing 54 may be provided separately from the sheath 62 with the clip 10 preloaded therein. For example, the housing 54 may be provided on an elongate member, such as a tubular or U-shaped sleeve (not shown), that may be advanced over and coupled to the sheath 52 at any time before deployment of the clip 10. The housing actuator may be coupled to the sleeve and/or may be attachable to the sleeve.

The sheath 52 may be advanced over a guidewire or other rail (not shown) previously positioned through the passage 92 into the blood vessel 90 using a conventional procedure. The blood vessel 90 can be a peripheral vessel, such as a femoral, radial, or carotid artery, although other body lumens may be accessed using the sheath 52, as will be appreciated by those skilled in the art.

The passage 92, and consequently the sheath 52, may be oriented at a substantially acute angle “alpha” with respect to the vessel 90, thereby facilitating introduction of devices through the lumen 60 of the sheath 52 into the vessel 90 with minimal risk of damage to the vessel 90. One or more devices, such as a guide wire, a catheter, and the like (not shown), may be inserted through the sheath 52 and advanced to a desired location within the patient's body. For example, the devices may be used to perform a therapeutic or diagnostic procedure, such as angioplasty, atherectomy, stent implantation, and the like, within the patient's vasculature.

After the procedure is complete, the device(s) may be removed from the sheath 52. The sheath 52 may be manipulated to position the distal end 64 with respect to the opening 92, e.g., to ensure that the housing 54 is advanced to properly deploy the clip 10 in the wall 98 of the vessel 90. Bleed back or mechanical locators may be used to facilitate this positioning.

As shown in FIG. 10B, with the sheath 52 properly positioned, the housing 54 may be actuated, for example, to advance the housing 54 distally into the passage 92 to deliver the clip 10. Movement of the housing 54 with respect to the distal end 64 of the sheath 52 can be limited, e.g., by the actuator assembly. Thus, the housing 54 may only be advanced a fixed distance such that the clip 10 substantially engages the wall 98 of the blood vessel 90, e.g., until the tines 18 penetrate but do not pass completely through the wall 98. Once the clip 10 is successfully deployed within the passage 92, i.e., into the wall 98 of the vessel 90, the apparatus 50 may be withdrawn from the passage 92.

In addition, as the clip 10 is deployed from the housing 54, the clip 10 may expand radially to an enlarged diameter (not shown), for example, if the clip 10 includes expandable elements (not shown), such as those described above. Thus, the clip 10 may be compressed into the housing 54, e.g., thereby allowing a smaller profile housing 54 to be used. The clip 10 may be expanded upon deployment to engage a larger area of tissue adjacent the opening in the wall 98 of the vessel 90.

As shown in FIG. 10C, as the distal end 64 of the sheath 52 is withdrawn proximally from around the clip 10, the tines 18 of the clip 10 are free to return towards the planar configuration. Thus, the tines 18 begin automatically to move from a substantially axial configuration to a less transverse configuration. Because the tines 18 are engaged to the tissue, however, they may not return completely to the planar configuration. Because of the bias to the planar configuration, however, the tines 18 automatically pull the tissue together, thereby closing and/or sealing the passage 92, as shown in FIG. 10D. In addition, if desired a sealant or other material may be introduced into the passage 92 in conjunction with or separate from delivery of the clip 10 to further seal the passage 92, as is known to those skilled in the art.

Turning to FIGS. 11A-11C, another method is shown in which the apparatus 50 may be used to deliver a clip 10, e.g., to engage intervening tissue 96 to close and/or seal an incision, puncture, or other passage 92 that extends from a patient's skin 94 through the intervening tissue 96, to a wall 98 of the vessel 90. As shown in FIG. 11A, the sheath 52 may be inserted or otherwise positioned within the blood vessel 90, i.e., through the passage 92. One or more devices (not shown) may be inserted through the sheath 52 to perform a procedure within the patient's body. After the procedure is complete, the device(s) may be removed from the sheath 52, and the sheath 52 may be manipulated to position the distal end 64 within the passage 92.

Turning to FIG. 11B, with the sheath 52 properly positioned, the housing 54 may be actuated, for example, to advance the housing 54 distally into the passage 92 to deliver the clip 10 to a location between the patient's skin 94 and the vessel wall 98. The clip 10 may be deployed from the housing 54, thereby substantially engaging fascia or other intervening tissue 96 with the tines 18. Once the clip 10 is successfully deployed within the passage 92, the apparatus 50 may be withdrawn from the passage 92.

As shown in FIG. 11C, as the distal end 64 of the sheath 52 is withdrawn proximally from around the clip 10, the tines 18 of the clip 10 are free to return towards the planar configuration. Because of the bias to the planar configuration, the tines 18 automatically pull the tissue together, thereby closing and/or sealing the passage 92, as shown in FIG. 10D.

In a further alternative, shown in FIG. 12, a clip 450 may be provided that includes a first set of tines 418 having a first length l₁, and a second set of tines 419 having a second length l₂substantially shorter than the first length l₁. During use, similar to one of the methods described above, the clip 450 may be deployed such that the first set of tines 418 penetrate into and/or engage the wall of a blood vessel or other body lumen (not shown), while the second set of tines 418 engage extra-vascular tissue, i.e., tissue between the vessel wall and the patient's skin. Thus, the clip 450 may simultaneously close both the opening in the vessel wall and the passage through the intervening tissue.

Turning to FIG. 13, another embodiment of a clip 510 is shown for engaging tissue, in accordance with the present invention. The clip 510 includes a peripheral body 512 and a plurality of tissue engaging portions 514. Each tissue engaging portion 514 includes a pair of legs 516 terminating in a tine 518 configured for penetrating or otherwise engaging tissue. The tissue engaging portions 514 are disposed substantially symmetrically about a central axis 524. The body 512 also can include a plurality of expandable cells 520 that are connected by hinged regions 522 that also connect adjacent tissue engaging portions 514, the cells 520 behaving similar to the embodiments described above.

In another embodiment, the body 512 and tissue engaging portions 514 are integrally formed from a single sheet of material, such as a Nitinol, similar to the embodiments described above. The clip 510 is shown in a relaxed state with the tissue engaging portions 514 disposed radially outward in a substantially planar configuration. Similar to the previous embodiments, the tissue engaging portions 514 may be deflected such that they extend from the body 512 substantially transversely with respect the plane defined by the sheet (similar to FIG. 1B).

The tissue engaging portions 514 can be biased from the transverse configuration away from one another, i.e., towards the planar configuration. Thus, with the tissue engaging portions 514 in the transverse configuration, the tines 518 may be engaged with tissue. When the clip 510 is released, e.g., from within a delivery device, the tissue engage portions 514 may attempt to return to the planar configuration, thereby securing the tissue with respect to the clip 510.

In addition, the clip 510 may include expandable cells 520 that are expandable from a compressed state to an expanded state (similar to FIG. 1C), similar to the previous embodiments. The expandable cells 520 can be biased to the expanded state, but may be compressed to the compressed state, e.g., by constraining the clip 510. Alternatively, any of the clips described herein may be biased to the compressed state but may be expanded to the expanded state, e.g., by constraining the clip over a sheath or other elongate member.

Turning to FIG. 14, yet another embodiment of a clip 610 is shown that includes a peripheral body 612 and a plurality of tissue engaging portions 614 terminating in tines 618. The clip 610 may be formed from a single sheet of material, such as Nitinol or may be formed from a wire, rod or tube (not shown), similar to the embodiments described above. The tissue engaging regions 614 are disposed in opposing sets oriented away from one another along an axis of symmetry 624, defining a substantially planar configuration.

The tissue engaging portions 614 may be directed substantially transversely with respect to a plane defined by the planar configuration, for example, by loading the clip 614 into a housing or lumen of a delivery device (not shown). The tissue engaging portions 614 can be biased to move away from one another, i.e., towards the planar configuration. In an alternative embodiment, the looped regions 626 or other regions of the body 612 may include expandable elements (not shown), e.g., having a zig-zag shape, a diamond shape, and the like.

Turning to FIG. 15, still another embodiment of a clip 710 is shown that includes a peripheral body 712 and a plurality of tissue engaging portions 714 terminating in tines 718. The clip 710 is similar to the previous embodiment, except that the tissue engaging regions 714 are disposed in opposing sets along an axis of symmetry 724, but are oriented in a common direction. The tissue engaging portions 714 may be directed substantially transversely with respect to a plane defined by the planar configuration. The tissue engaging portions 714 can be biased to return towards the planar configuration shown. In an alternative embodiment, the looped regions 726 or other regions of the body 712 may include expandable elements (not shown), e.g., having a zig-zag shape, a diamond shape, and the like, similar to the previous embodiments.

The clip 710 may be constrained on a delivery apparatus (not shown), similar to that described above, such that the tissue engaging portions 714 are all directed substantially transversely, and optionally distally, to facilitate their engagement into tissue during deployment, as will be appreciated by those skilled in the art. Unlike previous embodiments, which may close tissue around an opening, this embodiment may be useful when it is desired to maintain the relative position of tissue being engaged by the clip 710.

Turning now to the drawings, FIGS. 16A-16C show another embodiment of a closure device or clip 810 for closing an incision, puncture, or other passage through tissue, e.g., communicating with a blood vessel or other body lumen (not shown). The clip 810 includes a body 812, which may be generally annular in shape and surrounds a central axis 824, and a plurality of tines 818 extending from the body 812. As used herein, an “annular-shaped body” includes any hollow body, e.g., including one or more structures surrounding an opening, whether the body is substantially flat or has a significant thickness or depth. Thus, although an annular-shaped body may be circular, it may include other noncircular shapes as well, such as elliptical or other shapes that are asymmetrical about a central axis.

The body 812 may include a plurality of looped or curved elements 828 that are connected to one another to form the body 812. Each looped element 828 may include an inner or first curved region 832 and an outer or second curved region 34. In another embodiment, the first and second curved regions 832, 834 are out of phase with one another and are connected alternately to one another, thereby defining an endless sinusoidal pattern. Alternatively, other generally zigzag patterns may be provided that repeat periodically, e.g., saw tooth or square tooth patterns (not shown), instead of a sinusoidal pattern, thereby defining inner and outer regions that alternate about the body 812. When the clip 810 is in a substantially planar configuration, as shown in FIG. 16A, the first curved regions 832 may define an inner periphery 836 of the body 812 and the clip 810, and the second curved regions 834 may define an outer periphery 838.

The plurality of tines 818 may be biased to extend generally inwardly, e.g., towards one another and/or towards the central axis 824. The tines 818 may be disposed on the first curved regions 832, and oriented toward the central axis 824 when the clip 810 is in the planar configuration. In another embodiment, the tines 818 may be provided in pairs opposite from one another or provided otherwise symmetrically with respect to the central axis 824.

The tines 818 may include a variety of pointed tips, such as a bayonet tip, and/or may include barbs (not shown) for penetrating or otherwise engaging tissue. For example, to increase the penetration ability of the clip 810 and/or to lower the insertion force required to penetrate tissue, each tine 818 may include a tapered edge (not shown) extending towards the tip along one side of the tine 818. Alternatively, each tine 818 may be provided with a tapered edge on each side of the tine 818 extending towards the tip.

Additionally, as shown in FIGS. 16A-16C, the tines 818 may be disposed on alternating first curved regions 832. Thus, at least one period of a zigzag pattern may be disposed between adjacent tines 818, which may enhance flexibility of the clip 810, as explained further below.

As shown in FIGS. 16B and 16C (where opposite ends 833a, 833b are connected to one another), the body 812 and/or the tines 818 may be deflected such that the tines 818 extend transversely with respect to the plane defined in the planar configuration, thereby defining a transverse configuration for the clip 810. The tines 818 can be oriented substantially parallel to the central axis 824 in the transverse configuration, as shown in FIG. 16B. In the transverse configuration, the body 812 may have a generally annular shape defining a length, L₁, which extends generally parallel to the central axis 824, and corresponds generally to an amplitude of the zigzag pattern. The body 812 can be sufficiently flexible such that the clip 810 may assume a generally circular or elliptical shape (not shown), e.g., conforming to an exterior surface of a delivery device (not shown) used to deliver the clip 810.

In another embodiment, the tines 818 and/or body 812 are biased to move from the transverse configuration towards the planar configuration of FIG. 16A. Thus, with the tines 818 in the transverse configuration, the tines 818 may penetrate and/or be engaged with tissue at a puncture site. When the clip 810 is released, the tines 818 may attempt to return towards one another as the clip 810 moves towards the planar configuration, thereby drawing the engaged tissue together and substantially closing and/or sealing the puncture site, as explained further below.

The looped elements 828 may distribute stresses in the clip 810 as it is deformed between the planar and transverse configurations, thereby minimizing localized stresses that may otherwise plastically deform, break, or otherwise damage the clip 810 during delivery. In addition, when the clip 810 is in the transverse configuration, the looped elements 828 may be movable between a compressed state, such as that shown in FIG. 16B, and an expanded state, such as that shown in FIG. 16C. The looped elements 828 can be biased towards the expanded state, but may be compressed to the compressed state, e.g., by constraining the clip 810. Alternatively, only a portion of the looped elements 828 may be biased towards the expanded state, e.g., the first curved regions 832, and/or the looped elements 828 may be biased towards the compressed state. Furthermore, the looped elements 828 reduce the force required to be exerted on the clip 810 to transition the clip 810 from the planar configuration to the transverse configuration before loading onto a delivery device (not shown).

With the clip 810 in the transverse configuration, the looped elements 828 may be circumferentially and/or radially compressed to the compressed state until the clip 810 defines a first diameter or circumference 826a, such as that shown in FIG. 16B. The clip 810 may be constrained in the compressed state, e.g., by loading the clip 10 onto a carrier assembly of a delivery device (not shown), as described further below. When released from the constraint, e.g., when deployed from the carrier assembly, the clip 810 may automatically expand towards the expanded state, such as that shown in FIG. 16C, thereby defining a second diameter or circumference 826b. Thus, the looped elements 828 may facilitate reducing the profile of the clip 810 during delivery, e.g., to facilitate introducing the clip 10 through a smaller puncture or passage. Once the clip 810 is deployed entirely from the delivery device, the looped elements 828 may resiliently expand as the clip 810 returns towards the planar configuration, as explained further below.

To manufacture the clip 810 (or, similarly, any of the other clips described herein), the body 812 and the tines 818 may be integrally formed from a single sheet of material, e.g., a superelastic alloy, such as a nickel-titanium alloy (“Nitinol”). Portions of the sheet may be removed using conventional methods, such as laser cutting, chemical etching, photo chemical etching, stamping, using an electrical discharge machine (EDM), and the like, to form the clip. The tines 818 may be sharpened to a point, i.e., tips may be formed on the tines 818 using conventional methods, such as chemical etching, mechanical grinding, and the like.

The clip 810 may be polished to a desired finish using conventional methods, such as electro-polishing, chemical etching, tumbling, sandblasting, sanding, and the like. Polishing may perform various functions depending on the method used to form the clip 810. For a clip formed by laser cutting or using an EDM, polishing may remove heat affected zones (HAZ) and/or burrs from the clip. For a clip formed by photo chemical etching, polishing may create a smoother surface finish. For a clip formed by stamping, polishing may remove or reduce burrs from the bottom side of the clip, and/or may smooth the “roll” that may result on the topside of the clip from the stamping process.

In addition or alternatively, the clip 810 may be formed from a shape memory alloy, e.g., Nitinol, with the looped elements 828 formed initially in the compressed state and/or the clip 810 in the planar configuration. With the clip 810 deformed to the transverse configuration, the clip 810 may be expanded, e.g., by applying a force radially outwards against an inner surface of the clip 810, thereby expanding the looped elements 30 to the expanded state. The looped elements 828 may then be heat treated, e.g., by heating the clip 10 to an austenitic state, to cause the looped elements 828 to “remember” the expanded state, as is known to those skilled in the art. It may also be necessary to further heat treat the clip 810 further, e.g., with the tines in the planar configuration to cause the body 812 and/or tines 818 to “remember” and be biased towards the planar configuration, as is known to those skilled in the art. The clip 810 may then be cooled, e.g., to a martensitic state, which may be at or close to ambient temperature, and manipulated, e.g., malleably deformed to the transverse configuration, for example, by loading the clip 810 onto a delivery device (not shown), as described below. Thus, if the clip 810 is subsequently heated to a predetermined temperature, e.g., at or below body temperature, the material may remember the planar configuration and/or expanded state and become biased towards them.

FIGS. 17A-17C show another embodiment of a closure device or clip 910 that includes a generally annular-shaped body 912 defining a plane and disposed about a central axis 9124 extending through the plane. The body 912 can include a plurality of looped elements 928 that are connected to one another to form the body 912, similar to the previous embodiment. Each looped element 928 includes an inner or first curved region 932 and an outer or second curved region 934. Similar to the previous embodiment, the first and second curved regions 932, 934 may form an endless sinusoidal pattern or other generally zigzag pattern. When the clip 910 is in a substantially planar configuration, as shown in FIG. 17A, the first curved regions 932 may define an inner periphery 936, and the second curved regions 934 may define an outer periphery.

Unlike the previous embodiment, the clip 910 includes a plurality of primary tines 916 and a plurality of secondary tines 918. Each of the primary and secondary tines 916, 918 may include a variety of known pointed tips, similar to the previous embodiment.

Each of the primary tines 914 may have a length l₁, although alternatively each of the primary tines 914 may have a different length than one another. The primary tines 914 may be disposed in one or more opposing pairs, e.g., on opposing first curved regions 932, and may be oriented towards and/or across the central axis 924 in the planar configuration. In the planar configuration, the lengths l₁may be sufficiently long such that the primary tines 914 at least partially overlap one another, i.e., extend across the central axis 924 towards an opposing tine 914. Therefore, the tips of the primary tines 914 may extend past the central axis 924 and/or the primary tines 914 in each pair may lie substantially parallel to each other when the clip 910 is in the planar configuration.

Each of the secondary tines 916 may be disposed on a first or inner curved region 932, e.g., such that one or more secondary tines 916 may be provided between opposing pairs of primary tines 914. Each of the secondary tines 916 may have a length l.sub.2 that is substantially less than the length l₁of the primary tines 914.

A secondary tine 916 can be is disposed on either side of each primary tine 914. For example, the clip 910 shown in FIGS. 17A-17C has first and second primary tines 914, and each of the first and second primary tines 914 has a secondary tine 916 on either side of it. Thus, the clip 910 may have a total of two primary tines 914 and four secondary tines 916. Optionally, the secondary tines 916 may be disposed substantially symmetrically about the central axis 924. The tines 914, 916 may be provided on every other first curved regions 932. For example, a first curved region 932 having neither a primary tine 914 nor a secondary tine 916 may separate each adjacent tine, e.g., between two adjacent secondary tines 916, or between a secondary tine 916 and a primary tine 914.

As shown in FIGS. 17B and 17C, the body 912 and/or the tines 914, 916 may be deflected such that they extend transversely with respect to the plane defined in FIG. 17A. The primary tines 914 and secondary tines 916 can be oriented substantially parallel to the central axis 924 to define a transverse configuration, as shown in FIG. 16B. In the transverse configuration, the body 912 has a generally annular shape defining a length, LE₁, which extends generally parallel to the central axis 924, and corresponds generally to an amplitude of the sinusoidal pattern. The body 912 can be sufficiently flexible such that the clip 910 may assume a generally circular or elliptical shape (not shown), e.g., conforming to an exterior surface of a delivery device (not shown).

The tines 914, 916 may be biased towards one another and/or towards the central axis 924, i.e., due to the bias of the clip 910 towards the planar configuration of FIG. 17A, similar to the previous embodiment. With the clip 910 in the transverse configuration, the clip 910 may be delivered such that the primary tines 914 entirely penetrate the wall of a blood vessel or other body lumen, while the secondary tines 916 only partially penetrate the wall due to their relative lengths, as explained further below.

The looped elements 928 may be expandable between a compressed state, as shown in FIG. 17B, and an expanded state, as shown in FIG. 17C, similar to the previous embodiment. The looped elements 928 can be biased to the expanded state, but may be resiliently compressed to the compressed state, e.g., by constraining the clip 910.

Turning to FIG. 18, an alternative embodiment of a clip 1010 is shown that includes a body 912 including looped elements 930, and primary tines 914, similar to the previous embodiment, but has no supplemental or secondary tines 916. The reference numbers for elements of the clip 1010 are consistent with like elements used for the clip 910.

Any of the clips of the present invention may include one or more radiopaque markers or other markers visible using external imaging, such as fluoroscopy. For example, using the clip 910 of FIGS. 17A-17C as an example, the entire clip 910 may be coated with radiopaque material, which may be a high density material such as gold, platinum, platinum/iridium, and the like.

Alternatively, the clip 910 may be partially coated with radiopaque material by using masking techniques. For example, the entire clip 910 may first be coated with radiopaque material. The clip 910 may then be masked at locations where the radiopaque coating is desired. For example, the looped elements 928 of the clip 910 may be left unmasked during this process if it is desired to leave the looped elements 928 uncoated by radiopaque material. This may be desirable, e.g., to prevent radiopaque material from adversely affecting the flexibility of the looped elements 928. The clip 910 may then be treated to remove the radiopaque material from the unmasked areas, in this example, the looped elements 928. The masking may then be removed using conventional processes, leaving the rest of the clip 910 coated with radiopaque material.

Turning to FIG. 19, in another alternative, one or more discrete markers 902 may be provided at predetermined locations on the clip 910. For example, high density or radiopaque material 902 may be crimped or otherwise secured onto opposing double looped or circular regions 928. In another embodiment, shown in FIG. 20, a plurality of pockets 904 may be provided on the looped elements 928 into which high density plugs (not shown) may be bonded or otherwise secured. These various radiopaque markers may also be incorporated in any of the embodiments described herein.

Turning to FIG. 21, another embodiment of a clip 1110 is shown that, similar to clip 910, may include a plurality of looped elements 1128 that interconnect to form a body 1112. Each looped element 1128 may have a first or inner curved region 1132 and a second or outer curved region 1134. Primary tines 1114 may be disposed on opposing first curved regions 1132, which, optionally, may include a barb 1102 thereon to enhance engagement with tissue. Secondary tines 1116 may be provided on first curved regions 1132 on either side of each primary tine 1114. In addition, a first curved region 1132 without a tine 1114, 1116 may separate adjacent tines, as described above with regard to the previous embodiments.

The clip 1110 also includes stop members 1106 on one or more of the tines 1114, 1116, e.g., adjacent the respective first curved region 1132. Each stop member 1106 may be blunt-shaped, e.g., generally triangularly with an apex 1107 of the stop member 1106 extending from the first curved region 1132, and the tine 1114, 1116 extending from a wide or blunt base 1107 of the stop member 1106. During use, the blunt bases 1107 may limit penetration of the respective tines 1114, 1116 into tissue by reducing an effective length of the respective tine 1114, 1116. For example, when the tines 1114, 1116 are driven into tissue, the tines 1114, 1116 may penetrate the tissue until the blunt bases 1107 contact the tissue, whereupon the tines 1114, 1116 may be prevented from penetrating further into the tissue.

Turning to FIG. 22, another embodiment of a clip 1210(i) is shown that includes a body 1212, a plurality of tines 1214, and a plurality of spring elements 1240(i) that interconnect between adjacent tines 1214. The body 1212 includes outer curved regions 1234 that extend between adjacent tines 414, thereby defining an outer periphery for the clip 1210(i). The clip 1210(i) may be moveable between a substantially planar configuration such as that shown in FIG. 22, and a transverse configuration (not shown), and can be biased towards the planar configuration, similar to the previous embodiments.

In the embodiment shown, the spring elements 1240(i) generally are hollow diamond shaped elements, including curved inner regions 1232(i) oriented towards the central axis 1224 of the body 1212 when the clip 1210(i) is in the planar configuration. The spring elements 1240(i) may serve multiple purposes. First, the spring elements 1240(i) may bias the clip 1210(i), e.g., allowing the clip 410(i) to at least partially expand resiliently. For example, when the clip 1210(i) is deflected into the transverse configuration (not shown), the spring elements 1240(i) may allow the tines 1214 to be moved away from the central axis 1224 and/or one another. Thus, during deployment, the tines 1214 may be deflected radially outwardly or otherwise expanded to engage a larger area of tissue.

As the tines 414 are expanded, the spring elements 1214(i) may deform to become wider (along a dimension extending generally between the adjacent tines 1214) and shorter (along a dimension extending generally parallel to the tines 1214). Once a force causing the tines 1214 to expand is removed, the spring elements 1214(i) may resiliently try to return towards their original shape, thereby pulling the tines 1214 closer towards one another.

In addition, the curved inner regions 1232(i) of the spring elements 1214(i) may provide stops limiting penetration of the tines 1214 into tissue, similar to the stop members described above. For example, when the clip 1210(i) is in the transverse configuration and the spring elements 1214(i) are expanded, the curved inner regions 1232(i) may be become more oblique, possibly becoming generally linear. Thus, when the tines 1214 are driven into tissue, the curved inner regions 1232(i) may limit penetration of the tines 1214.

Finally, after the clip 1210(i) is deployed, e.g., the tines 1214 are penetrated into tissue, the curved inner regions 1232(i) may return towards their original shape, and may pinch or otherwise engage tissue between the inner curved regions 1232(i) and the adjacent tines 1214. Thus, contracting the spring elements 1240(i) may enhance the ability of the clip 1210(i) to seal a puncture site, e.g., by pulling engaged tissue inwardly towards the central axis 1224 of the clip 1210(i).

Turning to FIG. 23, an alternative embodiment of a clip 1210(ii) is shown that is substantially similar to the clip 1210(i) shown in FIG. 22, with the exception of the shape of the spring elements 1240(ii). Rather than diamond shaped elements, the spring elements 1240(ii) are looped elements generally defining a circular shape.

Turning now to FIG. 27, another embodiment of a clip 1510 of the present invention is illustrated. Similar to the previous embodiments, the clip 1510 includes a generally annular-shaped body 1512 that defines a plane. The body 1512 is disposed about a central axis 1524 that extends through the plane. The body 1512 can include a plurality of outer curved elements 1528 that extend between adjacent tines 1516 and are connected to each other to form the body 1512. When the clip 1510 is in a substantially planar configuration, as shown in FIG. 27, the curved elements 1528 define an outer periphery 1538 of the clip 1510.

The tines 1516 are curved or arcuately shaped and include distal tips 1515 that extend toward the central axis 1524 when the clip 1510 is in the substantially planar configuration. Optionally, one or more of the tines 1516 may include barbs 1517, similar to the previous embodiments. The curve of the tines 1516 can all be in phase with one another such that the tines 1516 spiral about the central axis 1524. This may allow a length of the tines 1516 to be maximized for a given diameter of the body 1512.

For example, the tines 1516 may have a length that is greater than a radius of the body 1512 without the distal tips 1515 of the tines 1516 touching one another. Thus, due to the arcuate shape of each tine 1516, the tines 1516 of clip 1510 may be generally longer than the straight tines of the previous clips having comparable diameters. The tines 1516 may, therefore, penetrate deeper into tissue than the tines of the other clips.

As with the previous embodiments, the body 1512 and/or the tines 1516 of clip 1510 may be deflected until the tines 1516 extend transversely with respect to the plane defined in the planar configuration, thereby defining a transverse configuration. In the transverse configuration, the tines 1516 may be oriented substantially parallel to the central axis 1524. Additionally, as with the previous embodiments, the tines 1516 and/or body 1512 may be biased to move from the transverse configuration towards the planar configuration. The clip 1510 may be delivered in substantially the same manner as will be described with respect to other clips of the present invention.

Any of the clips of the present invention may be coated with a substance that enhances hemostasis and/or healing of a blood vessel, e.g., by increasing a rate of regeneration of endothelium on the interior surface of the vessel, or by decreasing inflammatory response at the treatment site. In one embodiment, a suitable synthetic peptide coating may be applied to a clip to attract endothelial cells to the surface. An exemplary synthetic peptide coating may, for example, attach to the same cell binding sites as collagen. In another embodiment, a clip may be coated with a combination of clotting factors in order to promote hemostasis. For example, one side of the clip may be coated with Factor III and an endopeptidase, such as PTA, to accelerate the intrinsic clotting pathway. On the opposite side of the clip, a combination of a protein cofactor proaccelerin (Factor V) and an activated endopeptidase, such as serum prothrombin conversion accelerator (SPCA), cothromboplastin, and the like, may be applied to accelerate the extrinsic clotting pathway. The clips of the present invention may also be coated with any suitable hydrophilic polymer that swells in the presence of bodily fluids in order to reduce, minimize, or stop blood flow, thereby aiding the hemostasis process.

The clips of the present invention may be delivered using various apparatus and methods. An exemplary apparatus 1300 suitable for delivering a clip of the present invention is shown in FIG. 24. Other suitable apparatus that may be used to deliver a clip of the present invention are disclosed in U.S. Pat. No. 6,942,674, which is assigned to the assignee of the present application, the disclosures of which, and any references therein, are incorporated herein in their entirety by this reference.

Generally, the apparatus 1300 includes an introducer sheath 1352, and a housing or carrier assembly 1354 slidably disposed on the sheath 1352. The sheath 1352 includes a substantially flexible or semi-rigid tubular body 1358 including a lumen 1360 extending between its proximal and distal ends 1362, 1364. The distal end 1364 has a size and shape configured to facilitate insertion into a blood vessel, e.g., having a tapered tip for facilitating substantially atraumatic introduction through the passage and at least partially into the vessel. The lumen 1360 has a size for inserting one or more devices therethrough, such as a catheter, guidewire, and the like (not shown). The sheath 1352 also can include one or more seals (not shown), such as a hemostatic valve, within the lumen 1360 at or near the proximal end 1362 that provides a fluid-tight seal, yet accommodates inserting one or more devices into the lumen 1360 without fluid passing proximally from the sheath 1352.

Optionally, the sheath 1352 may include a side port 1366 that communicates with the lumen 1360, for example, to deliver fluids into the lumen 1360. Alternatively, or in addition, the side port 1366 may be used to provide a “bleed back” indicator. An exemplary “bleed back” indicator and related methods of use are disclosed in U.S. Pat. No. 6,626,918, which is assigned to the assignee of the present application, the disclosures of which, and any references therein, are incorporated herein in their entirety by this reference.

The apparatus 1300 may also include a mechanical locator or obturator 1400, such as that disclosed in U.S. application Ser. No. 10/081,723, now U.S. Pat. No. 6,942,674, the disclosures of which, and any references therein, are incorporated herein in their entirety by this reference, that may be part of an actuator assembly that is attachable to the proximal end of the sheath 1352. Alternatively, the mechanical locator or obturator 1400 may be a separate device that is insertable into the lumen 1360, e.g., through the actuator assembly. Generally, the obturator 1400 is an elongate member including a distal tip 1414 and a distal portion 1416. The distal tip 1414 may be substantially soft and/or flexible such that the distal tip 1414 may substantially atraumatically enter the vessel 1390 (not shown, see FIGS. 25A-25D). The distal portion 1416 generally includes one or more wings or other expandable elements 1418 for providing tactile feedback, as described further below.

The carrier assembly 1354 is slidably disposed on an exterior of the sheath 1352, and is configured for releasably carrying a clip 910 (shown in phantom), which may any of the clips described herein. The carrier assembly 1354 may be substantially permanently attached to the sheath 1352 and/or may be actuated from the proximal end 1362 of the sheath 1352, for example, by the actuator assembly (not shown), to advance the clip 910 distally during deployment. Alternatively, the clip 910 may be carried by an actuator assembly, as disclosed in co-pending U.S. application Ser. No. 10/081,725, now U.S. Pat. No. 6,749,621, filed on the same day as the present application and entitled “Sheath Apparatus and Methods for Delivering a Closure Device,” which is assigned to the assignee of the present application, the disclosures of which, and any references therein, are incorporated herein in their entirety by this reference.

Turning to FIGS. 25A-D, the apparatus 1300 may be used to deliver the clip 910 to close and/or seal an incision, puncture, or other passage 1392 that extends from a patient's skin 1394, through intervening tissue 1396, and into a wall 1398 of a vessel 1390 or other body lumen. Alternatively, the apparatus 1300 may be used to deliver the clip 910 to engage tissue in other procedures, e.g., to connect tissue segments together or otherwise to secure tissue structures with respect to one another. For example, the apparatus 1300 and clip 910 may be used to attach an anastomosis during a bypass procedure. It will be appreciated by those skilled in the art that the clip 910 and/or apparatus 1300 may be useful in a variety of procedures.

As shown in FIG. 25A, the sheath 1352 may be inserted or otherwise positioned within the vessel 1390, i.e., through the passage 1392. The sheath 1352 may be advanced over a guidewire or other rail (not shown) previously positioned through the passage 1392 into the vessel 1390 or advanced in conjunction with a pointed stylet directly through tissue using conventional procedures. The vessel 1390 can be a peripheral vessel, such as a femoral, radial, or carotid artery, although other body lumens may be accessed using the sheath 1352, as will be appreciated by those skilled in the art.

The passage 1392, and consequently the sheath 1352, may be oriented at an angle “alpha” with respect to the vessel 1390, thereby facilitating introducing devices through the lumen 1360 of the sheath 1352 into the vessel 1390 with minimal risk of damage to the vessel 1390. One or more devices, such as a guide wire, a catheter, and the like (not shown), may be inserted through the sheath 1352 and advanced to a desired location within the patient's body. For example, the devices may be used to perform a therapeutic or diagnostic procedure, such as angioplasty, atherectomy, stent implantation, and the like, within the patient's vasculature.

After the procedure is complete, any devices used during the procedure may be removed from the sheath 1352, and the obturator 1400 may be inserted into the lumen 1360. For example, the obturator 1400 may be part of an actuator assembly (not shown), and may be advanced through the lumen when the actuator assembly is attached to the proximal end of the sheath 1352. Alternatively, the actuator assembly and obturator 1400 may be coupled separately to the sheath 1352.

When the obturator 1400 is fully inserted within the sheath 1352, the distal portion 1416 of the obturator 1400 may extend beyond the distal end 1364 of the sheath 1352. In an alternative embodiment, the obturator 1400 may be attached to an exterior surface (not shown) of the sheath 1352, for example, along a track, e.g., including cooperating slots, grooves, and the like (not shown) in the sheath 1352 and obturator 1400.

Turning to FIG. 25B, the expandable elements 1418 on the distal portion of the obturator 1400 may then be directed to their expanded configuration, for example, by activating a switch on the proximal end (not shown) of the obturator 1400. With the sheath 1352 and obturator 1400 coupled to one another, the sheath 1352 and obturator 1400 may be moved in conjunction with one another.

As shown in FIG. 25C, the sheath 1352 may be partially withdrawn from the vessel 1390, until the expandable elements 1418 contact the wall 1398 of the vessel 1390. Thus, the expandable elements 1418 may provide a tactile indication of the position of the sheath 1352 with respect to the wall 1398 of the vessel 1390. In addition, the expandable elements 1418 may assist in “presenting” the wall 1398 of the vessel 1390, e.g., for receiving the clip 910.

Generally, the clip 910 is carried by the carrier assembly 1354 before the procedure. The clip 910 may be constrained in its transverse configuration on the carrier assembly 1354, and the carrier assembly 1354 may be provided on or adjacent the proximal end of the sheath 1352. Because the tines, which may include primary and secondary tines 914, 916 may be biased towards one another, the tines 914, 916 may slidably contact an inner surface (not shown) of the carrier assembly 1354 or an outer surface of the sheath 1352, thereby constraining the clip 910 in its transverse configuration.

Turning to FIG. 25D, with the sheath 1352 properly positioned, the carrier assembly 1354 may then be actuated, for example, to advance the carrier assembly 1354 distally over the sheath 1352 to deliver the clip 910. The carrier assembly 1354 may only be advanced a predetermined fixed distance relative to the distal end of the sheath 1352, and consequently, the expandable elements 1418 of the obturator 1400, such that the clip 910 substantially engages the wall 1398 of the blood vessel 1390. This predetermined distance may facilitate properly deploying the clip 910 with respect to the wall 1398 of the vessel 1390, e.g., to prevent advancing the clip 910 too far, i.e., into the vessel 1390.

As the clip 910 is deployed from the carrier assembly 1354, the clip 910 may be expanded to an enlarged diameter. For example, a distal end of the carrier assembly 1354 may include a ramped region (not shown) that may deflect the tines 914, 916, and/or the body of the clip 910 radially outwardly. As the clip 910 is advanced over the ramped region, the tines 914, 916 may be deflected radially outwardly as they are being driven into the surrounding tissue, thereby engaging a larger region of tissue than if the tines 914, 916 had been maintained substantially axially.

Alternatively, the clip 910 may include expandable looped elements and/or spring elements (not shown), such as those described above, that may facilitate expanding the clip 910 as it is deployed from the carrier assembly 1354 and/or the sheath 1352. For example, the looped elements of the clip 910 may be compressed when the clip 910 is loaded into the carrier assembly 1354, e.g., thereby allowing a relatively smaller profile carrier assembly 1354 to be used. The clip 910 may automatically expand upon deployment from the carrier assembly 1354 to engage a larger region of tissue surrounding the opening, such as an arteriotomy 1391 in the wall 1398 of the vessel 1390 (see FIG. 26A).

Once the clip 910 is deployed entirely or otherwise released from the sheath 1352, the clip 910 may resiliently move towards its substantially planar configuration, such as that shown in FIG. 26B.

During delivery of the clip 910, radiopaque markers (not shown) on the clip 910, the carrier assembly 1354, and/or the expandable members 1418 may be monitored, e.g., using fluoroscopy, to facilitate observing and/or positioning the apparatus 1300. Thus, a relative position of the clip 910 with respect to the expandable elements 1418, and consequently to the wall 1398 of the vessel 1390, may be ascertained before the clip 910 is deployed from the carrier assembly 1354.

Turning to FIGS. 26A and 26B, in another embodiment, the expandable elements 1418 of the obturator 1400 may be rotationally offset from the one or more tines 914 on the clip 910. For example, if the clip 910 includes primary tines (such as those shown in FIGS. 17A and 18), the obturator 600 and clip 910 may have a predetermined relative angular orientation about the central axis 924. The clip 910 can be loaded onto the carrier assembly 1354 in a predetermined angular orientation and the obturator 600 is receivable in the sheath 1352 only in a predetermined angular orientation that is offset such that the tines 914, 916 are out of axial alignment with the expandable elements 1418, as shown in FIG. 26A.

This predetermined rotational orientation may substantially minimize the possibility of the primary tines 914 contacting and/or damaging the expandable elements 1418. For example, with particular reference to FIG. 26A, a relative angular orientation of the clip 910 and obturator 1400 is shown relative to an arteriotomy 591 in the wall 598 of the vessel 590. Here, the expandable elements 618 are oriented to crisscross diagonally the arteriotomy 591 within the interior of the vessel 590. Generally, because of the natural structure of the tissue in the wall of a vessel, an arteriotomy generally tends to adopt an elongate shape that extends transversely to the direction of flow (i.e., across the circumference of the vessel wall).

The primary tines 914 are oriented such that the primary tines 914 pierce the wall 1398 of the vessel 1390 on either side of the arteriotomy 1391, as shown. With the expandable elements 1418 crisscrossing diagonally, risk of contact with the primary tines 914 is substantially reduced. Thus, the primary tines 914 may be sufficiently long to extend entirely through the wall 1398 of the vessel 1390 while avoiding the expandable elements 618.

The expandable elements 1418 may then be collapsed and/or withdrawn into the distal end 1364 of the sheath 1352. As the clip 910 is released entirely from the sheath 1352, the primary tines 914 may partially overlap, as shown in FIG. 26B, thereby pulling the arteriotomy 1391 closed, similar to a single-thread suture. For example, the expandable elements 1418 may be automatically collapsed immediately before or after the clip 910 is deployed from the carrier assembly 1354 or when the carrier assembly 1354 reaches its extreme distal position. The distal portion 1416 of the obturator 1400 can be collapsed and retracted into the sheath 1354 after the primary tines 914 have pierced the wall 1398 of the vessel 1390, but before the clip 910 is entirely released from the sheath 1352.

In addition, if the clip 910 includes secondary tines 916 (such as those shown in FIG. 17A), the secondary tines 916 may partially penetrate the wall 1398 of the vessel 1390 during deployment of the clip 910. The lengths of the secondary tines 916 can be relatively short or stop members (not shown) may be provided that prevent the secondary tines 916 from piercing entirely through the wall 1398. When the clip 910 is released, the secondary tines 916 may pull the tissue inwardly, behaving somewhat similarly to a purse-string suture, to enhance closing the arteriotomy 1391.

Once the clip 910 is successfully deployed into the wall 1398 of the vessel 1390, e.g., on either side of an arteriotomy 1391, the apparatus 1300 may be withdrawn from the passage 1392. The entire apparatus 1300 may be removed in one step, or alternatively, the obturator 1400 may first be withdrawn from the sheath 1352 before withdrawing the sheath 1352, thereby leaving the clip 910 in place to close the arteriotomy 1391 and/or seal the passage 1392. In addition, if desired, a sealant or other material may be introduced into the passage 1392 in conjunction with or separate from delivery of the clip 910 to further seal the passage 1392, as is known to those skilled in the art.

According to another aspect, the clips described herein can be manufactured in various manners. These clips can be useful for engaging tissue so as to connect tissue segments together or to close and/or seal openings through tissue such as a puncture wound in a body lumen. These clips may be used by deforming them from their generally planar configuration such that the tines are pointing in a direction generally transverse to the plane, holding the clip in this deformed condition, deploying the clip proximal to the tissue to be engaged and removing the deforming force such that the clip engages the tissue and attempts to return to its original generally planar configuration. The methods and apparatus disclosed in the above-mentioned U.S. patent application Ser. No. 10/081,726 and Ser. No. 09/732,178, now U.S. Pat. Nos. 6,623,510 and 6,719,777 can be used to deploy the clips of the present invention to engage tissue and close or seal an opening.

In such use, the deformation of the clip causes the tines to be directed generally axially away from the body of the clip and it is the elastic property of the deformed clip which causes it to attempt to return to its original generally planar configuration. The body of the device may comprise a series of looped elements which generally define an endless zigzag pattern, e.g., a sinusoidal pattern, extending about a central access. The looped elements are believed to facilitate deforming the device between the planar and transverse configurations, e.g., by distributing stresses through the device and minimizing localized stresses in the curved regions.

In another embodiment of the present invention, a clip precursor is first formed from a sheet of material, such as a superelastic alloy, such as a nickel-titanium alloy (“Nitinol”) alloy. The property of superelasticity and of certain alloys which possess that property is disclosed in U.S. Pat. No. 4,665,906, the disclosures of which, and any references therein, are incorporated herein in their entirety by this reference. This forming can be done by removing portions of the material by cutting, chemical etching, laser cutting, photochemical etching, stamping, electrical discharge machining and the like to produce a precursor such as that shown in FIG. 28A which has radially outward extending tines. The precursor can then be polished using one or more processes such as electropolishing, tumbling, sand blasting, sanding and the like or such polishing can be done as a final step after the clip is formed. Forming of a precursor in this manner does not require working to tolerances as close as those which would be required if the clip was to be manufactured in its final configuration shown in FIG. 28B because the radially outwardly extending tines of the precursor shown in FIG. 28A are easily accessible by the forming tool whereas attempting to directly form the clip with radially inwardly extending tines which are closely spaced requires difficult high precision metal cutting. Thus, manufacture of a precursor which is then reconfigured to final clip shape permits the achievement of closer spacing between the elements of the final clip than would otherwise be achievable with conventional methods.

The precursor 1610 comprises a hoop-shaped planar body 1611 which has outwardly extending primary (longer) tines 1612 and secondary (shorter) tines 1613. For example, the primary trials may be 0.070 to 0.105 inches in length and the secondary tines may be 0.025 to 0.035 inches in length. Each of the tines terminates in a point 1614. When the precursor 1610 has been reconfigured into clip 1616 shown in FIG. 28B, the tines 1612 and 1613 become the tissue engaging portions of the clip. The tines may be sharpened or given a shape, e.g., barbs (not shown), while the device is in the precursor state. The body 1611 may compromise connecting links such as loops 1615. These links may have any suitable shape provided that such shape does not interfere with inversion of the precursor 1610.

The precursor 1610 is then inverted to reconfigure it into the shape of clip 1616. In this embodiment in which the precursor is formed from a sheet of nickel-titanium alloy, the inverted precursor is then heat set, e.g., by heating to a temperature of 510° C., and then quenched to cool to room temperature. The clip 1616 will now be in the austenitic state.

Heat setting and quenching are essential to successful practice of the invention with superelastic alloys. As explained in more detail in U.S. Pat. No. 4,665,906, the disclosures of which, and any references therein, are incorporated herein in their entirety by this reference, a superelastic alloy such as nickel-titanium exists in two states, the austenitic state and the martensitic state. Such alloys will initially be in the austenitic state, e.g., when the precursor is formed. However, when the precursor is inverted to take the shape of the final clip, the stress experienced by the alloy during the inversion will cause the alloy to be partially or wholly converted to the martensitic state. Such a martensitic state is commonly referred to as stress-induced martensite. Such martensite structure has the property of superelasticity and the inverted precursor would revert to its original shape if not held in the inverted configuration.

Since, if the inverted precursor was left in the martensitic state, it would want to elastically revert to its original uninverted state, it must be converted back to austenite. Thus, heating and quenching are required to convert the inverted precursor from the martensitic state to the austenitic state such that the clip is stable in its planar configuration as shown in FIG. 28B and will retain that configuration.

The times and temperatures for heat setting of superelastic alloys of various compositions can be determined from existing literature or can be determined empirically without any difficulty. The clips are small in size and the heating and quenching may be done with any conventional heating and quenching equipment. For example, once inverted, the inverted precursor can be held in that configuration and placed in a fixture which will hold it in the inverted configuration during heat setting.

When clips are manufactured according to the present invention, the space between the tines may actually be eliminated, i.e., after inverting the precursor, the tines may be in contact with each other, in either a side-by-side or an over-and-under relationship. The number, length and spacing of the tines may be varied according to the desires of the manufacturer. Furthermore, while use of a planar precursor is a convenience in manufacturing, a planar configuration is not required. For example, the precursor could be bent along a diameter or major or minor axis of the precursor and could be heat set in such a bent configuration. Alternatively, the clip, while generally planar, may have the tines extending at an acute angle to the plane defined by the body as shown in FIG. 31 in which the body 1611 and tines 1612 are shown. Furthermore, manufacturing from a sheet of material is a convenience, but other manufacturing techniques, including joining of components such as the tines to the body, can be accomplished by welding, brazing, or other known methods of joining materials. In such cases, one or more of such components may be circular in cross-section or tubular in configuration.

Still further, the clip need not be fabricated from a single material, e.g., the tines may be manufactured from a different material than the body. In such cases, a portion of the clip such as the tines may be bioabsorbable provided that the final clip is capable of elastic recovery after being deformed. An advantage of the present invention is that it permits the production of clips with tines that are 30 to 40% or more longer than those which could be made with prior direct cutting methods, because there is no limit on the length of the tine which is formed on the precursor. Thus, after the precursor is inverted, the tines may overlap the annular body.

In the alternative embodiment of this invention illustrated in FIGS. 29A and 29B, the precursor 1620 is manufactured in an expanded oversize configuration to provide space for removing material from a sheet of material, such as a superelastic alloy, such as nickel-titanium, by conventional methods such as cutting, chemical etching, photochemical etching, stamping, electric discharge machining, laser cutting or the like.

The precursor 1620 is reconfigured by imposing radially inwardly directed force on body 1621 such that precursor 1620 takes a smaller planar shape such as one of those shown in FIG. 29B. The precursor 20 has a planar body 1621, tines 1622 and 1623 having points 1624 and such tines are connected by links 1625 as previously described with regard to FIG. 28A. The reconfigured precursor is then heat set and quenched as described above to complete the manufacture of clip 1626.

Clips of still other configurations can be manufactured in the manner of clip 1626 by starting with a differently shaped precursor such as precursor 1630 shown in FIG. 30A. Precursor 1630 can be reconfigured by being subjected to radially inward deforming forces as shown in FIG. 30B or by opposed laterally inward forces as shown in FIG. 30C. In each case, the planar body 1631 having tines 1632 and 1633 with points 1634 and links 1635 will be caused to take a smaller dimension and will be heat set as described above to form clips 1636 and 1637. Clips manufactured according to the method of the present invention can have a multitude of configurations other than those shown in FIGS. 28B, 29B, and 30C and 30D. For example, the configurations shown in U.S. patent application Ser. No. 09/732,178 and Ser. No. 10/081,726, now U.S. Pat. Nos. 6,719,777 and 6,623,510, could be manufactured according to the present invention.

It has been found that Nitinol sheet is stronger in one direction than in others, which may be the result of crystal orientation in the Nitinol. The clip precursors can be formed such that the primary tines are aligned with the strongest orientation of the Nitinol. It has been found, as shown in FIG. 7, that the greatest strength of the primary tines is achieved if those tines are transverse to the grain orientation of the Nitinol. Thus, FIG. 34 illustrates clip precursor 1660 having primary tines 1661 as the precursor would be cut from sheet 1662. The grain orientation of sheet 1662 is shown by the double-headed arrow 1663. Typically, a plurality of precursors 1660 would be cut from the same sheet, each with its primary tines transverse to the grain orientation of the sheet. In addition, even if clips are formed directly without using precursors, it is desirable that their primary tines be transverse to the grain orientation.

The clips of the present invention may have primary or secondary tines which have the same or different lengths and the tines may be straight or curved. For example, radially opposed tines may have one tine at “12 o'clock” which is longer than the opposing tine at “6 o'clock.” Exemplary configurations of clip precursors with primary tines of different length are shown in FIGS. 32 and 33. In FIG. 32, clip precursor 1640 is shown with a primary tine 1641 which is shorter than primary tine 1642. Similarly, in FIG. 33, a clip precursor is shown which has a primary tine 1651 which is shorter than primary tine 1652.

The clips of the present invention may also be delivered using the apparatus and methods described in U.S. patent application Ser. No. 10/081,723, filed Feb. 21, 2002, now U.S. Pat. No. 6,942,674, which is assigned to the assignee of the present application, the disclosures of which, and any references therein, are incorporated herein in their entirety by this reference. Similarly, the apparatus and methods disclosed in U.S. patent application Ser. No. 10/081,717, filed Feb. 21, 2002, now U.S. Pat. No. 6,695,867, which is assigned to the Assignee of the present application, the disclosures of which, and any references therein, are incorporated herein in their entirety by this reference.

Other features can be added to the clips including radio-opaque markers, and/or porous surfaces to promote tissue ingrowth or the clip may be coated in whole or in part with a bioabsorbable material and/or coated with a material containing a substance which is delivered to the patient for therapeutic, diagnostic or other purposes. Such coatings may comprise peptides, clotting factors or other materials designed to benefit the patient.

While the principal object of the present invention is to provide a manufacturing method which facilitates the production of clips having a small footprint, the present invention can also be used to make clips of larger dimensions since, no matter what methods are used to cut the precursor from a sheet of material, the ease of manufacture of even larger size clips is facilitated. Thus, the advantages of the present invention may be realized with regard to clips having larger sizes and clips having a variety of configurations.

Turning now to the drawings, FIGS. 35A-35C show another embodiment of a closure device or clip 1710 for closing an incision, puncture, or other passage through tissue, e.g., communicating with a blood vessel or other body lumen (not shown). The clip 1710 includes a body 1712, which may be generally annular in shape and surrounds a central axis 1724, a plurality of primary tines 1714 and a plurality of secondary tines 1716 extending from the body 1712. As used herein, an “annular-shaped body” includes any hollow body, e.g., including one or more structures surrounding an opening, whether the body is substantially flat or has a significant thickness or depth. Thus, although an annular-shaped body may be circular, it may include other noncircular shapes as well, such as elliptical or other shapes that are asymmetrical about a central axis.

The body 1712 includes a plurality of looped or curved elements 1728 that are connected to one another to form the body 1712. Each looped element 1728 may include an inner or first curved region 1732 and an outer or second curved region 1734. In another embodiment, the first and second curved regions 1732, 1734 are out of phase with one another and are connected alternately to one another, thereby defining an endless sinusoidal pattern. Alternatively, other generally zigzag patterns may be provided that repeat periodically, e.g., saw tooth or square tooth patterns (not shown), instead of a sinusoidal pattern, thereby defining inner and outer regions that alternate about the body 1712.

The plurality of tines 1714 and 1716 may be biased to extend generally inwardly, e.g., towards one another and/or towards the central axis 1724. The tines 1714 and 1716 may be disposed on the first curved regions 1732, and oriented toward the central axis 1724 when the clip 1710 is in the planar configuration. The primary tines 14 are offset from the axis of symmetry 1737 of the loops from which they extend and are connected to a first curved region 1732 by a straight connecting element having a longer side 1735 and a shorter side 1736. In another embodiment, the tines 14 and 1716 may be provided in pairs opposite from one another or provided otherwise symmetrically with respect to the central axis 1724.

The tines 1714 and 1716 may include a variety of pointed tips, such as a bayonet tip, and/or may include barbs (not shown) for penetrating or otherwise engaging tissue. For example, to increase the penetration ability of the clip 1710 and/or to lower the insertion force required to penetrate tissue, each primary tine 1714, as shown in FIG. 35A as element 1718, and each secondary tine 1716 may include a tapered edge (not shown) extending towards the tip along one side of the tine 1714 or 1716. Alternatively, as shown in FIGS. 35A-35C, each tine 1714 or 16 may be provided with a tapered edge on each side of the tine 1714 or 1716 extending towards the tip.

Additionally, as shown in FIGS. 35A-35C, the tines 1714 and 1716 may be disposed on alternating first curved regions 1732. Thus, at least one period of a zigzag pattern may be disposed between adjacent tines 1714 and 1716, which may enhance flexibility of the clip 1710, as explained further below.

As shown in FIGS. 35B and 35C (where opposite ends 1733a, 1733b are connected to one another), the body 1712 and/or the tines 1714 and 1716 may be deflected such that the tines 1716 extend transversely with respect to the plane defined in the planar configuration, thereby defining a transverse configuration for the clip 1710. The tines 1714 and 1716 can be oriented substantially parallel to the central axis 1724 in the transverse configuration, as shown in FIG. 35B. In the transverse configuration, the body 1712 may have a generally annular shape defining a length, LE₁, that extends generally parallel to the central axis 1724, and corresponds generally to an amplitude of the zigzag pattern. The body 1712 can be sufficiently flexible such that the clip 1710 may assume a generally circular or elliptical shape (not shown), e.g., conforming to an exterior surface of a delivery device (not shown) used to deliver the clip 1710.

In another embodiment, the tines 1714 and 1716 and/or body 1712 are biased to move from the transverse configuration towards the planar configuration of FIG. 35A. Thus, with the tines 14 and 16 in the transverse configuration, the tines 1714 and 1716 may penetrate and/or be engaged with tissue at a puncture site. When the clip 1710 is released, the tines 1714 and 1716 may attempt to return towards one another as the clip 1710 moves towards the planar configuration, thereby drawing the engaged tissue together and substantially closing and/or sealing the puncture site, as explained further below.

The looped elements 1728 may distribute stresses in the clip 1710 as it is deformed between the planar and transverse configurations, thereby minimizing localized stresses that may otherwise plastically deform, break, or otherwise damage the clip 1710 during delivery. In addition, when the clip 1710 is in the transverse configuration, the looped elements 1728 may be movable between a compressed state, such as that shown in FIG. 35B, and an expanded state, such as that shown in FIG. 35C. The looped elements 1728 can be biased towards the expanded state, but may be compressed to the compressed state, e.g., by constraining the clip 1710. Alternatively, only a portion of the looped elements 1728 may be biased towards the expanded state, e.g., the first curved regions 1732, and/or the looped elements 1728 may be biased towards the compressed state. Furthermore, the looped elements 1728 reduce the force required to be exerted on the clip 1710 to transition the clip 1710 from the planar configuration to the transverse configuration before loading onto a delivery device (not shown).

With the clip 1710 in the transverse configuration, the looped elements 1728 may be circumferentially and/or radially compressed to the compressed state until the clip 1710 defines a first diameter or circumference 1726a, such as that shown in FIG. 35B. The clip 1710 may be constrained in the compressed state, e.g., by loading the clip 1710 onto a carrier assembly of a delivery device (not shown), as described further below. When released from the constraint, e.g., when deployed from the carrier assembly, the clip 1710 may automatically expand towards the expanded state, such as that shown in FIG. 35C, thereby defining a second diameter or circumference 1726b. Thus, the looped elements 1728 may facilitate reducing the profile of the clip 1710 during delivery, e.g., to facilitate introducing the clip 1710 through a smaller puncture or passage. Once the clip 1710 is deployed entirely from the delivery device, the looped elements 1728 may resiliently expand as the clip 1710 returns towards the planar configuration, as explained further below.

To manufacture the clip 1710 (or, similarly, any of the other clips described herein), the body 1712 and the tines 1714 and 1716 may be integrally formed from a single sheet of material, e.g., a superelastic alloy, such as Nitinol. Portions of the sheet may be removed using conventional methods, such as laser cutting, chemical etching, photo chemical etching, stamping, using an electrical discharge machine (EDM), and the like, or the method disclosed in U.S. patent application Ser. No. 10/335,075, filed Dec. 31, 2002, to form the clip. The tines 1714 and 1716 may be sharpened to a point, i.e., tips may be formed on the tines 1714 and 1716 using conventional methods, such as chemical etching, mechanical grinding, and the like.

The clip 1710 may be polished to a desired finish using conventional methods, such as electro-polishing, chemical etching, tumbling, sandblasting, sanding, and the like. Polishing may perform various functions depending on the method used to form the clip 1710. For a clip formed by laser cutting or using an EDM, polishing may remove heat affected zones (HAZ) and/or burrs from the clip. For a clip formed by photo chemical etching, polishing may create a smoother surface finish. For a clip formed by stamping, polishing may remove or reduce burrs from the bottom side of the clip, and/or may smooth the “roll” that may result on the topside of the clip from the stamping process.

In addition or alternatively, the clip 1710 may be formed from a shape memory alloy, e.g., Nitinol, with the looped elements 1728 formed initially in the compressed state and/or the clip 1710 in the planar configuration. With the clip 1710 deformed to the transverse configuration, the clip 1710 may be expanded, e.g., by applying a force radially outwards against an inner surface of the clip 1710, thereby expanding the looped elements 1728 to the expanded state. The looped elements 1728 may then be heat treated, e.g., by heating the clip 1710 to an austenitic state, to cause the looped elements 1728 to “remember” the expanded state, as is known to those skilled in the art. It may also be necessary to further heat treat the clip 1710 further, e.g., with the tines in the planar configuration to cause the body 1712 and/or tines 1714 and 1716 to “remember” and be biased towards the planar configuration, as is known to those skilled in the art. The clip 1710 may then be cooled, e.g., to a martensitic state, which may be at or close to ambient temperature, and manipulated, e.g., malleably deformed to the transverse configuration, for example, by loading the clip 1710 onto a delivery device (not shown), as described below. Thus, if the clip 1710 is subsequently heated to a predetermined temperature, e.g., at or below body temperature, the material may remember the planar configuration and/or expanded state and become biased towards them.

Each of the primary tines 1714 may have a length l₁, although alternatively, as shown in FIG. 35A, each of the primary tines 1714 may have a different length than one another. The primary tines 1714 may be disposed in one or more opposing pairs, e.g., on opposing first curved regions 1732, and may be oriented towards and/or across the central axis 1724 in the planar configuration. In the planar configuration, the lengths l₁may be sufficiently long such that the primary tines 1714 at least partially overlap one another, i.e., extend across the central axis 1724 towards an opposing tine 1714. Therefore, the tips of the primary tines 1714 may extend past the central axis 1724 and/or the primary tines 14 in each pair may lie substantially parallel to each other when the clip 1710 is in the planar configuration.

Each of the secondary tines 16 may be disposed on a first or inner curved region 32, e.g., such that one or more secondary tines 16 may be provided between opposing pairs of primary tines 14. Each of the secondary tines 16 may have a length l₂that is substantially less than the length l₁of the primary tines 14.

A secondary tine 1716 can be disposed on either side of each primary tine 1714. For example, the clip 1710 shown in FIGS. 35A-35C has first and second primary tines 1714, and each of the first and second primary tines 1714 has a secondary tine 1716 on either side of it. Thus, the clip 1710 may have a total of two primary tines 1714 and four secondary tines 1716. Optionally, the secondary tines 1716 may be disposed substantially symmetrically about the central axis 1724. The tines 1714, 1716 may be provided on every other first curved regions 1732. For example, a first curved region 1732 having neither a primary tine 1714 nor a secondary tine 1716 may separate each adjacent tine, e.g., between two adjacent secondary tines 16, or between a secondary tine 16 and a primary tine 1714.

With the clip 1710 in the transverse configuration, the clip 1710 may be delivered such that the primary tines 1714 entirely penetrate the wall of a blood vessel or other body lumen, while the secondary tines 1716 only partially penetrate the wall due to their relative lengths, as explained further below.

As shown in FIG. 35A, primary tines 1714 are connected to curved regions 1732 by linear regions 1735 and 1736 which are of different lengths. Thus, primary tines 1714 are offset from the axis of symmetry 1737 of the loops having the curved regions to which they are attached. The offsetting of primary tines is also disclosed in patent application Ser. No. 10/335,075, filed Dec. 31, 2002, which discloses the use of curved configurations to connect the primary tines to the curved regions of the clip. It has been found desirable to use linear, or straight, regions, as shown as elements 1735 and 1736 in FIG. 35A to connect the primary tines 1714 of the present invention to the curved regions 1732.

FIG. 36 illustrates a clip of the same general type as that of FIG. 35A, but in a somewhat different embodiment in which primary tines 1714a overlap body 1712 at locations comprising first curved regions 1732.

FIGS. 37A-37C illustrate various designs of clips configured according to the present invention in which the primary tines, which are offset from the axis of symmetry of the loop from which they extend, are connected directly to a first curved region or are connected to the curved region by extending one side of the curved region to form one side of the primary tine and connecting the other side of the primary tine with a curved connecting element.

Turning to FIGS. 37A-37C in more detail, FIG. 37A illustrates clip 1826 has body 1821, primary tines 1822, secondary tines 1823 and loops 1825. Each loop has an axis of symmetry such as that indicated by 1827. The tines are provided with point 1824. In this embodiment, the primary tines 1822 are offset from the axis of symmetry of the loop from which they extend and are connected directly to the first curved section of such loop.

In FIG. 37B, the clip 1936 has body 1931 having primary tines 1932 and secondary tines 1933 is illustrated. The body 1931 is provided with loops 1935 and the primary tines 1932 comprise a first side 1937 which is an extension of a side of the loop 1938 from which tine 1937 extends and another side 1939 which is connected directly to the loop from which it extends. The primary tines are offset from the axis of symmetry, indicated by 1940 of the loop from which they extend.

The clip of FIG. 37C is similar in some respects to the clip of 37B, but is generally elliptical in shape rather than generally circular in shape. Thus, clip 2037 comprises body 2031 which has loops 2035, primary tines 2032, secondary tines 2033 which tines have points 2034. In this embodiment, the primary tines 2032 extend beyond the innermost reach of the first curved regions which are opposite the first curved regions from which the primary tines extend. The primary tines are offset from the axis of symmetry 2038 of the loop from which they extend. The primary tines of the clip of FIG. 37C are connected to the loops from which they extend in the same manner as those of FIG. 37B.

FIG. 38 illustrates a clip 2110 in which the primary tines 2114 and 2116 are of different lengths. The primary tines 2114 and 2116 are offset from the axis of symmetry 2130 of the loop from which they extend and are connected to the loop in the same manner as the primary tines of FIG. 37B.

Any of the clips of the present invention may include one or more radiopaque markers or other markers visible using external imaging, such as fluoroscopy. For example, using the clip 1710 of FIGS. 35A-35C as an example, the entire clip 1710 may be coated with radiopaque material, which may be a high density material such as gold, platinum, platinum/iridium, and the like.

Alternatively, the clip 1710 may be partially coated with radiopaque material by using masking techniques. For example, the entire clip 1710 may first be coated with radiopaque material. The clip 1710 may then be masked at locations where the radiopaque coating is desired. For example, the looped elements 1728 of the clip 1710 may be left unmasked during this process if it is desired to leave the looped elements 1728 uncoated by radiopaque material. This may be desirable, e.g., to prevent radiopaque material from adversely affecting the flexibility of the looped elements 1728. The clip 1710 may then be treated to remove the radiopaque material from the unmasked areas, in this example, the looped elements 1728. The masking may then be removed using conventional processes, leaving the rest of the clip 1710 coated with radiopaque material.

In another alternative, one or more discrete markers may be provided at predetermined locations on the clip 1710. For example, high density or radiopaque material may be crimped or otherwise secured onto opposing double looped or circular regions 1728. In another embodiment, a plurality of pockets may be provided on the looped elements 1728 into which high density plugs (not shown) may be bonded or otherwise secured. These various radiopaque markers may also be incorporated in any of the embodiments described herein.

As described herein, the clips of the present invention may be delivered using various apparatus and methods. Suitable apparatus that may be used to deliver a clip of the present invention are disclosed in U.S. application Ser. No. 10/081,723, filed on Feb. 21, 2002, now U.S. Pat. No. 6,942,674, and entitled “Apparatus and Methods for Delivering a Closure Device” and in U.S. application Ser. No. 10/356,214, filed Jan. 30, 2003, and Ser. No. 10/638,115, filed Aug. 8, 2003, and Ser. No. 10/081,725, filed Feb. 2, 2001, now U.S. Pat. No. 6,749,621, which are assigned to the assignee of the present application, the disclosures of which, and any references therein, are incorporated herein in their entirety by this reference.

While the invention is susceptible to various modifications, and alternative forms, specific examples thereof have been shown in the drawings and are herein described in detail. It should be understood, however, that the invention is not to be limited to the particular forms or methods disclosed, but to the contrary, the invention is to cover all modifications, equivalents and alternatives falling within the spirit and scope of the appended claims. For example, and not by way of limitation, the features and structures of one clip can be used with any other clip described herein. Similarly, the structures and methods useable to deploy a clip can be used to deploy other clips, including, but not limited to, those clips described herein.

Claims

1. A medical device comprising: a plurality of members forming a body, the body being configured to transition from a delivery configuration to a deployed configuration, the plurality of members forming a plurality of openings each with a long axis extending substantially longitudinally relative to a longitudinal axis of the medical device in the delivery configuration, wherein each opening has a mid-portion having a width in a direction transverse to the long axis of the opening greater than widths of a remainder of the opening in the deployed configuration; anda plurality of end portions disposed at a distal portion of the medical device, each end portion extending towards the longitudinal axis in the deployed configuration.
2. The medical device of claim 1, wherein each end portion extends away from the opening to engage tissue disposed adjacent to the tissue engaging portion.
3. The medical device of claim 1, wherein the plurality of end portions are disposed substantially symmetrically about the longitudinal axis.
4. The medical device of claim 1, wherein the openings are biased toward an expanded, deployed configuration.
5. The medical device of claim 1, wherein the plurality of members comprises a first member adjacent to a second member, the first member and the second member being coupled together at a hinged region.
6. The medical device of claim 1, wherein the plurality of end portions extend distally from a proximal end of the plurality of openings.
7. The medical device of claim 1, wherein the body is formed of a shape memory material.
8. A method comprising: locating an opening in tissue; andfollowing locating the opening, deploying a medical device near the opening so that a portion of the medical device engages tissue, the medical device comprising: a plurality of members forming a body, the body being configured to transition from a delivery configuration to a deployed configuration, the plurality of members forming a plurality of openings with a long axis extending substantially longitudinally relative to a longitudinal axis of the medical device in the delivery configuration, wherein each opening has a mid-portion having a width in a direction transverse to the long axis of the opening greater than widths of a remainder of the opening in the deployed configuration; anda plurality of end portions disposed at a distal portion of the medical device, each end portion extending towards the longitudinal axis in the deployed configuration.
9. The method of claim 8, wherein deploying the medical device further comprises advancing the medical device along an elongate member until the medical device disengages from the elongate member.
10. The method of claim 9, further comprising removing the elongate member from the opening in tissue.
11. The method of claim 8, wherein deploying the medical device further comprises advancing the medical device to move the plurality of end portions with the plurality of members, the plurality of members forming a plurality of spring elements.
12. The method of claim 8, wherein locating the tissue further comprises positioning a locator through the opening in tissue.
13. The method of claim 8, further comprising monitoring a position of the medical device.
14. The method of claim 13, wherein monitoring the position of the medical device comprising monitoring one or more radiopaque markers using fluoroscopy.
15. The method of claim 14, further comprising monitoring a relative position of the medical device to a distal tip of a locator locating the opening in tissue.

CROSS-REFERENCE TO RELATED APPLICATIONS

This a continuation application of U.S. patent application Ser. No. 14/246,926, filed Apr. 7, 2014, which is a continuation application of U.S. patent application Ser. No. 11/396,141, filed 31 Mar. 2006, now U.S. Pat. No. 8,690,910, which is (i) a continuation-in-part application of U.S. patent application Ser. No. 10/787,073, filed Feb. 24, 2004, now U.S. Pat. No. 7,806,904, which is a continuation-in-part application of U.S. patent application Ser. No. 10/435,104, filed May 9, 2003, now U.S. Pat. No. 7,879,071, which is a divisional application of U.S. patent application Ser. No. 10/081,726, filed Feb. 21, 2002, now U.S. Pat. No. 6,623,510, which is a continuation-in-part application of U.S. patent application Ser. No. 09/732,178, filed Dec. 7, 2000, now U.S. Pat. No. 6,719,777, and (ii) is also a continuation-in-part application of U.S. patent application Ser. No. 10/335,075, filed Dec. 31, 2002, now U.S. Pat. No. 7,211,101, which is a continuation-in-part application of U.S. patent application Ser. No. 10/081,726, filed Feb. 21, 2002, now U.S. Pat. No. 6,623,510, which is a continuation-in-part application of U.S. patent application Ser. No. 09/732,178, filed Dec. 7, 2000, now U.S. Pat. No. 6,719,777, each of the disclosures of which, and any references therein, are incorporated herein in their entirety by this reference.

US Referenced Citations (1123)

Number	Name	Date	Kind
287046	Norton	Oct 1883	A
438400	Brennen	Oct 1890	A
556082	Boeddinghaus	Mar 1896	A
1088393	Backus	Feb 1914	A
1123290	Von Herff	Jan 1915	A
1331401	Summers	Feb 1920	A
1596004	De Bengoa	Aug 1926	A
1647958	Ciarlante	Nov 1927	A
1880569	Weis	Oct 1932	A
2087074	Tucker	Jul 1937	A
2210061	Caminez	Aug 1940	A
2254620	Miller	Sep 1941	A
2316297	Southerland et al.	Apr 1943	A
2371978	Perham	Mar 1945	A
2453227	James	Nov 1948	A
2583625	Bergan	Jan 1952	A
2684070	Kelsey	Jul 1954	A
2755699	Forster	Jul 1956	A
2910067	White	Oct 1959	A
2944311	Schneckenberger	Jul 1960	A
2951482	Sullivan	Sep 1960	A
2969887	Darmstadt et al.	Jan 1961	A
3015403	Fuller	Jan 1962	A
3113379	Frank	Dec 1963	A
3120230	Skold	Feb 1964	A
3142878	Santora	Aug 1964	A
3209754	Brown	Oct 1965	A
3482428	Kapitanov et al.	Dec 1969	A
3494533	Green et al.	Feb 1970	A
3510923	Blake	May 1970	A
3517128	Hines	Jun 1970	A
3523351	Filia	Aug 1970	A
3557794	Van Patten	Jan 1971	A
3586002	Wood et al.	Jun 1971	A
3604425	Le Roy	Sep 1971	A
3618447	Goins	Nov 1971	A
3677243	Nerz	Jul 1972	A
3757629	Schneider	Sep 1973	A
3805337	Branstetter	Apr 1974	A
3823719	Cummings	Jul 1974	A
3828791	Santos	Aug 1974	A
3856016	Davis	Dec 1974	A
3874388	King et al.	Apr 1975	A
3908662	Razgulov et al.	Sep 1975	A
3926194	Greenberg et al.	Dec 1975	A
3939820	Grayzel	Feb 1976	A
3944114	Coppens	Mar 1976	A
3960147	Murray	Jun 1976	A
3985138	Jarvik	Oct 1976	A
4007743	Blake	Feb 1977	A
4014492	Rothfuss	Mar 1977	A
4018228	Goosen	Apr 1977	A
4047533	Perciaccante et al.	Sep 1977	A
4064881	Meredith	Dec 1977	A
4112944	Williams	Sep 1978	A
4153321	Pombrol	May 1979	A
4162673	Patel	Jul 1979	A
4169476	Hiltebrandt	Oct 1979	A
4192315	Hilzinger et al.	Mar 1980	A
4201215	Crossett et al.	May 1980	A
4204541	Kapitanov	May 1980	A
4207870	Eldridge	Jun 1980	A
4214587	Sakura, Jr.	Jul 1980	A
4215699	Patel	Aug 1980	A
4217902	March	Aug 1980	A
4273129	Boebel	Jun 1981	A
4274415	Kanamoto et al.	Jun 1981	A
4278091	Borzone	Jul 1981	A
4317445	Robinson	Mar 1982	A
4317451	Cerwin et al.	Mar 1982	A
4318401	Zimmerman	Mar 1982	A
4327485	Rix	May 1982	A
4345606	Littleford	Aug 1982	A
4359052	Staub	Nov 1982	A
4368736	Kaster	Jan 1983	A
4396139	Hall et al.	Aug 1983	A
4407286	Noiles et al.	Oct 1983	A
4411654	Boarini et al.	Oct 1983	A
4412832	Kling et al.	Nov 1983	A
4428376	Mericle	Jan 1984	A
4440170	Golden et al.	Apr 1984	A
4449531	Cerwin et al.	May 1984	A
4475544	Reis	Oct 1984	A
4480356	Martin	Nov 1984	A
4485816	Krumme	Dec 1984	A
RE31855	Osborne	Mar 1985	E
4505273	Braun et al.	Mar 1985	A
4505274	Speelman	Mar 1985	A
4523591	Kaplan et al.	Jun 1985	A
4523695	Braun et al.	Jun 1985	A
4525157	Valaincourt	Jun 1985	A
4526174	Froehlich	Jul 1985	A
4570633	Golden	Feb 1986	A
4586503	Kirsch et al.	May 1986	A
4592498	Braun et al.	Jun 1986	A
4596559	Fleischhacker	Jun 1986	A
4607638	Crainich	Aug 1986	A
4610251	Kumar	Sep 1986	A
4610252	Catalano	Sep 1986	A
4635634	Santos	Jan 1987	A
4635637	Schreiber	Jan 1987	A
4644956	Morgenstern	Feb 1987	A
4651737	Deniega	Mar 1987	A
4664305	Blake, III et al.	May 1987	A
4665906	Jervis	May 1987	A
4687469	Osypka	Aug 1987	A
4693249	Schenck et al.	Sep 1987	A
4719917	Barrows et al.	Jan 1988	A
4724840	McVay et al.	Feb 1988	A
4738658	Magro et al.	Apr 1988	A
4744364	Kensey	May 1988	A
4747407	Liu et al.	May 1988	A
4759364	Boebel	Jul 1988	A
4771782	Millar	Sep 1988	A
4772266	Groshong	Sep 1988	A
4777950	Kees, Jr.	Oct 1988	A
4789090	Blake, III	Dec 1988	A
4832688	Sagae et al.	May 1989	A
4836204	Landymore et al.	Jun 1989	A
4852568	Kensey	Aug 1989	A
4860746	Yoon	Aug 1989	A
4865026	Barrett	Sep 1989	A
4874122	Froelich et al.	Oct 1989	A
4878915	Brantigan	Nov 1989	A
4885003	Hillstead	Dec 1989	A
4886067	Palermo	Dec 1989	A
4887601	Richards	Dec 1989	A
4890612	Kensey	Jan 1990	A
4900303	Lemelson	Feb 1990	A
4902508	Badylak et al.	Feb 1990	A
4917087	Walsh et al.	Apr 1990	A
4917089	Sideris	Apr 1990	A
4929240	Kirsch et al.	May 1990	A
4934364	Green	Jun 1990	A
4950258	Kawai et al.	Aug 1990	A
4957499	Lipatov et al.	Sep 1990	A
4961729	Vaillancourt	Oct 1990	A
4967949	Sandhaus	Nov 1990	A
4976721	Blasnik et al.	Dec 1990	A
4983176	Cushman et al.	Jan 1991	A
4997436	Oberlander	Mar 1991	A
4997439	Chen	Mar 1991	A
5002562	Oberlander	Mar 1991	A
5007921	Brown	Apr 1991	A
5011487	Shichman	Apr 1991	A
5015247	Michelson	May 1991	A
5021059	Kensey et al.	Jun 1991	A
5026390	Brown	Jun 1991	A
5030226	Green et al.	Jul 1991	A
5032127	Frazee et al.	Jul 1991	A
5035692	Lyon et al.	Jul 1991	A
5041129	Hayhurst et al.	Aug 1991	A
5042707	Taheri	Aug 1991	A
5047047	Yoon	Sep 1991	A
5053008	Bajaj	Oct 1991	A
5059201	Asnis	Oct 1991	A
5061274	Kensey	Oct 1991	A
5061283	Silvestrini	Oct 1991	A
5078731	Hayhurst	Jan 1992	A
5092941	Miura	Mar 1992	A
5100418	Yoon et al.	Mar 1992	A
5100422	Berguer et al.	Mar 1992	A
5108420	Marks	Apr 1992	A
5108421	Fowler	Apr 1992	A
5114032	Laidlaw	May 1992	A
5114065	Storace	May 1992	A
5116349	Aranyi	May 1992	A
5122122	Allgood	Jun 1992	A
5122156	Granger et al.	Jun 1992	A
5131379	Sewell, Jr.	Jul 1992	A
5141520	Goble et al.	Aug 1992	A
5147381	Heimerl et al.	Sep 1992	A
5156609	Nakao et al.	Oct 1992	A
5163343	Gish	Nov 1992	A
5167634	Corrigan, Jr. et al.	Dec 1992	A
5167643	Lynn	Dec 1992	A
5171249	Stefanchik et al.	Dec 1992	A
5171250	Yoon	Dec 1992	A
5171259	Inoue	Dec 1992	A
5176648	Holmes et al.	Jan 1993	A
5192288	Thompson et al.	Mar 1993	A
5192300	Fowler	Mar 1993	A
5192301	Kamiya et al.	Mar 1993	A
5192302	Kensey et al.	Mar 1993	A
5192602	Spencer et al.	Mar 1993	A
5193533	Body et al.	Mar 1993	A
5197971	Bonutti	Mar 1993	A
5207697	Carusillo et al.	May 1993	A
5209756	Seedhorm et al.	May 1993	A
5217024	Dorsey et al.	Jun 1993	A
5222974	Kensey et al.	Jun 1993	A
5226908	Yoon	Jul 1993	A
5236435	Sewell, Jr.	Aug 1993	A
5242456	Nash et al.	Sep 1993	A
5242457	Akopov et al.	Sep 1993	A
5242459	Buelna	Sep 1993	A
5243857	Velez	Sep 1993	A
5246156	Rothfuss et al.	Sep 1993	A
5246443	Mai	Sep 1993	A
5250058	Miller et al.	Oct 1993	A
5254105	Haaga	Oct 1993	A
5255679	Imran	Oct 1993	A
5269792	Kovac et al.	Dec 1993	A
5275610	Eberbach	Jan 1994	A
5275616	Fowler	Jan 1994	A
5281422	Badylak et al.	Jan 1994	A
5282808	Kovac et al.	Feb 1994	A
5282827	Kensey et al.	Feb 1994	A
5284488	Sideris	Feb 1994	A
5289963	McGarry et al.	Mar 1994	A
5290243	Chodorow et al.	Mar 1994	A
5290310	Makower et al.	Mar 1994	A
5292309	Van Tassel et al.	Mar 1994	A
5292332	Lee	Mar 1994	A
5304183	Gourlay et al.	Apr 1994	A
5304184	Hathaway et al.	Apr 1994	A
5304204	Bregen	Apr 1994	A
5306254	Nash et al.	Apr 1994	A
5309927	Welch	May 1994	A
5318542	Hirsch et al.	Jun 1994	A
5320639	Rudnick	Jun 1994	A
5322694	Sixsmith	Jun 1994	A
5327908	Gerry	Jul 1994	A
5330445	Haaga	Jul 1994	A
5330503	Yoon	Jul 1994	A
5334216	Vidal et al.	Aug 1994	A
5334217	Das	Aug 1994	A
5335680	Moore	Aug 1994	A
5340360	Stefanchik	Aug 1994	A
5342393	Stack	Aug 1994	A
5344439	Otten	Sep 1994	A
5350399	Erlebacher et al.	Sep 1994	A
5352229	Goble et al.	Oct 1994	A
5354279	Hofling	Oct 1994	A
5364406	Sewell, Jr.	Nov 1994	A
5364408	Gordon	Nov 1994	A
5366458	Korthoff et al.	Nov 1994	A
5366479	McGarry et al.	Nov 1994	A
5383896	Gershony et al.	Jan 1995	A
5383897	Wholey	Jan 1995	A
RE34866	Kensey et al.	Feb 1995	E
5391174	Weston	Feb 1995	A
5392978	Valez et al.	Feb 1995	A
5395030	Kuramoto et al.	Mar 1995	A
5411520	Nash et al.	May 1995	A
5413571	Katsaros et al.	May 1995	A
5413584	Schulze	May 1995	A
5416584	Kay	May 1995	A
5417699	Klein et al.	May 1995	A
5419765	Weldon et al.	May 1995	A
5419777	Hofling	May 1995	A
5421832	Lefebvre	Jun 1995	A
5423857	Rosenman et al.	Jun 1995	A
5425489	Shichman et al.	Jun 1995	A
5425740	Hutchinson, Jr.	Jun 1995	A
5431639	Shaw	Jul 1995	A
5431667	Thompson et al.	Jul 1995	A
5433721	Hooven et al.	Jul 1995	A
5437631	Janzen	Aug 1995	A
5439479	Shichman et al.	Aug 1995	A
5443477	Marin et al.	Aug 1995	A
5443481	Lee	Aug 1995	A
5445167	Yoon et al.	Aug 1995	A
5449359	Groiso	Sep 1995	A
5451235	Lock et al.	Sep 1995	A
5456400	Shichman et al.	Oct 1995	A
5462561	Voda	Oct 1995	A
5464413	Siska, Jr. et al.	Nov 1995	A
5464416	Steckel	Nov 1995	A
5466241	Leroy et al.	Nov 1995	A
5470010	Rothfuss et al.	Nov 1995	A
5471982	Edwards et al.	Dec 1995	A
5474557	Mai	Dec 1995	A
5474569	Zinreich et al.	Dec 1995	A
5476505	Limon	Dec 1995	A
5478352	Fowler	Dec 1995	A
5478353	Yoon	Dec 1995	A
5478354	Tovey et al.	Dec 1995	A
5484420	Russo	Jan 1996	A
5486195	Myers et al.	Jan 1996	A
5496332	Sierra et al.	Mar 1996	A
5497933	DeFonzo et al.	Mar 1996	A
5507744	Tay et al.	Apr 1996	A
5507755	Gresl et al.	Apr 1996	A
5510115	Breillatt, Jr. et al.	Apr 1996	A
5522840	Krajicek	Jun 1996	A
5527322	Klein et al.	Jun 1996	A
5536251	Evard et al.	Jul 1996	A
5540712	Kleshinski et al.	Jul 1996	A
5540716	Hlavacek	Jul 1996	A
5544802	Crainich	Aug 1996	A
5545178	Kensey et al.	Aug 1996	A
5547474	Kloeckl et al.	Aug 1996	A
5560532	DeFonzo et al.	Oct 1996	A
5571120	Yoon	Nov 1996	A
5573784	Badylak et al.	Nov 1996	A
5575771	Walinsky	Nov 1996	A
5582616	Bolduc et al.	Dec 1996	A
5584879	Reimold et al.	Dec 1996	A
5591205	Fowler	Jan 1997	A
5593412	Martinez et al.	Jan 1997	A
5601602	Fowler	Feb 1997	A
5609597	Lehrer	Mar 1997	A
5613974	Andreas et al.	Mar 1997	A
5618291	Thompson et al.	Apr 1997	A
5620452	Yoon	Apr 1997	A
5620461	Muijs et al.	Apr 1997	A
5626614	Hart	May 1997	A
5634936	Linden et al.	Jun 1997	A
5643318	Tsukernik et al.	Jul 1997	A
5645565	Rudd et al.	Jul 1997	A
5645566	Brenneman et al.	Jul 1997	A
5645567	Crainich	Jul 1997	A
5649959	Hannam et al.	Jul 1997	A
D383539	Croley	Sep 1997	S
5674231	Green et al.	Oct 1997	A
5674244	Mathys	Oct 1997	A
5676689	Kensey et al.	Oct 1997	A
5676974	Valdes et al.	Oct 1997	A
5681280	Rusk et al.	Oct 1997	A
5681334	Evans et al.	Oct 1997	A
5683405	Yacoubian et al.	Nov 1997	A
5690674	Diaz	Nov 1997	A
5695504	Gifford, III et al.	Dec 1997	A
5695505	Yoon	Dec 1997	A
5695524	Kelley et al.	Dec 1997	A
5697943	Sauer et al.	Dec 1997	A
5700273	Buelna et al.	Dec 1997	A
5709224	Behl et al.	Jan 1998	A
5715987	Kelley et al.	Feb 1998	A
5716375	Fowler	Feb 1998	A
5720755	Dakov	Feb 1998	A
5725498	Janzen et al.	Mar 1998	A
5725552	Kotula et al.	Mar 1998	A
5725554	Simon et al.	Mar 1998	A
5728110	Vidal et al.	Mar 1998	A
5728114	Evans et al.	Mar 1998	A
5728116	Rosenman	Mar 1998	A
5728122	Leschinsky et al.	Mar 1998	A
5728132	Van Tassel et al.	Mar 1998	A
5728133	Kontos	Mar 1998	A
5732872	Bolduc et al.	Mar 1998	A
5735873	MacLean	Apr 1998	A
5746753	Sullivan et al.	May 1998	A
5749826	Faulkner	May 1998	A
5752966	Chang	May 1998	A
5755726	Pratt et al.	May 1998	A
5755727	Kontos	May 1998	A
5755778	Kleshinski	May 1998	A
5766217	Christy	Jun 1998	A
5766246	Mulhauser et al.	Jun 1998	A
5769870	Salahieh et al.	Jun 1998	A
5776147	Dolendo	Jul 1998	A
5779707	Bertholet et al.	Jul 1998	A
5780807	Saunders	Jul 1998	A
5782844	Yoon et al.	Jul 1998	A
5782860	Epstein et al.	Jul 1998	A
5782861	Cragg et al.	Jul 1998	A
5795958	Rao et al.	Aug 1998	A
5797928	Kogasaka	Aug 1998	A
5797931	Bito et al.	Aug 1998	A
5797933	Snow et al.	Aug 1998	A
5797958	Yoon	Aug 1998	A
5797960	Stevens et al.	Aug 1998	A
5810776	Bacich et al.	Sep 1998	A
5810846	Virnich et al.	Sep 1998	A
5810851	Yoon	Sep 1998	A
5817113	Gifford, III et al.	Oct 1998	A
5820631	Nobles	Oct 1998	A
5827298	Hart et al.	Oct 1998	A
5830125	Scribner et al.	Nov 1998	A
5830217	Ryan	Nov 1998	A
5830221	Stein et al.	Nov 1998	A
5833698	Hinchliffe et al.	Nov 1998	A
5843164	Frantzen et al.	Dec 1998	A
5843167	Dwyer et al.	Dec 1998	A
5853421	Leschinsky et al.	Dec 1998	A
5853422	Huebsch et al.	Dec 1998	A
5855312	Toledano	Jan 1999	A
5858082	Cruz et al.	Jan 1999	A
5860991	Klein et al.	Jan 1999	A
5861003	Latson et al.	Jan 1999	A
5861005	Kontos	Jan 1999	A
5861043	Carn	Jan 1999	A
5865791	Whayne et al.	Feb 1999	A
5868755	Kanner et al.	Feb 1999	A
5868762	Cragg et al.	Feb 1999	A
5868763	Spence et al.	Feb 1999	A
5871474	Hermann et al.	Feb 1999	A
5871501	Leschinsky et al.	Feb 1999	A
5871525	Edwards et al.	Feb 1999	A
5873876	Christy	Feb 1999	A
5873891	Sohn	Feb 1999	A
5879366	Shaw et al.	Mar 1999	A
5891088	Thompson et al.	Apr 1999	A
5897487	Ouchi	Apr 1999	A
5902310	Foerster et al.	May 1999	A
5904696	Rosenman	May 1999	A
5904697	Gifford, III et al.	May 1999	A
5904703	Gilson	May 1999	A
5906631	Imran	May 1999	A
5907893	Zadno-Azizi et al.	Jun 1999	A
5908149	Welch et al.	Jun 1999	A
5910155	Ratcliff et al.	Jun 1999	A
5919207	Taheri	Jul 1999	A
5922009	Epstein et al.	Jul 1999	A
5928208	Chu et al.	Jul 1999	A
5928231	Klein et al.	Jul 1999	A
5928251	Aranyi et al.	Jul 1999	A
5928260	Chin et al.	Jul 1999	A
5935147	Kensey et al.	Aug 1999	A
5938667	Peyser et al.	Aug 1999	A
5941890	Voegele et al.	Aug 1999	A
5947999	Groiso	Sep 1999	A
5948001	Larsen	Sep 1999	A
5951518	Licata et al.	Sep 1999	A
5951575	Bolduc et al.	Sep 1999	A
5951576	Wakabayashi	Sep 1999	A
5951589	Epstein et al.	Sep 1999	A
5954732	Hart et al.	Sep 1999	A
5957900	Ouchi	Sep 1999	A
5957936	Yoon et al.	Sep 1999	A
5957938	Zhu et al.	Sep 1999	A
5957940	Tanner et al.	Sep 1999	A
5964782	Lafontaine et al.	Oct 1999	A
5972023	Tanner et al.	Oct 1999	A
5972034	Hofmann et al.	Oct 1999	A
5976161	Kirsch et al.	Nov 1999	A
5976174	Ruiz	Nov 1999	A
5984934	Ashby et al.	Nov 1999	A
5984948	Hasson	Nov 1999	A
5984949	Levin	Nov 1999	A
5993468	Rygaard	Nov 1999	A
5993476	Groiso	Nov 1999	A
6001110	Adams	Dec 1999	A
6004341	Zhu et al.	Dec 1999	A
6007563	Nash et al.	Dec 1999	A
6007574	Pulnev et al.	Dec 1999	A
6010517	Baccaro	Jan 2000	A
6013084	Ken et al.	Jan 2000	A
6015815	Mollison	Jan 2000	A
6019779	Thorud et al.	Feb 2000	A
6022372	Kontos	Feb 2000	A
6024750	Mastri	Feb 2000	A
6024756	Huebsch et al.	Feb 2000	A
6030364	Durgin et al.	Feb 2000	A
6030413	Lazarus	Feb 2000	A
6033427	Lee	Mar 2000	A
6036703	Evans et al.	Mar 2000	A
6036720	Abrams et al.	Mar 2000	A
6045570	Epstein et al.	Apr 2000	A
6048358	Barak	Apr 2000	A
6056688	Benderev et al.	May 2000	A
6056768	Cates et al.	May 2000	A
6056769	Epstein et al.	May 2000	A
6056770	Epstein et al.	May 2000	A
6059800	Hart et al.	May 2000	A
6059825	Hobbs et al.	May 2000	A
6063085	Tay et al.	May 2000	A
6063114	Nash et al.	May 2000	A
6071300	Brenneman et al.	Jun 2000	A
6074395	Trott et al.	Jun 2000	A
6077281	Das	Jun 2000	A
6077291	Das	Jun 2000	A
6080182	Shaw et al.	Jun 2000	A
6080183	Tsugita et al.	Jun 2000	A
6090130	Nash et al.	Jul 2000	A
6102271	Longo et al.	Aug 2000	A
6110184	Weadock	Aug 2000	A
6113610	Poncet	Sep 2000	A
6113611	Allen et al.	Sep 2000	A
6113612	Swanson et al.	Sep 2000	A
6117125	Rothbarth et al.	Sep 2000	A
6117144	Nobles et al.	Sep 2000	A
6117148	Ravo	Sep 2000	A
6117157	Tekulve	Sep 2000	A
6117159	Huebsch et al.	Sep 2000	A
6120524	Taheri	Sep 2000	A
6126675	Schervinsky et al.	Oct 2000	A
6136010	Modesitt et al.	Oct 2000	A
6146385	Torrie et al.	Nov 2000	A
6149660	Laufer et al.	Nov 2000	A
6149667	Hovland et al.	Nov 2000	A
6152144	Lesh et al.	Nov 2000	A
6152936	Christy et al.	Nov 2000	A
6152937	Peterson et al.	Nov 2000	A
6165204	Levinson et al.	Dec 2000	A
6171277	Ponzi	Jan 2001	B1
6171329	Shaw et al.	Jan 2001	B1
6174322	Schneidt	Jan 2001	B1
6179849	Yencho et al.	Jan 2001	B1
6179860	Fulton, III et al.	Jan 2001	B1
6183775	Ventouras	Feb 2001	B1
6193708	Ken et al.	Feb 2001	B1
6193734	Bolduc et al.	Feb 2001	B1
6197042	Ginn et al.	Mar 2001	B1
6198974	Webster, Jr.	Mar 2001	B1
6200329	Fung et al.	Mar 2001	B1
6200330	Benderev et al.	Mar 2001	B1
6206895	Levinson	Mar 2001	B1
6206913	Yencho et al.	Mar 2001	B1
6206931	Cook et al.	Mar 2001	B1
6210407	Webster	Apr 2001	B1
6210418	Storz et al.	Apr 2001	B1
6217554	Green	Apr 2001	B1
6220248	Voegele et al.	Apr 2001	B1
6221102	Baker et al.	Apr 2001	B1
6231561	Frazier et al.	May 2001	B1
6238705	Liu et al.	May 2001	B1
6241740	Davis et al.	Jun 2001	B1
6245079	Nobles et al.	Jun 2001	B1
6248124	Pedros et al.	Jun 2001	B1
6254617	Spence et al.	Jul 2001	B1
6254642	Taylor	Jul 2001	B1
6258115	Dubrul	Jul 2001	B1
6261309	Urbanski	Jul 2001	B1
6267773	Gadberry et al.	Jul 2001	B1
6273903	Wilk	Aug 2001	B1
6277140	Ginn et al.	Aug 2001	B2
6280460	Bolduc et al.	Aug 2001	B1
6287322	Zhu et al.	Sep 2001	B1
6287335	Drasler et al.	Sep 2001	B1
6290674	Roue et al.	Sep 2001	B1
6296657	Brucker	Oct 2001	B1
6302870	Jacobsen et al.	Oct 2001	B1
6302898	Edwards et al.	Oct 2001	B1
6305891	Burlingame	Oct 2001	B1
6309416	Swanson et al.	Oct 2001	B1
6319258	McAllen, III et al.	Nov 2001	B1
6322580	Kanner	Nov 2001	B1
6328727	Frazier et al.	Dec 2001	B1
6329386	Mollison	Dec 2001	B1
6334865	Redmond et al.	Jan 2002	B1
6348064	Kanner	Feb 2002	B1
6355052	Neuss et al.	Mar 2002	B1
6355061	Quiachon et al.	Mar 2002	B1
6358258	Arcia et al.	Mar 2002	B1
6375671	Kobayashi et al.	Apr 2002	B1
D457958	Dycus	May 2002	S
6383208	Sancoff et al.	May 2002	B1
6391048	Ginn et al.	May 2002	B1
6395015	Borst et al.	May 2002	B1
6398752	Sweezer et al.	Jun 2002	B1
6402765	Monassevitch et al.	Jun 2002	B1
6409739	Nobles et al.	Jun 2002	B1
6419669	Frazier et al.	Jul 2002	B1
6421899	Zitnay	Jul 2002	B1
6423054	Ouchi	Jul 2002	B1
6425911	Akerfeldt et al.	Jul 2002	B1
6428472	Haas	Aug 2002	B1
6428548	Durgin	Aug 2002	B1
6443158	Lafontaine et al.	Sep 2002	B1
6443963	Baldwin et al.	Sep 2002	B1
6447540	Fontaine et al.	Sep 2002	B1
6450391	Kayan et al.	Sep 2002	B1
6455053	Okada et al.	Sep 2002	B1
6458130	Frazier et al.	Oct 2002	B1
6461364	Ginn et al.	Oct 2002	B1
6482224	Michler et al.	Nov 2002	B1
6485504	Johnson et al.	Nov 2002	B1
6488692	Spence et al.	Dec 2002	B1
6494848	Sommercorn et al.	Dec 2002	B1
6500115	Krattiger et al.	Dec 2002	B2
6506210	Kanner	Jan 2003	B1
6508828	Akerfeldt et al.	Jan 2003	B1
6514280	Gilson	Feb 2003	B1
6517555	Caro	Feb 2003	B1
6517569	Mikus et al.	Feb 2003	B2
6527737	Kaneshige	Mar 2003	B2
6533762	Kanner et al.	Mar 2003	B2
6533812	Swanson et al.	Mar 2003	B2
6537288	Vargas et al.	Mar 2003	B2
6544230	Flaherty et al.	Apr 2003	B1
6547806	Ding	Apr 2003	B1
6551303	Van Tassel et al.	Apr 2003	B1
6551319	Lieberman	Apr 2003	B2
6558349	Kirkman	May 2003	B1
6569173	Blatter et al.	May 2003	B1
6569185	Ungs	May 2003	B2
6572629	Kalloo et al.	Jun 2003	B2
6582452	Coleman et al.	Jun 2003	B2
6582482	Gillman et al.	Jun 2003	B2
6596012	Akerfeldt et al.	Jul 2003	B2
6596013	Yang et al.	Jul 2003	B2
6599303	Peterson et al.	Jul 2003	B1
6599311	Biggs et al.	Jul 2003	B1
6602263	Swanson et al.	Aug 2003	B1
6610072	Christy et al.	Aug 2003	B1
6613059	Schaller et al.	Sep 2003	B2
6616686	Coleman et al.	Sep 2003	B2
6620165	Wellisz	Sep 2003	B2
6623509	Ginn	Sep 2003	B2
6623510	Carley et al.	Sep 2003	B2
6626918	Ginn et al.	Sep 2003	B1
6626919	Swanstrom	Sep 2003	B1
6626920	Whayne	Sep 2003	B2
6626930	Allen et al.	Sep 2003	B1
6632197	Lyon	Oct 2003	B2
6632238	Ginn et al.	Oct 2003	B2
6634537	Chen	Oct 2003	B2
6645205	Ginn	Nov 2003	B2
6645225	Atkinson	Nov 2003	B1
6652538	Kayan et al.	Nov 2003	B2
6652555	VanTassel et al.	Nov 2003	B1
6652556	VanTassel et al.	Nov 2003	B1
6663633	Pierson, III	Dec 2003	B1
6663655	Ginn et al.	Dec 2003	B2
6669714	Coleman et al.	Dec 2003	B2
6673083	Kayan et al.	Jan 2004	B1
6676665	Foley et al.	Jan 2004	B2
6676671	Robertson et al.	Jan 2004	B2
6676685	Pedros et al.	Jan 2004	B2
6679894	Damarati	Jan 2004	B2
6679904	Gleeson et al.	Jan 2004	B2
6685707	Roman et al.	Feb 2004	B2
6689147	Koster, Jr.	Feb 2004	B1
6689150	VanTassel et al.	Feb 2004	B1
6695867	Ginn et al.	Feb 2004	B2
6699256	Logan et al.	Mar 2004	B1
6702825	Frazier et al.	Mar 2004	B2
6702826	Liddicoat et al.	Mar 2004	B2
6712836	Berg et al.	Mar 2004	B1
6712837	Akerfeldt et al.	Mar 2004	B2
6719777	Ginn et al.	Apr 2004	B2
6726704	Loshakove et al.	Apr 2004	B1
6730108	Van Tassel et al.	May 2004	B2
6743195	Zucker	Jun 2004	B2
6743243	Roy et al.	Jun 2004	B1
6743259	Ginn	Jun 2004	B2
6746472	Frazier et al.	Jun 2004	B2
6749621	Pantages et al.	Jun 2004	B2
6749622	McGuckin et al.	Jun 2004	B2
6752813	Goldfarb et al.	Jun 2004	B2
6755842	Kanner et al.	Jun 2004	B2
6758855	Fulton, III et al.	Jul 2004	B2
6767356	Kanner et al.	Jul 2004	B2
6776784	Ginn	Aug 2004	B2
6780197	Roe et al.	Aug 2004	B2
6786915	Akerfeldt et al.	Sep 2004	B2
6790218	Jayaraman	Sep 2004	B2
6790220	Morris et al.	Sep 2004	B2
6814742	Kimura et al.	Nov 2004	B2
6837893	Miller	Jan 2005	B2
6837906	Ginn	Jan 2005	B2
6846319	Ginn et al.	Jan 2005	B2
6860895	Akerfeldt et al.	Mar 2005	B1
6890343	Ginn et al.	May 2005	B2
6896687	Dakov	May 2005	B2
6896692	Ginn et al.	May 2005	B2
6913607	Ainsworth et al.	Jul 2005	B2
6926723	Mulhauser et al.	Aug 2005	B1
6926731	Coleman et al.	Aug 2005	B2
6929634	Dorros et al.	Aug 2005	B2
6942641	Seddon	Sep 2005	B2
6942674	Belef et al.	Sep 2005	B2
6942691	Chuter	Sep 2005	B1
6949113	Van Tassel et al.	Sep 2005	B2
6964668	Modesitt et al.	Nov 2005	B2
6969391	Gazzani	Nov 2005	B1
6969397	Ginn	Nov 2005	B2
6989003	Wing et al.	Jan 2006	B2
6989016	Tallarida et al.	Jan 2006	B2
7001398	Carley et al.	Feb 2006	B2
7001400	Modesitt et al.	Feb 2006	B1
7008435	Cummins	Mar 2006	B2
7008439	Janzen et al.	Mar 2006	B1
7011671	Welch	Mar 2006	B2
7025776	Houser et al.	Apr 2006	B1
7033379	Peterson	Apr 2006	B2
7060084	Loshakove et al.	Jun 2006	B1
7063711	Loshakove et al.	Jun 2006	B1
7074232	Kanner et al.	Jul 2006	B2
7076305	Imran et al.	Jul 2006	B2
7083635	Ginn	Aug 2006	B2
7087064	Hyde	Aug 2006	B1
7087088	Berg et al.	Aug 2006	B2
7094245	Adams et al.	Aug 2006	B2
7108709	Cummins	Sep 2006	B2
7111768	Cummins et al.	Sep 2006	B2
7112225	Ginn	Sep 2006	B2
7144411	Ginn et al.	Dec 2006	B2
7163551	Anthony et al.	Jan 2007	B2
7169158	Sniffin et al.	Jan 2007	B2
7169164	Borillo et al.	Jan 2007	B2
7175646	Brenneman et al.	Feb 2007	B2
7211101	Carley et al.	May 2007	B2
7220268	Blatter	May 2007	B2
7229452	Kayan	Jun 2007	B2
7261716	Strobel et al.	Aug 2007	B2
7306614	Weller et al.	Dec 2007	B2
7311720	Mueller et al.	Dec 2007	B2
7316704	Bagaoisan et al.	Jan 2008	B2
7316706	Bloom et al.	Jan 2008	B2
7322995	Buckman et al.	Jan 2008	B2
7326230	Ravikumar	Feb 2008	B2
7331979	Khosravi et al.	Feb 2008	B2
7335220	Khosravi et al.	Feb 2008	B2
D566272	Walberg et al.	Apr 2008	S
7361178	Hearn et al.	Apr 2008	B2
7361183	Ginn	Apr 2008	B2
7361185	O'Malley et al.	Apr 2008	B2
7393363	Ginn	Jul 2008	B2
7396359	Derowe et al.	Jul 2008	B1
7427279	Frazier et al.	Sep 2008	B2
7431729	Chanduszko	Oct 2008	B2
7445596	Kucklick et al.	Nov 2008	B2
7452327	Durgin et al.	Nov 2008	B2
7465286	Patterson et al.	Dec 2008	B2
7533790	Knodel et al.	May 2009	B1
7549983	Roue et al.	Jun 2009	B2
7556632	Zadno	Jul 2009	B2
7582103	Young et al.	Sep 2009	B2
7582104	Corcoran et al.	Sep 2009	B2
7597704	Frazier et al.	Oct 2009	B2
7597706	Kanner et al.	Oct 2009	B2
7618427	Ortiz et al.	Nov 2009	B2
7622628	Bergin et al.	Nov 2009	B2
D611144	Reynolds	Mar 2010	S
7678135	Maahs et al.	Mar 2010	B2
7713282	Frazier et al.	May 2010	B2
7722641	van der Burg et al.	May 2010	B2
7727189	VanTassel et al.	Jun 2010	B2
7735493	van der Burg et al.	Jun 2010	B2
7780696	Daniel et al.	Aug 2010	B2
7806904	Carley et al.	Oct 2010	B2
7819895	Ginn et al.	Oct 2010	B2
7824419	Boraiah	Nov 2010	B2
7841502	Walberg et al.	Nov 2010	B2
7842068	Ginn	Nov 2010	B2
7850709	Cummins et al.	Dec 2010	B2
7850710	Huss	Dec 2010	B2
7850797	Carley et al.	Dec 2010	B2
7854810	Carley et al.	Dec 2010	B2
7857828	Jabba et al.	Dec 2010	B2
7867249	Palermo et al.	Jan 2011	B2
7875054	LaFontaine	Jan 2011	B2
7879071	Carley et al.	Feb 2011	B2
7887555	Carley et al.	Feb 2011	B2
7887563	Cummins et al.	Feb 2011	B2
7901428	Ginn et al.	Mar 2011	B2
7905900	Palermo	Mar 2011	B2
7918873	Cummins et al.	Apr 2011	B2
7931669	Ginn et al.	Apr 2011	B2
7931671	Tenerz	Apr 2011	B2
7967842	Bakos	Jun 2011	B2
7972359	Kreidler	Jul 2011	B2
8007512	Ginn et al.	Aug 2011	B2
8038688	Modesitt et al.	Oct 2011	B2
8043305	Frazier et al.	Oct 2011	B2
8043329	Khairkhahan et al.	Oct 2011	B2
8052715	Quinn et al.	Nov 2011	B2
8080032	van der Burg et al.	Dec 2011	B2
8083768	Ginn et al.	Dec 2011	B2
8103327	Harley et al.	Jan 2012	B2
8105352	Egnelöv	Jan 2012	B2
8128644	Carley et al.	Mar 2012	B2
8142470	Quinn et al.	Mar 2012	B2
8172749	Melsheimer	May 2012	B2
8182497	Carley et al.	May 2012	B2
8192459	Cummins et al.	Jun 2012	B2
8197496	Roue et al.	Jun 2012	B2
8197527	Borillo et al.	Jun 2012	B2
8202283	Carley et al.	Jun 2012	B2
8202293	Ellingwood et al.	Jun 2012	B2
8202294	Jabba et al.	Jun 2012	B2
8211122	McIntosh	Jul 2012	B2
8216260	Lam et al.	Jul 2012	B2
8221384	Frazier et al.	Jul 2012	B2
8221445	Van Tassel et al.	Jul 2012	B2
8226681	Clark et al.	Jul 2012	B2
8236026	Carley et al.	Aug 2012	B2
8257390	Carley et al.	Sep 2012	B2
8287563	Khairkhahan et al.	Oct 2012	B2
8303624	Fortson	Nov 2012	B2
8313497	Walberg et al.	Nov 2012	B2
8323309	Khairkhahan et al.	Dec 2012	B2
8323312	Clark	Dec 2012	B2
8398656	Palermo et al.	Mar 2013	B2
8398676	Roorda et al.	Mar 2013	B2
8403929	Weisshaupt et al.	Mar 2013	B2
8409228	Blatter et al.	Apr 2013	B2
8469995	Cummins et al.	Jun 2013	B2
8480687	Ducharme et al.	Jul 2013	B2
8486092	Carley et al.	Jul 2013	B2
8486108	Carley et al.	Jul 2013	B2
8491609	Stone	Jul 2013	B2
8518057	Walberg et al.	Aug 2013	B2
8523897	van der Burg et al.	Sep 2013	B2
8529587	Ellingwood et al.	Sep 2013	B2
8535343	van der Burg et al.	Sep 2013	B2
8556930	Ellingwood	Oct 2013	B2
8556932	Ziobro	Oct 2013	B2
8562630	Campbell	Oct 2013	B2
8574244	Reynolds	Nov 2013	B2
8579932	Pantages	Nov 2013	B2
8585836	Carley et al.	Nov 2013	B2
8590760	Cummins et al.	Nov 2013	B2
8597325	Ginn	Dec 2013	B2
8603108	Roue et al.	Dec 2013	B2
8603116	Roorda	Dec 2013	B2
8603136	Ginn	Dec 2013	B2
8617184	Oepen	Dec 2013	B2
8647361	Borillo et al.	Feb 2014	B2
8657852	Roorda et al.	Feb 2014	B2
8663268	Quinn et al.	Mar 2014	B2
8663273	Khairkhahan et al.	Mar 2014	B2
8672953	Reyes et al.	Mar 2014	B2
8685055	VanTassel et al.	Apr 2014	B2
8690910	Carley et al.	Apr 2014	B2
8728119	Cummins	May 2014	B2
8758396	Ginn et al.	Jun 2014	B2
8758398	Carley	Jun 2014	B2
8758399	Fortson et al.	Jun 2014	B2
8758400	Ginn et al.	Jun 2014	B2
8784447	Coleman et al.	Jul 2014	B2
8808310	Jones et al.	Aug 2014	B2
8820602	Walberg et al.	Sep 2014	B2
8821534	Voss	Sep 2014	B2
8834494	Schorr et al.	Sep 2014	B2
8858594	Clark	Oct 2014	B2
8893947	Reynolds et al.	Nov 2014	B2
8905937	Ellingwood et al.	Dec 2014	B2
8926633	Carly	Jan 2015	B2
8926656	Palermo et al.	Jan 2015	B2
8956388	Ginn et al.	Feb 2015	B2
8992549	Bennett, III	Mar 2015	B2
9050068	Walberg et al.	Jun 2015	B2
9050087	Ginn et al.	Jun 2015	B2
9060769	Coleman et al.	Jun 2015	B2
9089311	Fortson et al.	Jul 2015	B2
9089674	Ginn et al.	Jul 2015	B2
9149276	Voss	Oct 2015	B2
9173644	Voss	Nov 2015	B2
9241696	Mehl	Jan 2016	B2
9271706	Stopek et al.	Mar 2016	B2
9271707	Palermo et al.	Mar 2016	B2
9282965	Kokish	Mar 2016	B2
9295469	Cummins et al.	Mar 2016	B2
9314230	Roorda et al.	Apr 2016	B2
9320522	Carley et al.	Apr 2016	B2
9332976	Yribarren	May 2016	B2
9345460	Houser et al.	May 2016	B2
9364209	Voss	Jun 2016	B2
9398914	Ellingwood et al.	Jul 2016	B2
9402625	Coleman et al.	Aug 2016	B2
9414820	Voss et al.	Aug 2016	B2
9414824	Fortson et al.	Aug 2016	B2
9486191	Gianotti et al.	Nov 2016	B2
9498196	Pantages et al.	Nov 2016	B2
9554786	Carley et al.	Jan 2017	B2
9579091	Ginn et al.	Feb 2017	B2
9585646	Carley et al.	Mar 2017	B2
9585647	Clark	Mar 2017	B2
20010007077	Ginn et al.	Jul 2001	A1
20010021855	Levinson	Sep 2001	A1
20010031972	Robertson et al.	Oct 2001	A1
20010031973	Nobles et al.	Oct 2001	A1
20010044639	Levinson	Nov 2001	A1
20010046518	Sawhney	Nov 2001	A1
20010047180	Grudem et al.	Nov 2001	A1
20020022822	Cragg et al.	Feb 2002	A1
20020026215	Redmond et al.	Feb 2002	A1
20020026216	Grimes	Feb 2002	A1
20020029050	Gifford, III et al.	Mar 2002	A1
20020038127	Blatter et al.	Mar 2002	A1
20020042622	Vargas et al.	Apr 2002	A1
20020045908	Nobles et al.	Apr 2002	A1
20020045909	Kimura et al.	Apr 2002	A1
20020049427	Wiener et al.	Apr 2002	A1
20020049453	Nobles et al.	Apr 2002	A1
20020056460	Boyd et al.	May 2002	A1
20020058960	Hudson et al.	May 2002	A1
20020062104	Ashby et al.	May 2002	A1
20020077656	Ginn et al.	Jun 2002	A1
20020077657	Ginn et al.	Jun 2002	A1
20020077658	Ginn	Jun 2002	A1
20020082641	Ginn et al.	Jun 2002	A1
20020095164	Andreas et al.	Jul 2002	A1
20020095181	Beyar	Jul 2002	A1
20020099389	Michler et al.	Jul 2002	A1
20020106409	Sawhney et al.	Aug 2002	A1
20020107542	Kanner et al.	Aug 2002	A1
20020151921	Kanner et al.	Oct 2002	A1
20020151963	Brown et al.	Oct 2002	A1
20020169475	Gainor et al.	Nov 2002	A1
20020183786	Girton	Dec 2002	A1
20020183787	Wahr et al.	Dec 2002	A1
20020188170	Santamore et al.	Dec 2002	A1
20020198562	Ackerfeldt et al.	Dec 2002	A1
20020198589	Leong	Dec 2002	A1
20030004543	Gleeson et al.	Jan 2003	A1
20030009180	Hinchliffe et al.	Jan 2003	A1
20030018358	Saadat	Jan 2003	A1
20030023248	Parodi	Jan 2003	A1
20030032981	Kanner et al.	Feb 2003	A1
20030033006	Phillips et al.	Feb 2003	A1
20030045893	Ginn	Mar 2003	A1
20030055455	Yang et al.	Mar 2003	A1
20030060846	Egnelov et al.	Mar 2003	A1
20030065358	Frecker et al.	Apr 2003	A1
20030078465	Pai et al.	Apr 2003	A1
20030083679	Grudem et al.	May 2003	A1
20030088269	Ashby	May 2003	A1
20030093096	McGuckin et al.	May 2003	A1
20030093108	Avellanet et al.	May 2003	A1
20030097140	Kanner	May 2003	A1
20030109890	Kanner et al.	Jun 2003	A1
20030125766	Ding	Jul 2003	A1
20030139819	Beer et al.	Jul 2003	A1
20030144695	McGuckin, Jr. et al.	Jul 2003	A1
20030158578	Pantages et al.	Aug 2003	A1
20030167063	Kerr	Sep 2003	A1
20030195504	Tallarida et al.	Oct 2003	A1
20030208211	Kortenbach	Nov 2003	A1
20040002763	Phillips et al.	Jan 2004	A1
20040009205	Sawhney	Jan 2004	A1
20040044350	Martin et al.	Mar 2004	A1
20040049224	Buehlmann et al.	Mar 2004	A1
20040059376	Breuniger	Mar 2004	A1
20040068273	Fariss et al.	Apr 2004	A1
20040078053	Berg et al.	Apr 2004	A1
20040082906	Tallarida et al.	Apr 2004	A1
20040087985	Loshakove et al.	May 2004	A1
20040092962	Thornton et al.	May 2004	A1
20040092964	Modesitt et al.	May 2004	A1
20040092968	Caro et al.	May 2004	A1
20040092973	Chanduszko et al.	May 2004	A1
20040093024	Lousararian et al.	May 2004	A1
20040093027	Fabisiak et al.	May 2004	A1
20040097978	Modesitt et al.	May 2004	A1
20040106980	Solovay et al.	Jun 2004	A1
20040127940	Ginn et al.	Jul 2004	A1
20040143290	Brightbill	Jul 2004	A1
20040143291	Corcoran et al.	Jul 2004	A1
20040147957	Pierson, III	Jul 2004	A1
20040158127	Okada	Aug 2004	A1
20040158287	Cragg et al.	Aug 2004	A1
20040158309	Wachter et al.	Aug 2004	A1
20040167511	Buehlmann et al.	Aug 2004	A1
20040191277	Sawhney et al.	Sep 2004	A1
20040215232	Belhe et al.	Oct 2004	A1
20040225301	Roop et al.	Nov 2004	A1
20040243216	Gregorich	Dec 2004	A1
20040249412	Snow et al.	Dec 2004	A1
20040254591	Kanner et al.	Dec 2004	A1
20040267193	Bagaoisan et al.	Dec 2004	A1
20040267308	Bagaoisan et al.	Dec 2004	A1
20040267312	Kanner et al.	Dec 2004	A1
20050038460	Jayaraman	Feb 2005	A1
20050038500	Boylan et al.	Feb 2005	A1
20050059982	Zung et al.	Mar 2005	A1
20050075654	Kelleher	Apr 2005	A1
20050075665	Brenzel et al.	Apr 2005	A1
20050085851	Fiehler et al.	Apr 2005	A1
20050085854	Ginn	Apr 2005	A1
20050085855	Forsberg	Apr 2005	A1
20050090859	Ravlkumar	Apr 2005	A1
20050119695	Carley et al.	Jun 2005	A1
20050121042	Belhe et al.	Jun 2005	A1
20050148818	Mesallum	Jul 2005	A1
20050149066	Stafford	Jul 2005	A1
20050149117	Khosravi et al.	Jul 2005	A1
20050152949	Hotchkiss et al.	Jul 2005	A1
20050154401	Weldon et al.	Jul 2005	A1
20050165357	McGuckin et al.	Jul 2005	A1
20050169974	Tenerez et al.	Aug 2005	A1
20050177189	Ginn et al.	Aug 2005	A1
20050187564	Jayaraman	Aug 2005	A1
20050203552	Laufer et al.	Sep 2005	A1
20050222614	Ginn et al.	Oct 2005	A1
20050228405	Maruyama et al.	Oct 2005	A1
20050228443	Yassinzadeh	Oct 2005	A1
20050245876	Khosravi et al.	Nov 2005	A1
20050256532	Nayak et al.	Nov 2005	A1
20050267495	Ginn et al.	Dec 2005	A1
20050267524	Chanduszko	Dec 2005	A1
20050273136	Belef et al.	Dec 2005	A1
20050273137	Ginn	Dec 2005	A1
20050283188	Loshakove et al.	Dec 2005	A1
20060030867	Zadno	Feb 2006	A1
20060034930	Khosravi et al.	Feb 2006	A1
20060047313	Khanna et al.	Mar 2006	A1
20060064115	Allen et al.	Mar 2006	A1
20060069397	Nobles et al.	Mar 2006	A1
20060100664	Pai et al.	May 2006	A1
20060142784	Kontos	Jun 2006	A1
20060162509	Wang	Jul 2006	A1
20060190014	Ginn et al.	Aug 2006	A1
20060190036	Wendel et al.	Aug 2006	A1
20060190037	Ginn et al.	Aug 2006	A1
20060195123	Ginn et al.	Aug 2006	A1
20060195125	Sakakine et al.	Aug 2006	A1
20060206146	Tenerez	Sep 2006	A1
20060217744	Bender et al.	Sep 2006	A1
20060229553	Hammack et al.	Oct 2006	A1
20060253037	Ginn et al.	Nov 2006	A1
20060253072	Pai et al.	Nov 2006	A1
20060281968	Duran et al.	Dec 2006	A1
20060287673	Brett et al.	Dec 2006	A1
20060293698	Douk	Dec 2006	A1
20070005093	Cox	Jan 2007	A1
20070010851	Chanduszko et al.	Jan 2007	A1
20070027476	Harris et al.	Feb 2007	A1
20070027525	Ben-Muvhar	Feb 2007	A1
20070049968	Sibbitt, Jr. et al.	Mar 2007	A1
20070049970	Belef et al.	Mar 2007	A1
20070060858	Sogard et al.	Mar 2007	A1
20070060895	Sibbitt, Jr. et al.	Mar 2007	A1
20070060950	Khosravi et al.	Mar 2007	A1
20070073337	Abbott et al.	Mar 2007	A1
20070078302	Ortiz et al.	Apr 2007	A1
20070083230	Javois	Apr 2007	A1
20070083231	Lee	Apr 2007	A1
20070093869	Bloom et al.	Apr 2007	A1
20070112304	Voss	May 2007	A1
20070112365	Hilal et al.	May 2007	A1
20070112385	Conlon	May 2007	A1
20070123816	Zhu et al.	May 2007	A1
20070123817	Khosravi et al.	May 2007	A1
20070149996	Coughlin	Jun 2007	A1
20070167981	Opolski et al.	Jul 2007	A1
20070172430	Brito et al.	Jul 2007	A1
20070179527	Eskuri et al.	Aug 2007	A1
20070185529	Coleman et al.	Aug 2007	A1
20070185530	Chin-Chen et al.	Aug 2007	A1
20070203507	McLaughlin et al.	Aug 2007	A1
20070208376	Meng	Sep 2007	A1
20070225755	Preinitz et al.	Sep 2007	A1
20070225756	Preinitz et al.	Sep 2007	A1
20070225757	Preinitz et al.	Sep 2007	A1
20070225758	Preinitz et al.	Sep 2007	A1
20070239209	Fallman	Oct 2007	A1
20070265658	Nelson et al.	Nov 2007	A1
20070275036	Green, III et al.	Nov 2007	A1
20070276488	Wachter et al.	Nov 2007	A1
20070282373	Ashby et al.	Dec 2007	A1
20080009794	Bagaoisan et al.	Jan 2008	A1
20080033459	Shafi et al.	Feb 2008	A1
20080045979	Ma	Feb 2008	A1
20080058839	Nobles et al.	Mar 2008	A1
20080065151	Ginn	Mar 2008	A1
20080082123	Forsberg et al.	Apr 2008	A1
20080086075	Isik et al.	Apr 2008	A1
20080091235	Sirota	Apr 2008	A1
20080093414	Bender et al.	Apr 2008	A1
20080097509	Beyar et al.	Apr 2008	A1
20080114378	Matsushita	May 2008	A1
20080114395	Mathisen et al.	May 2008	A1
20080177288	Carlson	Jul 2008	A1
20080208225	Seibold et al.	Aug 2008	A1
20080215089	Williams et al.	Sep 2008	A1
20080215090	Gonzales et al.	Sep 2008	A1
20080243148	Mikkaichi et al.	Oct 2008	A1
20080243182	Bates et al.	Oct 2008	A1
20080249504	Lattouf et al.	Oct 2008	A1
20080262541	Sater et al.	Oct 2008	A1
20080269801	Coleman et al.	Oct 2008	A1
20080287988	Smith et al.	Nov 2008	A1
20080294001	Surti	Nov 2008	A1
20080300628	Ellingwood	Dec 2008	A1
20080312667	Drasler et al.	Dec 2008	A1
20080312686	Ellingwood	Dec 2008	A1
20080312740	Wachter et al.	Dec 2008	A1
20090054912	Heanue et al.	Feb 2009	A1
20090062846	Ken	Mar 2009	A1
20090112306	Bonsignore et al.	Apr 2009	A1
20090132031	Cook et al.	May 2009	A1
20090137900	Bonner et al.	May 2009	A1
20090157101	Reyes et al.	Jun 2009	A1
20090171388	Dave et al.	Jul 2009	A1
20090187215	Mackiewicz et al.	Jul 2009	A1
20090216267	Willard et al.	Aug 2009	A1
20090221960	Albrecht et al.	Sep 2009	A1
20090227938	Fasching et al.	Sep 2009	A1
20090230168	Coleman et al.	Sep 2009	A1
20090254119	Sibbitt, Jr. et al.	Oct 2009	A1
20090259233	Bogart et al.	Oct 2009	A1
20090281555	Stone	Nov 2009	A1
20090299133	Gifford, III et al.	Dec 2009	A1
20090312789	Kassab et al.	Dec 2009	A1
20100022821	Dubi et al.	Jan 2010	A1
20100042118	Garrison et al.	Feb 2010	A1
20100042144	Bennett	Feb 2010	A1
20100114119	McLawhorn et al.	May 2010	A1
20100130965	Sibbitt, Jr. et al.	May 2010	A1
20100179567	Voss et al.	Jul 2010	A1
20100179589	Roorda et al.	Jul 2010	A1
20100185216	Garrison et al.	Jul 2010	A1
20100185234	Fortson et al.	Jul 2010	A1
20100249828	Mavani et al.	Sep 2010	A1
20110054492	Clark	Mar 2011	A1
20110082495	Ruiz	Apr 2011	A1
20110137340	Cummins	Jun 2011	A1
20110178548	Tenerz	Jul 2011	A1
20110190793	Nobles et al.	Aug 2011	A1
20110190811	Shanley	Aug 2011	A1
20110218568	Voss	Sep 2011	A1
20110270282	Lemke	Nov 2011	A1
20120101520	Ginn et al.	Apr 2012	A1
20120245623	Kariniemi et al.	Sep 2012	A1
20130053792	Fischell et al.	Feb 2013	A1
20130178872	Shriver	Jul 2013	A1
20130310853	Zaugg et al.	Nov 2013	A1
20140018850	Ellingwood	Jan 2014	A1
20140039549	Belsky et al.	Feb 2014	A1
20140081318	Houser et al.	Mar 2014	A1
20140309686	Ginn et al.	Oct 2014	A1
20150080914	Roundy et al.	Mar 2015	A1
20150190071	Ellingwood et al.	Jul 2015	A1
20150265279	Walberg et al.	Sep 2015	A1
20160000417	Voss et al.	Jan 2016	A1
20160051258	Cummins et al.	Feb 2016	A1
20160120546	Roundy et al.	May 2016	A1
20160151057	Voss	Jun 2016	A1
20160174954	Palermo et al.	Jun 2016	A1
20160192913	Kokish	Jul 2016	A1
20160213357	Mehl	Jul 2016	A1
20160242749	Voss	Aug 2016	A1
20170020496	Yribarren	Jan 2017	A1
20170020517	Coleman et al.	Jan 2017	A1
20170049426	Gianotti et al.	Feb 2017	A1
20170135680	Pantages et al.	May 2017	A1
20180256166	Cummins et al.	Sep 2018	A1

Foreign Referenced Citations (141)

Number	Date	Country
2003297432	Jul 2004	AU
2 339 060	Feb 2000	CA
197 11 288	Oct 1998	DE
29723736	Apr 1999	DE
19859952	Feb 2000	DE
102006056283	Jun 2008	DE
0 386 361	Sep 1990	EP
0 534 696	Mar 1993	EP
0 621 032	Oct 1994	EP
0 756 851	Feb 1997	EP
0 774 237	May 1997	EP
0 858 776	Aug 1998	EP
0 941 697	Sep 1999	EP
1 867 287	Dec 2007	EP
2 443 238	Jul 1980	FR
2 715 290	Jul 1995	FR
2 722 975	Feb 1996	FR
2 768 324	Mar 1999	FR
1 358 466	Jul 1974	GB
2 075 144	Nov 1981	GB
2 397 240	Jul 2004	GB
S20000722	Oct 2001	IE
S20000724	Oct 2001	IE
S20010547	Jul 2002	IE
S20010815	Jul 2002	IE
S20010748	Aug 2002	IE
S20010749	Aug 2002	IE
S20020452	Dec 2002	IE
S20020664	Feb 2003	IE
S20020665	Feb 2003	IE
S20020451	Jul 2003	IE
S20020552	Jul 2003	IE
S20030424	Dec 2003	IE
S20030490	Jan 2004	IE
S20040368	Nov 2005	IE
S20050342	Nov 2005	IE
58-181006	Dec 1983	JP
12 74750	Nov 1989	JP
11500642	Aug 1997	JP
2000102546	Apr 2000	JP
9302140	Jul 1995	NL
171425	Apr 1997	PL
2086192	Aug 1997	RU
495067	Dec 1975	SU
912155	Mar 1982	SU
1243708	Jul 1986	SU
1324650	Jul 1987	SU
1405828	Jun 1988	SU
1456109	Feb 1989	SU
1560133	Apr 1990	SU
WO 9600033	Jan 1996	WO
WO 9624291	Aug 1996	WO
WO 9700046	Jan 1997	WO
WO 9707741	Mar 1997	WO
WO 9720505	Jun 1997	WO
WO 9727897	Aug 1997	WO
WO 9806346	Feb 1998	WO
WO 9806448	Feb 1998	WO
WO 9816161	Apr 1998	WO
WO 9817179	Apr 1998	WO
WO 9818389	May 1998	WO
WO 9824374	Jun 1998	WO
WO 9825508	Jun 1998	WO
WO 9858591	Dec 1998	WO
WO 9921491	May 1999	WO
WO 9940849	Aug 1999	WO
WO 9960941	Dec 1999	WO
WO 9962408	Dec 1999	WO
WO 9962415	Dec 1999	WO
WO 0006029	Feb 2000	WO
WO 0007505	Feb 2000	WO
WO 0007640	Feb 2000	WO
WO 0027311	May 2000	WO
WO 0027313	May 2000	WO
WO 0056223	Sep 2000	WO
WO 0056227	Sep 2000	WO
WO 0056228	Sep 2000	WO
WO 0071032	Nov 2000	WO
WO 0121058	Mar 2001	WO
WO 0135832	May 2001	WO
WO 0137742	May 2001	WO
WO 0147594	Jul 2001	WO
WO 0149186	Jul 2001	WO
WO 0191628	Dec 2001	WO
WO 0219915	Mar 2002	WO
WO 0219920	Mar 2002	WO
WO 0219922	Mar 2002	WO
WO 0219924	Mar 2002	WO
WO 0228286	Apr 2002	WO
WO 0238055	May 2002	WO
WO 0245593	Jun 2002	WO
WO 0245594	Jun 2002	WO
WO 0262234	Aug 2002	WO
WO 0298302	Dec 2002	WO
WO 0313363	Feb 2003	WO
WO 0313364	Feb 2003	WO
WO 0347434	Jun 2003	WO
WO 0371955	Sep 2003	WO
WO 0371956	Sep 2003	WO
WO 0371957	Sep 2003	WO
WO 0394748	Nov 2003	WO
WO 03101310	Dec 2003	WO
WO 0404578	Jan 2004	WO
WO 0412602	Feb 2004	WO
WO 0460169	Jul 2004	WO
WO 0469054	Aug 2004	WO
WO 05000126	Jan 2005	WO
WO 05006990	Jan 2005	WO
WO 05041782	May 2005	WO
WO 05063129	Jul 2005	WO
WO 05082256	Sep 2005	WO
WO 05092204	Oct 2005	WO
WO 05110240	Nov 2005	WO
WO 05112782	Dec 2005	WO
WO 05115251	Dec 2005	WO
WO 05115521	Dec 2005	WO
WO 06000514	Jan 2006	WO
WO 06026116	Mar 2006	WO
WO 06052611	May 2006	WO
WO 06052612	May 2006	WO
WO 06078578	Jul 2006	WO
WO 06083889	Aug 2006	WO
WO 06115901	Nov 2006	WO
WO 06115904	Nov 2006	WO
WO 06118877	Nov 2006	WO
WO 0705585	Jan 2007	WO
WO 0725014	Mar 2007	WO
WO 0781836	Jul 2007	WO
WO 0788069	Aug 2007	WO
WO 08031102	Mar 2008	WO
WO 08036384	Mar 2008	WO
WO 08074027	Jun 2008	WO
WO 08150915	Dec 2008	WO
WO 09079091	Jun 2009	WO
WO 10062693	Jun 2010	WO
WO 10081101	Jul 2010	WO
WO 10081102	Jul 2010	WO
WO 10081103	Jul 2010	WO
WO 10081106	Jul 2010	WO
200100527	Jan 2001	ZA
200100528	Jan 2001	ZA

Non-Patent Literature Citations (674)

Entry
U.S. Appl. No. 13/837,801, Jul. 6, 2017, Office Action.
U.S. Appl. No. 14/023,428, Jul. 18, 2017, Office Action.
U.S. Appl. No. 14/023,428, Jan. 4, 2018, Notice of Allowance.
U.S. Appl. No. 14/312,339, May 23, 2017, Office Action.
U.S. Appl. No. 14/312,339, Aug. 28, 2017, Office Action.
U.S. Appl. No. 14/312,339, Dec. 28, 2017, Office Action.
U.S. Appl. No. 14/732,977, Sep. 26, 2017, Office Action.
U.S. Appl. No. 14/732,977, May 29, 2018, Notice of Allowance.
U.S. Appl. No. 14/839,658, May 30, 2017, Office Action.
U.S. Appl. No. 14/839,658, Sep. 19, 2017, Office Action.
U.S. Appl. No. 14/839,658, Feb. 28, 2018, Notice of Allowance.
U.S. Appl. No. 14/855,080, Apr. 2, 2018, Office Action.
U.S. Appl. No. 14/928,950, Sep. 26, 2017, Office Action.
U.S. Appl. No. 14/928,950, Mar. 30, 2018, Office Action.
U.S. Appl. No. 14/928,950, Jun. 4, 2018, Interview Summary.
U.S. Appl. No. 15/056,281, Feb. 5, 2018, Office Action.
U.S. Appl. No. 15/056,281, Jun. 13, 2018, Office Action.
U.S. Appl. No. 15/069,230, Feb. 15, 2018, Office Action.
U.S. Appl. No. 15/149,784, May 11, 2017, Office Action.
U.S. Appl. No. 15/356,028, Feb. 22, 2018, Office Action.
U.S. Appl. No. 09/610,128, filed Jul. 5, 2000, Kerievsky.
U.S. Appl. No. 09/866,551, filed May 25, 2001, Ginn.
U.S. Appl. No. 12/113,092, filed Apr. 30, 2008, Ginn et al.
U.S. Appl. No. 13/017,636, filed Jan. 31, 2011, Carley et al.
U.S. Appl. No. 15/131,786, filed Apr. 18, 2016, Roorda et al.
U.S. Appl. No. 60/693,531, filed Jun. 24, 2005, Carly.
U.S. Appl. No. 60/696,069, filed Jul. 1, 2005, Pantages et al.
U.S. Appl. No. 60/793,444, filed Apr. 20, 2006, Jones et al.
U.S. Appl. No. 60/946,026, filed Jun. 25, 2007, Ellingwood.
U.S. Appl. No. 60/946,030, filed Jun. 25, 2007, Voss et al.
U.S. Appl. No. 60/946,042, filed Jun. 25, 2007, Ellingwood et al.
U.S. Appl. No. 61/015,144, filed Dec. 19, 2007, Mackiewicz et al.
U.S. Appl. No. 61/109,822, filed Oct. 30, 2008, Mehl et al.
U.S. Appl. No. 61/139,995, filed Dec. 22, 2008, Clark.
U.S. Appl. No. 61/141,597, filed Dec. 30, 2008, Clark.
U.S. Appl. No. 61/143,748, filed Jan. 9, 2009, Mehl et al.
U.S. Appl. No. 61/143,751, filed Jan. 9, 2009, Voss et al.
U.S. Appl. No. 61/145,468, filed Jan. 16, 2009, Fortson, et al.
“Hand tool for forming telephone connections—comprises pliers with reciprocably driven ram crimping clip around conductors against anvil”, Derwent-ACC-No: 1978-B8090A. (Jan. 10, 1978).
Carpenter et al, Midterm results of the multicenter trial of the Powerlink bifurcated system for endovascular aortic aneurysm repair, Journal of Vascular Surgery, vol. 40, No. 5, Nov. 2004, p. 849-859.e5.
Database WPI; Section PQ, Week 200120; Derwent Publications Ltd., London GB; AN 2001-203165; XP002199926 & ZA 200 100 528 A (Anthony T), Feb. 28, 2001 (Feb. 28, 2001) abstract.
Deepak Mital et al, Renal Transplantation Without Sutures Using the Vascular Clipping System for Renal Artery and Vein Anastomosis—A New Technique, Transplantation Issue, Oct. 1996, pp. 1171-1173, vol. 62—No. 8, Section of Transplantation Surgery, Department of General Surgery, Rush-Presbyterian/St. Luke's Medical Center, Chigago, IL.
DL Wessel et al, Outpatient closure of the patent ductus arteriosus, Circulation, May 1988, pp. 1068-1071, vol. 77—No. 5, Department of Anesthesia, Children's Hospital, Boston, MA.
Eisenack et al, Percutaneous Endovascular Aortic Aneurysm Repair: A Prospective Evaluation of Safety, Efficiency, and Risk Factors, Journal of Endovascular Ther., 2009, vol. 16, p. 708-713.
E Pikoulis et al, Arterial reconstruction with vascular clips is safe and quicker than sutured repair, Cardiovascular Surgery, Dec. 1998, pp. 573-578(6), vol. 6—No. 6, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD.
G Gershony et al, Novel vascular sealing device for closure of percutaneous vascular access sites, Cathet. Cardiovasc. Diagn., Jan. 1998, pp. 82-88, vol. 45.
Greenhalgh et al, Endovascular versus open repair of abdominal aortic aneurysm, The New England journal of medicine, vol. 362, No. 20, 2010, p. 1863-1871.
Grossman, W., Cardiac Catheterization and Angiography, 3rd Ed., Lea & Febiger, Philadelphia, pp. 1-49, 52-247. 1986.
H De Swart et al, A new hemostatic puncture closure device for the immediate sealing of arterial puncture sites, American journal of cardiology, Aug. 1993, pp. 445-449, vol. 72—No. 5, Department of Cardiology, Academic Hospital Maastricht, The Netherlands.
Harrith M. Hasson M.D. , Laparoscopic Cannula Cone with Means for Cannula Stabilization and Wound Closure, The Journal of the American Association of Gynecologic Laparoscopists, May 1998, pp. 183-185, vol. 5—No. 2, Division of Obstetrics and Gynecology, University of Chicago, Chigago, IL.
Howell et al, Percutaneous Repair of Abdominal Aortic Aneurysms Using the aneuRx Stent Graft and the Percutaneous Vascular Surgery Device, Catheterization and cardiovascular interventions, vol. 55, No. 3, 2002, p. 281-287.
Inlet Medical Inc. Brochure, pp. 1-2, referencing OM Elashry et al, Comparative clinical study of port-closure techniques following laparoscopic surgery, Department of Surgery, Mallickrodt Institute of Radiography, J Am Coll Surg., Oct. 1996, pp. 335-344, vol. 183—No. 4.
Jean-Baptiste et al., Percutaneous closure devices for endovascular repair of infrarenal abdominal aortic aneurysms: a prospective, non-randomized comparative study, European Journal of Vascular and Endovascular Surgery, vol. 35, No. 4, 2008, p. 422-428.
J. Findlay et al, Carotid Arteriotomy Closure Using a Vascular Clip System, Neurosurgery, Mar. 1998, pp. 550-554, vol. 42—No. 3, Division of Neurosurgery, University of Alberta, Edmonton, Canada.
Jeremy L Gilbert PHD, Wound Closure Biomaterials and Devices, Shock., Mar. 1999, p. 226, vol. 11—No. 3, Institution Northwestern University (editorial review).
Jochen T. Cremer, MD, et al, Different approaches for minimally invasive closure of atrial septal defects, Ann. Thorac. Surg., Nov. 1998, pp. 1648-1652, vol. 67, a Division of Thoracic and Cardiovascular Surgery, Surgical Center, Hannover Medical School. Hannover, Germany.
K Narayanan et al, Simultaneous primary closure of four fasciotomy wounds in a single setting using the Sure-Closure device, Injury, Jul. 1996, pp. 449-451, vol. 27—No. 6, Department of Surgery, Mercy Hospital of Pittsburgh, PA.
Krajcer and Gregoric, Totally percutaneous aortic aneurysm repair: methods and outcomes using the fully integrated IntuiTrak endovascular system, The Journal of cardiovascular surgery, vol. 51, No. 4, 2010, p. 493-501.
Lederle et al, Outcomes following endovascular vs open repair of abdominal aortic aneurysm: a randomized trial, Jama, vol. 302, No. 14, 2009, p. 1535-1542.
Lee et al, Total percutaneous access for endovascular aortic aneurysm repair (“Preclose” technique), Journal of vascular surgery, vol. 45, No. 6, 2007, p. 1095-1101.
Malkawi et al, Percutaneous access for endovascular aneurysm repair: a systematic review, European Journal of Vascular and Endovascular Surgery, vol. 39, No. 6, 2010, p. 676-682.
Marshall A.C., Lock J.E., Structural and Compliant Anatomy of the Patent Foramen Ovale in Patients Undergoing Transcatheter Closure, Am Heart J Aug. 2000; 140(2); pp. 303-307.
MD Gonze et al, Complications associated with percutaneous closure devices, Conference: Annual Meeting of the Society for Clinical Vascular Surgery, The American journal of surgery, Mar. 1999, pp. 209-211, vol. 178, No. 3, Department of Surgery, Section of Vascular Surgery, Ochsner Medical Institutions, New Orleans, LA.
MD Hellinger et al, Effective peritoneal and fascial closure of abdominal trocar sites utilizing the Endo-Judge, J Laparoendosc Surg., Oct. 1996, pp. 329-332, vol. 6—No. 5, Orlando Regional Medical Center, FL.
Michael Gianturco, A Play on Catheterization, Forbes, Dec. 1996, p. 146, vol. 158—No. 15.
Morasch et al, Percutaneous repair of abdominal aortic aneurysm, Journal of vascular surgery, vol. 40, No. 1, 2004, p. 12-16.
P M N Werker, et al, Review of facilitated approaches to vascular anastomosis surgery, Conference: Utrecht MICABG Workshop 2, The Annals of thoracic surgery, Apr. 1996, pp. S122-S127, vol. 63—No. 6, Department of Plastic, Reconstructive and Hand surgery, University Hospital Utrecht Netherlands Departments of Cardiology and Cardiopulmonary Surgery, Heart Lung Institute, Utrecht Netherlands.; Utrect University Hospital Utrecht Netherlands.
Peter Rhee MD et al, Use of Titanium Vascular Staples in Trauma, Journal of Trauma-Injury Infection & Critical Care, Dec. 1998, pp. 1097-1099, vol. 45—No. 6, Institution from the Department of Surgery, Washington Hospital Center, Washington DC, and Uniformed Services University of the Health Sciences, Bethesda, Maryland.
ProstarXL—Percutaneous Vascular Surgical Device, www.Archive.org, Jun. 1998, Original Publisher: http://prostar.com, may also be found at http://web.archive.org/web/19980630040429/www.perclose.com/html/prstrxl.html.
Rachel et al, Percutaneous endovascular abdominal aortic aneurysm repair, Annals of vascular surgery, vol. 16, No. 1, 2002, p. 43-49.
SA Beyer-Enke et al, Immediate sealing of arterial puncture site following femoropopliteal angioplasty: A prospective randomized trial, Cardiovascular and Interventional Radiology 1996, Nov.-Dec. 1996, pp. 406-410, vol. 19—No. 6, Gen Hosp North, Dept Dianost & Intervent Radiol, Nurnberg, Germany (Reprint).
Scott Hensley, Closing Wounds. New Devices seal arterial punctures in double time, Modern Healthcare (United States), Mar. 23, 2008, p. 48.
Sigmund Silber et al, A novel vascular device for closure of percutaneous arterial access sites, The American Journal of Cardiology, Apr. 1999, pp. 1248-1252, vol. 83—No. 8.
Simonetta Blengino et al, A Randomized Study of the 8 French Hemostatic Puncture Closure Device vs Manual Compression After Coronary Interventions, Journal of the American College of Cardiology, Feb. 1995, p. 262A, vol. 25.—No. 2, Supplement 1.
Starnes et al, Totally percutaneous aortic aneurysm repair: experience and prudence, Journal of vascular surgery, vol. 43, No. 2, 2006, p. 270-276.
Stretch Comb by Scunci, retrieved via internet at www.scunci.com/productdetail, publication date unavailable.
Swee Lian Tan, MD, PHD, FACS, Explanation of Infected Hemostatic Puncture Closure Devices—A Case Report, Vascular and Endovascular Surgery, 1999, pp. 507-510, vol. 33—No. 5, Parkland Medical Center, Derry, New Hampshire.
SY Nakada et al, Comparison of newer laparoscopic port closure techniques in the porcine model, J Endourol, Oct. 1995, pp. 397-401, vol. 9—No. 5, Department of Surgery/Urology, University of Wisconsin Medical School, Madison.
Taber's Cyclopedic Medical Dictionary, 18th Ed. 1997, pp. 747 and 1420.
Teh et al, Use of the percutaneous vascular surgery device for closure of femoral access sites during endovascular aneurysm repair: lessons from our experience, European Journal of Vascular and Endovascular Surgery, vol. 22, No. 5, 2001, p. 418-423.
Thomas P. Baum RPA-C et al, Delayed Primary Closure Using Silastic Vessel Loops and Skin Staples: Description of the Technique and Case Reports, Annals of Plastic Surgery, Mar. 1999, pp. 337-340, vol. 42—No. 3, Institution Department of Plastic and Reconstructive Surgery, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY.
Tomoaki Hinohara, Percutaneous vascular surgery (Prostar® Plus and Techstar® for femoral artery site closure), Interventional Cardiology Newsletter, May-Jul. 1997, pp. 19-22, pp. 24-28, vol. 5—No. 3-4.
Torsello et al, Endovascular suture versus cutdown for endovascular aneurysm repair: a prospective randomized pilot study, Journal of vascular surgery, vol. 38, No. 1, 2003, p. 78-82.
Traul et al, Percutaneous endovascular repair of infrarenal abdominal aortic aneurysms: a feasibility study, Journal of vascular surgery, vol. 32, No. 4, 2000, p. 770-776.
UT Aker et al, Immediate arterial hemostasis after cardiac catheterization: initial experience with a new puncture closure device, Cathet Cardiovasc Diagn, Mar. 1994, pp. 228-232, vol. 33—No. 3, Missouri Baptist Medical Center, St. Louis.
Watelet et al, Percutaneous repair of aorflc aneurysms: a prospective study of suture-mediated closure devices, European journal of vascular and endovascular surgery, vol. 32, No. 3, 2006, p. 261-265.
Wei Qu et al, An absorbable pinned-ring device for microvascular anastomosis of vein grafts: Experimental studies, Microsurgery 1999, Mar. 1999, pp. 128-134, vol. 19—No. 3, Department of Orthopaedic Surgery, Hiroshima University School of Medicine, Hiroshima, Japan.
William G. Kussmaul III MD, et al., Rapid arterial hemostasis and decreased access site complications after cardiac catheterization and angioplasty: Results of a randomized trial of a novel hemostatic device, Journal of the American College of Cardiology, Jun. 1995, pp. 1685-1692, vol. 25—No. 7.
U.S. Appl. No. 09/478,179, Nov. 6, 2000, Notice of Allowance.
U.S. Appl. No. 09/546,998, May 6, 2002, Notice of Allowance.
U.S. Appl. No. 09/610,238, Mar. 26, 2001, Notice of Allowance.
U.S. Appl. No. 09/610,238, Sep. 5, 2001, Office Action.
U.S. Appl. No. 09/610,238, Feb. 11, 2002, Notice of Allowance.
U.S. Appl. No. 09/680,837, Jul. 9, 2002, Office Action.
U.S. Appl. No. 09/680,837, Nov. 6, 2002, Office Action.
U.S. Appl. No. 09/680,837, Mar. 25, 2003, Office Action.
U.S. Appl. No. 09/680,837, Jun. 16, 2003, Notice of Allowance.
U.S. Appl. No. 09/732,178, Aug. 1, 2002, Office Action.
U.S. Appl. No. 09/732,178, Dec. 24, 2002, Office Action.
U.S. Appl. No. 09/732,178, Jun. 10, 2003, Office Action.
U.S. Appl. No. 09/732,178, Jul. 3, 2003, Office Action.
U.S. Appl. No. 09/732,178, Nov. 17, 2003, Notice of Allowance.
U.S. Appl. No. 09/732,835, Sep. 11, 2003, Office Action.
U.S. Appl. No. 09/732,835, Feb. 9, 2004, Office Action.
U.S. Appl. No. 09/732,835, Mar. 17, 2004, Notice of Allowance.
U.S. Appl. No. 09/764,813, Mar. 26, 2001, Office Action.
U.S. Appl. No. 09/764,813, Jun. 4, 2001, Notice of Allowance.
U.S. Appl. No. 09/933,299, Feb. 26, 2003, Office Action.
U.S. Appl. No. 09/933,299, Jun. 16, 2003, Notice of Allowance.
U.S. Appl. No. 09/948,813, Jan. 31, 2003, Notice of Allowance.
U.S. Appl. No. 09/949,398, Mar. 4, 2003, Office Action.
U.S. Appl. No. 09/949,398, Jul. 28, 2003, Notice of Allowance.
U.S. Appl. No. 09/949,438, Dec. 17, 2002, Office Action.
U.S. Appl. No. 09/949,438, Apr. 21, 2003, Notice of Allowance.
U.S. Appl. No. 10/006,400, Aug. 27, 2004, Office Action.
U.S. Appl. No. 10/006,400, Feb. 23, 2005, Office Action.
U.S. Appl. No. 10/006,400, Apr. 11, 2005, Office Action.
U.S. Appl. No. 10/006,400, Jul. 27, 2005, Office Action.
U.S. Appl. No. 10/006,400, Mar. 6, 2006, Office Action.
U.S. Appl. No. 10/006,400, May 24, 2006, Office Action.
U.S. Appl. No. 10/006,400, Oct. 26, 2006, Office Action.
U.S. Appl. No. 10/006,400, Apr. 19, 2007, Office Action.
U.S. Appl. No. 10/006,400, Apr. 2, 2008, Office Action.
U.S. Appl. No. 10/006,400, Jan. 2, 2009, Office Action.
U.S. Appl. No. 10/006,400, Jul. 9, 2009, Notice of Allowance.
U.S. Appl. No. 10/006,400, Jan. 13, 2010, Notice of Allowance.
U.S. Appl. No. 10/006,400, Apr. 27, 2010, Notice of Allowance.
U.S. Appl. No. 10/006,400, Aug. 2, 2010, Notice of Allowance.
U.S. Appl. No. 10/081,717, Sep. 29, 2003, Notice of Allowance.
U.S. Appl. No. 10/081,723, Sep. 29, 2004, Office Action.
U.S. Appl. No. 10/081,723, May 13, 2005, Notice of Allowance.
U.S. Appl. No. 10/081,725, Feb. 9, 2004, Notice of Allowance.
U.S. Appl. No. 10/081,725, Apr. 13, 2004, Office Action.
U.S. Appl. No. 10/081,726, Apr. 11, 2003, Notice of Allowance.
U.S. Appl. No. 10/081,726, Jun. 9, 2003, Notice of Allowance.
U.S. Appl. No. 10/147,774, Nov. 4, 2004, Office Action.
U.S. Appl. No. 10/147,774, May 4, 2005, Office Action.
U.S. Appl. No. 10/147,774, Oct. 18, 2005, Office Action.
U.S. Appl. No. 10/147,774, Apr. 18, 2007, Notice of Allowance.
U.S. Appl. No. 10/147,774, Sep. 27, 2007, Notice of Allowance.
U.S. Appl. No. 10/147,774, Feb. 4, 2008, Notice of Allowance.
U.S. Appl. No. 10/147,774, Jun. 30, 2008, Office Action.
U.S. Appl. No. 10/147,774, Mar. 18, 2009, Office Action.
U.S. Appl. No. 10/147,774, Oct. 26, 2009, Office Action.
U.S. Appl. No. 10/147,774, Jun. 8, 2010, Office Action.
U.S. Appl. No. 10/147,774, Dec. 2, 2010, Notice of Allowance.
U.S. Appl. No. 10/240,183, Jul. 27, 2004, Office Action.
U.S. Appl. No. 10/240,183, Dec. 17, 2004, Office Action.
U.S. Appl. No. 10/240,183, Mar. 9, 2005, Notice of Allowance.
U.S. Appl. No. 10/240,183, Aug. 11, 2006, Office Action.
U.S. Appl. No. 10/264,306, Feb. 9, 2005, Office Action.
U.S. Appl. No. 10/264,306, Oct. 4, 2005, Office Action.
U.S. Appl. No. 10/264,306, May 10, 2006, Notice of Allowance.
U.S. Appl. No. 10/264,306, Jul. 2, 2007, Notice of Allowance.
U.S. Appl. No. 10/264,306, Feb. 4, 2008, Notice of Allowance.
U.S. Appl. No. 10/264,306, Jun. 27, 2008, Office Action.
U.S. Appl. No. 10/264,306, Feb. 26, 2009, Office Action.
U.S. Appl. No. 10/264,306, Aug. 13, 2009, Office Action.
U.S. Appl. No. 10/264,306, Jan. 27, 2010, Office Action.
U.S. Appl. No. 10/264,306, Jun. 15, 2010, Office Action.
U.S. Appl. No. 10/264,306, Oct. 29, 2010, Notice of Allowance.
U.S. Appl. No. 10/335,075, Aug. 10, 2005, Office Action.
U.S. Appl. No. 10/335,075, Dec. 19, 2005, Office Action.
U.S. Appl. No. 10/335,075, Apr. 21, 2006, Office Action.
U.S. Appl. No. 10/335,075, Dec. 27, 2006, Notice of Allowance.
U.S. Appl. No. 10/356,214, Nov. 30, 2005, Office Action.
U.S. Appl. No. 10/356,214, Aug. 23, 2006, Office Action.
U.S. Appl. No. 10/356,214, Feb. 13, 2007, Office Action.
U.S. Appl. No. 10/356,214, Sep. 12, 2007, Office Action.
U.S. Appl. No. 10/356,214, Mar. 6, 2008, Office Action.
U.S. Appl. No. 10/356,214, Nov. 4, 2008, Office Action.
U.S. Appl. No. 10/356,214, Apr. 29, 2009, Office Action.
U.S. Appl. No. 10/356,214, Jan. 13, 2010, Notice of Allowance.
U.S. Appl. No. 10/356,214, May 13, 2010, Notice of Allowance.
U.S. Appl. No. 10/356,214, Sep. 3, 2010, Notice of Allowance.
U.S. Appl. No. 10/435,104, Jun. 10, 2004, Office Action.
U.S. Appl. No. 10/435,104, Sep. 21, 2004, Notice of Allowance.
U.S. Appl. No. 10/435,104, Jan. 3, 2006, Examiner's Amendment.
U.S. Appl. No. 10/435,104, May 16, 2006, Office Action.
U.S. Appl. No. 10/435,104, Dec. 28, 2006, Notice of Allowance.
U.S. Appl. No. 10/435,104, Jul. 10, 2007, Notice of Allowance.
U.S. Appl. No. 10/435,104, Aug. 2, 2007, Notice of Allowance.
U.S. Appl. No. 10/435,104, Oct. 26, 2007, Notice of Allowance.
U.S. Appl. No. 10/435,104, Nov. 14, 2007, Notice of Allowance.
U.S. Appl. No. 10/435,104, Apr. 4, 2008, Notice of Allowance.
U.S. Appl. No. 10/435,104, Sep. 26, 2008, Notice of Allowance.
U.S. Appl. No. 10/435,104, Dec. 22, 2008, Notice of Allowance.
U.S. Appl. No. 10/435,104, Jul. 23, 2009, Notice of Allowance.
U.S. Appl. No. 10/435,104, Jan. 20, 2010, Notice of Allowance.
U.S. Appl. No. 10/435,104, Jun. 2, 2010, Office Action.
U.S. Appl. No. 10/435,104, Oct. 5, 2010, Notice of Allowance.
U.S. Appl. No. 10/455,768, Nov. 16, 2004, Office Action.
U.S. Appl. No. 10/455,768, Apr. 6, 2005, Notice of Allowance.
U.S. Appl. No. 10/486,067, Jan. 10, 2006, Office Action.
U.S. Appl. No. 10/486,067, Sep. 20, 2006, Notice of Allowance.
U.S. Appl. No. 10/486,070, Apr. 20, 2005, Office Action.
U.S. Appl. No. 10/486,070, Aug. 10, 2005, Office Action.
U.S. Appl. No. 10/486,070, Oct. 18, 2005, Notice of Allowance.
U.S. Appl. No. 10/517,004, Aug. 13, 2007, Office Action.
U.S. Appl. No. 10/517,004, Jan. 30, 2008, Office Action.
U.S. Appl. No. 10/517,004, Aug. 13, 2008, Notice of Allowance.
U.S. Appl. No. 10/517,004, Feb. 10, 2009, Notice of Allowance.
U.S. Appl. No. 10/517,004, Mar. 24, 2009, Notice of Allowance.
U.S. Appl. No. 10/517,004, Jun. 26, 2009, Notice of Allowance3.
U.S. Appl. No. 10/517,004, Jan. 11, 2010, Notice of Allowance4.
U.S. Appl. No. 10/517,004, Apr. 23, 2010, Notice of Allowance.
U.S. Appl. No. 10/517,004, Aug. 3, 2010, Notice of Allowance.
U.S. Appl. No. 10/519,778, Feb. 23, 2006, Office Action.
U.S. Appl. No. 10/519,778, May 31, 2006, Notice of Allowance.
U.S. Appl. No. 10/541,083, Oct. 16, 2007, Office Action.
U.S. Appl. No. 10/541,083, Oct. 31, 2007, Office Action.
U.S. Appl. No. 10/541,083, May 5, 2008, Office Action.
U.S. Appl. No. 10/541,083, Sep. 19, 2008, Notice of Allowance.
U.S. Appl. No. 10/541,083, Dec. 29, 2008, Notice of Allowance.
U.S. Appl. No. 10/541,083, Apr. 16, 2009, Notice of Allowance.
U.S. Appl. No. 10/541,083, Sep. 30, 2009, Notice of Allowance.
U.S. Appl. No. 10/541,083, Feb. 5, 2010, Notice of Allowance.
U.S. Appl. No. 10/541,083, May 10, 2010, Notice of Allowance.
U.S. Appl. No. 10/541,083, Aug. 17, 2010, Notice of Allowance.
U.S. Appl. No. 10/616,832, Jun. 30, 2006, Office Action.
U.S. Appl. No. 10/616,832, Oct. 20, 2006, Office Action.
U.S. Appl. No. 10/616,832, May 29, 2007, Office Action.
U.S. Appl. No. 10/616,832, Jan. 22, 2008, Office Action.
U.S. Appl. No. 10/616,832, Sep. 17, 2008, Office Action.
U.S. Appl. No. 10/616,832, Jul. 21, 2009, Office Action.
U.S. Appl. No. 10/616,832, Jan. 11, 2010, Notice of Allowance.
U.S. Appl. No. 10/616,832, May 12, 2010, Notice of Allowance.
U.S. Appl. No. 10/616,832, Sep. 20, 2010, Notice of Allowance.
U.S. Appl. No. 10/617,090, Mar. 22, 2005, Office Action.
U.S. Appl. No. 10/617,090, Jul. 6, 2005, Notice of Allowance.
U.S. Appl. No. 10/617,090, Oct. 5, 2005, Notice of Allowance.
U.S. Appl. No. 10/638,115, Sep. 22, 2006, Office Action.
U.S. Appl. No. 10/638,115, Jan. 31, 2007, Office Action.
U.S. Appl. No. 10/638,115, Sep. 18, 2007, Office Action.
U.S. Appl. No. 10/638,115, Feb. 7, 2008, Office Action.
U.S. Appl. No. 10/638,115, Oct. 29, 2008, Office Action.
U.S. Appl. No. 10/638,115, May 7, 2009, Notice of Allowance.
U.S. Appl. No. 10/638,115, Dec. 1, 2009, Notice of Allowance.
U.S. Appl. No. 10/638,115, Apr. 2, 2010, Notice of Allowance.
U.S. Appl. No. 10/638,115, Aug. 13, 2010, Notice of Allowance.
U.S. Appl. No. 10/667,144, Sep. 19, 2006, Office Action.
U.S. Appl. No. 10/667,144, May 2, 2007, Office Action.
U.S. Appl. No. 10/667,144, Nov. 19, 2007, Office Action.
U.S. Appl. No. 10/667,144, Dec. 5, 2007, Office Action.
U.S. Appl. No. 10/667,144, May 12, 2008, Office Action.
U.S. Appl. No. 10/667,144, Mar. 24, 2009, Office Action.
U.S. Appl. No. 10/667,144, Nov. 23, 2009, Office Action.
U.S. Appl. No. 10/667,144, Jun. 22, 2010, Office Action.
U.S. Appl. No. 10/667,144, Jun. 6, 2011, Office Action.
U.S. Appl. No. 10/667,144, Oct. 28, 2011, Notice of Allowance.
U.S. Appl. No. 10/669,313, Oct. 31, 2005, Office Action.
U.S. Appl. No. 10/669,313, Jan. 11, 2006, Notice of Allowance.
U.S. Appl. No. 10/669,313, Jun. 28, 2006, Notice of Allowance.
U.S. Appl. No. 10/682,459, Sep. 15, 2006, Office Action.
U.S. Appl. No. 10/682,459, Apr. 18, 2007, Office Action.
U.S. Appl. No. 10/682,459, Apr. 2, 2008, Office Action.
U.S. Appl. No. 10/682,459, Dec. 4, 2008, Office Action.
U.S. Appl. No. 10/682,459, Jun. 10, 2009, Office Action.
U.S. Appl. No. 10/682,459, Dec. 23, 2009, Office Action.
U.S. Appl. No. 10/682,459, Apr. 28, 2010, Office Action.
U.S. Appl. No. 10/682,459, Oct. 12, 2010, Office Action.
U.S. Appl. No. 10/682,459, Apr. 1, 2011, Notice of Allowance.
U.S. Appl. No. 10/786,444, Oct. 30, 2006, Office Action.
U.S. Appl. No. 10/786,444, Apr. 17, 2007, Office Action.
U.S. Appl. No. 10/786,444, Aug. 31, 2007, Office Action.
U.S. Appl. No. 10/786,444, Apr. 24, 2008, Office Action.
U.S. Appl. No. 10/786,444, Oct. 17, 2008, Office Action.
U.S. Appl. No. 10/786,444, Jun. 18, 2009, Office Action.
U.S. Appl. No. 10/786,444, Jan. 14, 2010, Office Action.
U.S. Appl. No. 10/786,444, Jul. 11, 2013, Notice of Allowance.
U.S. Appl. No. 10/787,073, Nov. 30, 2006, Office Action.
U.S. Appl. No. 10/787,073, Sep. 5, 2007, Office Action.
U.S. Appl. No. 10/787,073, Feb. 22, 2008, Office Action.
U.S. Appl. No. 10/787,073, Nov. 12, 2008, Office Action.
U.S. Appl. No. 10/787,073, Aug. 13, 2009, Office Action.
U.S. Appl. No. 10/787,073, Feb. 17, 2010, Notice of Allowance.
U.S. Appl. No. 10/787,073, Aug. 25, 2010, Notice of Allowance.
U.S. Appl. No. 10/908,721, Oct. 19, 2006, Office Action.
U.S. Appl. No. 10/908,721, Aug. 10, 2007, Office Action.
U.S. Appl. No. 10/908,721, Jan. 25, 2008, Office Action.
U.S. Appl. No. 10/908,721, Nov. 25, 2008, Office Action.
U.S. Appl. No. 10/908,721, Jun. 23, 2009, Office Action.
U.S. Appl. No. 10/908,721, Feb. 2, 2010, Office Action.
U.S. Appl. No. 10/908,721, Jul. 18, 2013, Notice of Allowance.
U.S. Appl. No. 11/048,503, Mar. 13, 2009, Office Action.
U.S. Appl. No. 11/048,503, Jun. 26, 2009, Office Action.
U.S. Appl. No. 11/048,503, Jan. 11, 2010, Notice of Allowance.
U.S. Appl. No. 11/048,503, Apr. 26, 2010, Notice of Allowance.
U.S. Appl. No. 11/048,503, Jul. 30, 2010, Notice of Allowance.
U.S. Appl. No. 11/113,549, Feb. 6, 2007, Office Action.
U.S. Appl. No. 11/113,549, May 30, 2007, Office Action.
U.S. Appl. No. 11/113,549, Nov. 9, 2007, Office Action.
U.S. Appl. No. 11/113,549, Apr. 16, 2008, Office Action.
U.S. Appl. No. 11/113,549, Jul. 21, 2009, Office Action.
U.S. Appl. No. 11/113,549, Jul. 6, 2010, Office Action.
U.S. Appl. No. 11/113,549, Jan. 4, 2011, Office Action.
U.S. Appl. No. 11/113,549, Mar. 14, 2014, Notice of Allowance.
U.S. Appl. No. 11/152,562, May 13, 2008, Office Action.
U.S. Appl. No. 11/152,562, Feb. 13, 2009, Office Action.
U.S. Appl. No. 11/152,562, Jul. 6, 2009, Office Action.
U.S. Appl. No. 11/152,562, Mar. 31, 2010, Office Action.
U.S. Appl. No. 11/152,562, Sep. 16, 2010, Notice of Allowance.
U.S. Appl. No. 11/198,811, Aug. 26, 2008, Office Action.
U.S. Appl. No. 11/198,811, Apr. 6, 2009, Office Action.
U.S. Appl. No. 11/198,811, Sep. 22, 2009, Office Action.
U.S. Appl. No. 11/198,811, Jun. 29, 2010, Notice of Allowance.
U.S. Appl. No. 11/344,793, Jan. 22, 2009, Office Action.
U.S. Appl. No. 11/344,868, Mar. 25, 2009, Office Action.
U.S. Appl. No. 11/344,891, Apr. 29, 2008, Office Action.
U.S. Appl. No. 11/344,891, Dec. 8, 2008, Office Action.
U.S. Appl. No. 11/344,891, Feb. 26, 2009, Office Action.
U.S. Appl. No. 11/344,891, Oct. 7, 2009, Office Action.
U.S. Appl. No. 11/344,891, May 7, 2010, Office Action.
U.S. Appl. No. 11/344,891, Jan. 22, 2013, Notice of Allowance.
U.S. Appl. No. 11/390,586, Jun. 24, 2009, Office Action.
U.S. Appl. No. 11/390,586, Jul. 6, 2010, Office Action.
U.S. Appl. No. 11/390,586, May 3, 2012, Notice of Allowance.
U.S. Appl. No. 11/396,141, May 22, 2009, Office Action.
U.S. Appl. No. 11/396,141, Aug. 26, 2009, Office Action.
U.S. Appl. No. 11/396,141, May 4, 2010, Office Action.
U.S. Appl. No. 11/396,141, Apr. 30, 2013, Office Action.
U.S. Appl. No. 11/396,141, Aug. 21, 2013, Office Action.
U.S. Appl. No. 11/396,141, Nov. 4, 2013, Notice of Allowance.
U.S. Appl. No. 11/396,731, Feb. 13, 2009, Office Action.
U.S. Appl. No. 11/396,731, May 22, 2009, Office Action.
U.S. Appl. No. 11/396,731, Jun. 29, 2010, Office Action.
U.S. Appl. No. 11/396,731, Mar. 22, 2011, Office Action.
U.S. Appl. No. 11/396,731, Sep. 1, 2011, Office Action.
U.S. Appl. No. 11/396,731, Feb. 12, 2015, Office Action.
U.S. Appl. No. 11/396,731, Jul. 9, 2015, Notice of Allowance.
U.S. Appl. No. 11/406,203, May 14, 2007, Office Action.
U.S. Appl. No. 11/406,203, Jan. 29, 2008, Notice of Allowance.
U.S. Appl. No. 11/406,203, May 23, 2008, Notice of Allowance.
U.S. Appl. No. 11/406,203, Sep. 22, 2008, Notice of Allowance.
U.S. Appl. No. 11/406,203, Mar. 3, 2009, Office Action.
U.S. Appl. No. 11/406,203, Sep. 16, 2009, Office Action.
U.S. Appl. No. 11/406,203, Jun. 18, 2010, Notice of Allowance.
U.S. Appl. No. 11/411,925, Jun. 6, 2007, Office Action.
U.S. Appl. No. 11/411,925, Feb. 5, 2008, Office Action.
U.S. Appl. No. 11/411,925, Jan. 12, 2009, Office Action.
U.S. Appl. No. 11/411,925, Sep. 10, 2009, Office Action.
U.S. Appl. No. 11/411,925, Oct. 1, 2013, Office Action.
U.S. Appl. No. 11/411,925, Feb. 5, 2014, Notice of Allowance.
U.S. Appl. No. 11/427,297, Jan. 30, 2009, Office Action.
U.S. Appl. No. 11/427,297, Sep. 15, 2009, Office Action.
U.S. Appl. No. 11/427,297, Sep. 15, 2010, Office Action.
U.S. Appl. No. 11/427,297, Mar. 21, 2011, Office Action.
U.S. Appl. No. 11/427,297, Jun. 26, 2012, Notice of Allowance.
U.S. Appl. No. 11/427,309, May 28, 2008, Office Action.
U.S. Appl. No. 11/427,309, Jan. 2, 2009, Office Action.
U.S. Appl. No. 11/427,309, Apr. 20, 2009, Office Action.
U.S. Appl. No. 11/427,309, Nov. 6, 2009, Office Action.
U.S. Appl. No. 11/427,309, Apr. 26, 2010, Office Action.
U.S. Appl. No. 11/427,309, Nov. 15, 2010, Office Action.
U.S. Appl. No. 11/427,309, Jun. 7, 2013, Notice of Allowance.
U.S. Appl. No. 11/455,993, Feb. 17, 2009, Office Action.
U.S. Appl. No. 11/455,993, Dec. 16, 2009, Office Action.
U.S. Appl. No. 11/455,993, Jan. 29, 2014, Office Action.
U.S. Appl. No. 11/455,993, Aug. 11, 2014, Notice of Allowance.
U.S. Appl. No. 11/532,325, Feb. 23, 2009, Office Action.
U.S. Appl. No. 11/532,325, Jun. 17, 2009, Office Action.
U.S. Appl. No. 11/532,325, Jan. 5, 2010, Office Action.
U.S. Appl. No. 11/532,325, Jul. 17, 2013, Office Action.
U.S. Appl. No. 11/532,325, Dec. 2, 2013, Office Action.
U.S. Appl. No. 11/532,325, Jan. 16, 2015, Notice of Allowance.
U.S. Appl. No. 11/532,576, Mar. 1, 2010, Office Action.
U.S. Appl. No. 11/532,576, Apr. 23, 2010, Office Action.
U.S. Appl. No. 11/532,576, Oct. 13, 2010, Notice of Allowance.
U.S. Appl. No. 11/674,930, Jan. 8, 2009, Office Action.
U.S. Appl. No. 11/674,930, Jun. 4, 2009, Office Action.
U.S. Appl. No. 11/674,930, Jan. 8, 2010, Office Action.
U.S. Appl. No. 11/674,930, Apr. 3, 2014, Notice of Allowance.
U.S. Appl. No. 11/675,462, Dec. 10, 2009, Office Action.
U.S. Appl. No. 11/675,462, Aug. 31, 2010, Office Action.
U.S. Appl. No. 11/675,462, Aug. 3, 2011, Office Action.
U.S. Appl. No. 11/675,462, Dec. 22, 2011, Notice of Allowance.
U.S. Appl. No. 11/744,089, Nov. 26, 2008, Office Action.
U.S. Appl. No. 11/744,089, Aug. 14, 2009, Office Action.
U.S. Appl. No. 11/744,089, Aug. 8, 2012, Office Action.
U.S. Appl. No. 11/744,089, Apr. 15, 2013, Office Action.
U.S. Appl. No. 11/744,089, Aug. 8, 2013, Notice of Allowance.
U.S. Appl. No. 11/757,108, Nov. 25, 2009, Office Action.
U.S. Appl. No. 11/767,818, Dec. 24, 2009, Office Action.
U.S. Appl. No. 11/767,818, Mar. 22, 2010, Office Action.
U.S. Appl. No. 11/767,818, Sep. 30, 2010, Office Action.
U.S. Appl. No. 11/767,818, Feb. 16, 2011, Office Action.
U.S. Appl. No. 11/767,818, Feb. 3, 2012, Notice of Allowance.
U.S. Appl. No. 11/852,190, Jun. 24, 2010, Office Action.
U.S. Appl. No. 11/852,190, Nov. 1, 2010, Office Action.
U.S. Appl. No. 11/852,190, Mar. 2, 2011, Office Action.
U.S. Appl. No. 11/852,190, Apr. 24, 2013, Office Action.
U.S. Appl. No. 11/852,190, Nov. 26, 2013, Office Action.
U.S. Appl. No. 11/852,190, Feb. 12, 2014, Notice of Allowance.
U.S. Appl. No. 11/958,281, Sep. 2, 2010, Office Action.
U.S. Appl. No. 11/958,281, Oct. 8, 2010, Office Action.
U.S. Appl. No. 11/958,281, Mar. 10, 2011, Office Action.
U.S. Appl. No. 11/958,295, Aug. 27, 2009, Office Action.
U.S. Appl. No. 11/958,295, May 25, 2010, Office Action.
U.S. Appl. No. 11/958,295, Jun. 13, 2014, Notice of Allowance.
U.S. Appl. No. 11/959,334, Aug. 19, 2009, Office Action.
U.S. Appl. No. 11/959,334, Jan. 12, 2010, Notice of Allowance.
U.S. Appl. No. 11/959,334, Apr. 14, 2010, Notice of Allowance.
U.S. Appl. No. 11/959,334, Jul. 23, 2010, Notice of Allowance.
U.S. Appl. No. 12/106,928, Jan. 23, 2009, Office Action.
U.S. Appl. No. 12/106,928, Oct. 5, 2009, Office Action.
U.S. Appl. No. 12/106,928, May 10, 2010, Office Action.
U.S. Appl. No. 12/106,928, Oct. 25, 2010, Office Action.
U.S. Appl. No. 12/106,928, Jun. 28, 2013, Office Action.
U.S. Appl. No. 12/106,928, Dec. 2, 2013, Office Action.
U.S. Appl. No. 12/106,928, Mar. 25, 2014, Advisory Action.
U.S. Appl. No. 12/106,928, Oct. 3, 2014, Notice of Allowance.
U.S. Appl. No. 12/106,937, Mar. 30, 2009, Office Action.
U.S. Appl. No. 12/106,937, Nov. 18, 2009, Office Action.
U.S. Appl. No. 12/106,937, Jun. 28, 2013, Office Action.
U.S. Appl. No. 12/106,937, Jan. 22, 2014, Office Action.
U.S. Appl. No. 12/106,937, Mar. 5, 2015, Notice of Allowance.
U.S. Appl. No. 12/113,851, Apr. 27, 2010, Office Action.
U.S. Appl. No. 12/113,851, Jun. 24, 2010, Office Action.
U.S. Appl. No. 12/113,851, Dec. 16, 2010, Office Action.
U.S. Appl. No. 12/113,851, Apr. 27, 2011, Office Action.
U.S. Appl. No. 12/113,851, Mar. 29, 2012, Office Action.
U.S. Appl. No. 12/113,851, Mar. 17, 2014, Office Action.
U.S. Appl. No. 12/113,851, Aug. 21, 2014, Office Action.
U.S. Appl. No. 12/113,851, Feb. 20, 2015, Notice of Allowance.
U.S. Appl. No. 12/114,031, Oct. 5, 2010, Office Action.
U.S. Appl. No. 12/114,031, Nov. 22, 2010, Office Action.
U.S. Appl. No. 12/114,031, May 11, 2011, Office Action.
U.S. Appl. No. 12/114,031, Aug. 2, 2011, Office Action.
U.S. Appl. No. 12/114,031, Mar. 6, 2012, Office Action.
U.S. Appl. No. 12/114,031, Mar. 10, 2014, Office Action.
U.S. Appl. No. 12/114,091, Oct. 27, 2010, Office Action.
U.S. Appl. No. 12/114,091, Dec. 17, 2010, Office Action.
U.S. Appl. No. 12/114,091, Jul. 7, 2011, Office Action.
U.S. Appl. No. 12/114,091, Apr. 5, 2012, Office Action.
U.S. Appl. No. 12/114,091, Nov. 8, 2012, Office Action.
U.S. Appl. No. 12/114,091, Feb. 12, 2015, Office Action.
U.S. Appl. No. 12/114,091, Jul. 23, 2015, Office Action.
U.S. Appl. No. 12/114,091, Apr. 6, 2016, Notice of Allowance.
U.S. Appl. No. 12/122,603, Mar. 3, 2011, Office Action.
U.S. Appl. No. 12/122,603, Apr. 22, 2011, Office Action.
U.S. Appl. No. 12/122,603, Sep. 23, 2011, Office Action.
U.S. Appl. No. 12/122,603, Nov. 20, 2013, Office Action.
U.S. Appl. No. 12/122,603, Apr. 30, 2014, Office Action.
U.S. Appl. No. 12/122,603, Apr. 9, 2015, Office Action.
U.S. Appl. No. 12/122,603, Sep. 23, 2015, Notice of Allowance.
U.S. Appl. No. 12/135,858, Jul. 13, 2011, Office Action.
U.S. Appl. No. 12/135,858, Feb. 16, 2012, Office Action.
U.S. Appl. No. 12/143,020, May 11, 2011, Office Action.
U.S. Appl. No. 12/143,020, Aug. 31, 2011, Office Action.
U.S. Appl. No. 12/143,020, Feb. 23, 2012, Notice of Allowance.
U.S. Appl. No. 12/338,977, Jan. 19, 2012, Office Action.
U.S. Appl. No. 12/338,977, Jul. 11, 2012, Office Action.
U.S. Appl. No. 12/338,977, Nov. 28, 2012, Office Action.
U.S. Appl. No. 12/338,977, Jun. 19, 2013, Office Action.
U.S. Appl. No. 12/393,877, Sep. 29, 2011, Office Action.
U.S. Appl. No. 12/393,877, Dec. 13, 2011, Office Action.
U.S. Appl. No. 12/393,877, May 21, 2012, Office Action.
U.S. Appl. No. 12/393,877, Aug. 4, 2014, Notice of Allowance.
U.S. Appl. No. 12/402,398, Mar. 9, 2010, Office Action.
U.S. Appl. No. 12/402,398, May 20, 2010, Office Action.
U.S. Appl. No. 12/402,398, Jan. 24, 2011, Office Action.
U.S. Appl. No. 12/402,398, Sep. 20, 2012, Office Action.
U.S. Appl. No. 12/402,398, Mar. 13, 2013, Notice of Allowance.
U.S. Appl. No. 12/403,256, Dec. 16, 2009, Office Action.
U.S. Appl. No. 12/403,256, Mar. 30, 2010, Office Action.
U.S. Appl. No. 12/403,256, Aug. 19, 2010, Notice of Allowance.
U.S. Appl. No. 12/403,277, Jul. 8, 2010, Office Action.
U.S. Appl. No. 12/403,277, Oct. 12, 2010, Office Action.
U.S. Appl. No. 12/403,277, Mar. 31, 2011, Office Action.
U.S. Appl. No. 12/403,277, Apr. 3, 2012, Office Action.
U.S. Appl. No. 12/403,277, Nov. 5, 2012, Office Action.
U.S. Appl. No. 12/403,277, Jan. 27, 2014, Office Action.
U.S. Appl. No. 12/403,277, Aug. 15, 2014, Office Action.
U.S. Appl. No. 12/481,377, Apr. 28, 2011, Office Action.
U.S. Appl. No. 12/481,377, Jun. 21, 2011, Office Action.
U.S. Appl. No. 12/481,377, Jan. 3, 2012, Office Action.
U.S. Appl. No. 12/481,377, Aug. 10, 2012, Notice of Allowance.
U.S. Appl. No. 12/548,274, Dec. 28, 2011, Office Action.
U.S. Appl. No. 12/548,274, Mar. 2, 2012, Office Action.
U.S. Appl. No. 12/548,274, Sep. 10, 2012, Office Action.
U.S. Appl. No. 12/548,274, Aug. 14, 2014, Office Action.
U.S. Appl. No. 12/608,769, Feb. 10, 2012, Office Action.
U.S. Appl. No. 12/608,769, Aug. 22, 2012, Office Action.
U.S. Appl. No. 12/608,769, Nov. 5, 2012, Notice of Allowance.
U.S. Appl. No. 12/608,773, Jun. 7, 2012, Office Action.
U.S. Appl. No. 12/608,773, Jul. 20, 2012, Office Action.
U.S. Appl. No. 12/608,773, Jan. 7, 2013, Office Action.
U.S. Appl. No. 12/608,773, Jul. 17, 2014, Office Action.
U.S. Appl. No. 12/608,773, Mar. 12, 2015, Office Action.
U.S. Appl. No. 12/608,773, Sep. 17, 2015, Notice of Allowance.
U.S. Appl. No. 12/642,319, Feb. 27, 2012, Office Action.
U.S. Appl. No. 12/642,319, Aug. 28, 2012, Office Action.
U.S. Appl. No. 12/642,319, Dec. 16, 2013, Office Action.
U.S. Appl. No. 12/642,319, May 27, 2014, Notice of Allowance.
U.S. Appl. No. 12/684,400, Feb. 13, 2012, Office Action.
U.S. Appl. No. 12/684,400, May 9, 2012, Office Action.
U.S. Appl. No. 12/684,400, Oct. 16, 2012, Office Action.
U.S. Appl. No. 12/684,400, Feb. 23, 2015, Office Action.
U.S. Appl. No. 12/684,400, Jul. 28, 2015, Notice of Allowance.
U.S. Appl. No. 12/684,470, Dec. 20, 2011, Office Action.
U.S. Appl. No. 12/684,470, Mar. 23, 2012, Office Action.
U.S. Appl. No. 12/684,470, Aug. 30, 2012, Office Action.
U.S. Appl. No. 12/684,470, Jun. 4, 2014, Office Action.
U.S. Appl. No. 12/684,470, Nov. 14, 2014, Office Action.
U.S. Appl. No. 12/684,470, Aug. 26, 2015, Office Action.
U.S. Appl. No. 12/684,470, Jan. 21, 2016, Office Action.
U.S. Appl. No. 12/684,470, Apr. 22, 2016, Notice of Allowance.
U.S. Appl. No. 12/684,542, Jan. 30, 2012, Office Action.
U.S. Appl. No. 12/684,542, Apr. 16, 2012, Office Action.
U.S. Appl. No. 12/684,542, Sep. 13, 2012, Office Action.
U.S. Appl. No. 12/684,542, Jun. 18, 2014, Office Action.
U.S. Appl. No. 12/684,542, Dec. 1, 2014, Office Action.
U.S. Appl. No. 12/684,562, Dec. 28, 2011, Office Action.
U.S. Appl. No. 12/684,562, Feb. 16, 2012, Office Action.
U.S. Appl. No. 12/684,562, Aug. 21, 2012, Office Action.
U.S. Appl. No. 12/684,562, Sep. 10, 2014, Office Action.
U.S. Appl. No. 12/684,562, Feb. 17, 2015, Notice of Allowance.
U.S. Appl. No. 12/684,569, Dec. 20, 2011, Office Action.
U.S. Appl. No. 12/684,569, Jan. 27, 2012, Office Action.
U.S. Appl. No. 12/684,569, Jul. 30, 2012, Office Action.
U.S. Appl. No. 12/684,569, Apr. 23, 2014, Office Action.
U.S. Appl. No. 12/688,065, Mar. 13, 2012, Office Action.
U.S. Appl. No. 12/688,065, Apr. 26, 2012, Office Action.
U.S. Appl. No. 12/688,065, Oct. 12, 2012, Office Action.
U.S. Appl. No. 12/688,065, Oct. 18, 2013, Office Action.
U.S. Appl. No. 12/688,065, Apr. 8, 2014, Office Action.
U.S. Appl. No. 12/724,304, Feb. 10, 2012, Office Action.
U.S. Appl. No. 12/724,304, Mar. 13, 2012, Interview Summary.
U.S. Appl. No. 12/724,304, Jul. 11, 2012, Notice of Allowance.
U.S. Appl. No. 12/848,642, Sep. 20, 2012, Office Action.
U.S. Appl. No. 12/848,642, Nov. 9, 2012, Office Action.
U.S. Appl. No. 12/848,642, Apr. 26, 2013, Office Action.
U.S. Appl. No. 12/848,642, Feb. 3, 2014, Notice of Allowance.
U.S. Appl. No. 12/850,242, Aug. 6, 2012, Office Action.
U.S. Appl. No. 12/850,242, Oct. 17, 2012, Office Action.
U.S. Appl. No. 12/850,242, Apr. 18, 2013, Office Action.
U.S. Appl. No. 12/850,242, Aug. 6, 2013, Notice of Allowance.
U.S. Appl. No. 12/897,358, Aug. 22, 2011, Office Action.
U.S. Appl. No. 12/897,358, Jan. 12, 2012, Notice of Allowance.
U.S. Appl. No. 12/897,358, Mar. 5, 2012, Notice of Allowance.
U.S. Appl. No. 12/941,809, Dec. 13, 2011, Office Action.
U.S. Appl. No. 12/941,809, Jan. 30, 2012, Office Action.
U.S. Appl. No. 12/941,809, Jun. 1, 2012, Office Action.
U.S. Appl. No. 12/941,809, Jul. 3, 2013, Office Action.
U.S. Appl. No. 12/941,809, Nov. 8, 2013, Office Action.
U.S. Appl. No. 12/941,809, Feb. 3, 2014, Notice of Allowance.
U.S. Appl. No. 12/945,646, Jan. 20, 2011, Office Action.
U.S. Appl. No. 12/945,646, Jul. 6, 2011, Office Action.
U.S. Appl. No. 12/945,646, Oct. 26, 2011, Office Action.
U.S. Appl. No. 12/945,646, Feb. 21, 2012, Notice of Allowance.
U.S. Appl. No. 12/950,628, Apr. 25, 2014, Notice of Allowance.
U.S. Appl. No. 12/955,859, May 26, 2011, Office Action.
U.S. Appl. No. 12/955,859, Jul. 21, 2011, Office Action.
U.S. Appl. No. 12/955,859, Dec. 15, 2011, Office Action.
U.S. Appl. No. 12/955,859, Aug. 6, 2012, Office Action.
U.S. Appl. No. 12/955,859, May 16, 2013, Office Action.
U.S. Appl. No. 12/955,859, Aug. 1, 2013, Notice of Allowance.
U.S. Appl. No. 12/961,331, Dec. 4, 2012, Office Action.
U.S. Appl. No. 12/961,331, Feb. 1, 2013, Office Action.
U.S. Appl. No. 12/961,331, Jul. 3, 2013, Office Action.
U.S. Appl. No. 12/961,331, Sep. 20, 2013, Advisory Action.
U.S. Appl. No. 12/961,331, Apr. 25, 2014, Notice of Allowance.
U.S. Appl. No. 12/966,923, Feb. 3, 2012, Notice of Allowance.
U.S. Appl. No. 12/973,204, Mar. 7, 2012, Notice of Allowance.
U.S. Appl. No. 12/987,792, Mar. 13, 2012, Office Action.
U.S. Appl. No. 12/987,792, Sep. 17, 2012, Office Action.
U.S. Appl. No. 12/987,792, Jan. 21, 2014, Office Action.
U.S. Appl. No. 12/987,792, Jun. 11, 2014, Office Action.
U.S. Appl. No. 12/987,792, Aug. 25, 2014, Notice of Allowance.
U.S. Appl. No. 13/026,989, Sep. 16, 2011, Office Action.
U.S. Appl. No. 13/026,989, Jun. 8, 2012, Office Action.
U.S. Appl. No. 13/026,989, Aug. 23, 2013, Office Action.
U.S. Appl. No. 13/028,041, Jan. 4, 2013, Office Action.
U.S. Appl. No. 13/028,041, Feb. 26, 2013, Office Action.
U.S. Appl. No. 13/028,041, Aug. 21, 2013, Notice of Allowance.
U.S. Appl. No. 13/030,922, Dec. 18, 2012, Office Action.
U.S. Appl. No. 13/030,922, Jan. 31, 2013, Office Action.
U.S. Appl. No. 13/030,922, Jul. 18, 2013, Office Action.
U.S. Appl. No. 13/030,922, Jan. 8, 2014, Notice of Allowance.
U.S. Appl. No. 13/039,087, Jul. 17, 2012, Office Action.
U.S. Appl. No. 13/039,087, Nov. 6, 2012, Notice of Allowance.
U.S. Appl. No. 13/111,371, Oct. 12, 2012, Office Action.
U.S. Appl. No. 13/111,371, Dec. 18, 2012, Office Action.
U.S. Appl. No. 13/111,371, Jun. 6, 2013, Notice of Allowance.
U.S. Appl. No. 13/112,618, Mar. 29, 2013, Office Action.
U.S. Appl. No. 13/112,618, Jun. 7, 2013, Office Action.
U.S. Appl. No. 13/112,618, Nov. 20, 2013, Office Action.
U.S. Appl. No. 13/112,618, Dec. 15, 2014, Office Action.
U.S. Appl. No. 13/112,618, May 18, 2015, Office Action.
U.S. Appl. No. 13/112,618, Jan. 29, 2016, Office Action.
U.S. Appl. No. 13/112,618, Jul. 6, 2016, Notice of Allowance.
U.S. Appl. No. 13/112,631, Mar. 29, 2013, Office Action.
U.S. Appl. No. 13/112,631, Jun. 26, 2013, Office Action.
U.S. Appl. No. 13/112,631, Dec. 2, 2013, Office Action.
U.S. Appl. No. 13/112,631, Nov. 20, 2014, Office Action.
U.S. Appl. No. 13/112,631, Apr. 15, 2015, Office Action.
U.S. Appl. No. 13/153,594, Jan. 29, 2013, Office Action.
U.S. Appl. No. 13/153,594, May 29, 2013, Office Action.
U.S. Appl. No. 13/153,594, Oct. 16, 2013, Notice of Allowance.
U.S. Appl. No. 13/222,899, Jan. 10, 2014, Office Action.
U.S. Appl. No. 13/222,899, Jul. 31, 2014, Office Action.
U.S. Appl. No. 13/222,899, Apr. 1, 2015, Office Action.
U.S. Appl. No. 13/222,899, Aug. 5, 2015, Office Action.
U.S. Appl. No. 13/222,899, Jan. 7, 2016, Notice of Allowance.
U.S. Appl. No. 13/308,227, Apr. 10, 2013, Office Action.
U.S. Appl. No. 13/308,227, Sep. 11, 2013, Office Action.
U.S. Appl. No. 13/308,227, Jul. 14, 2015, Office Action.
U.S. Appl. No. 13/308,227, Feb. 1, 2016, Notice of Allowance.
U.S. Appl. No. 13/488,233, Feb. 5, 2013, Notice of Allowance.
U.S. Appl. No. 13/490,143, Jan. 4, 2013, Office Action.
U.S. Appl. No. 13/490,143, Apr. 29, 2013, Notice of Allowance.
U.S. Appl. No. 13/525,839, Apr. 1, 2013, Office Action.
U.S. Appl. No. 13/525,839, Jul. 15, 2013, Notice of Allowance.
U.S. Appl. No. 13/615,547, Jan. 18, 2013, Office Action.
U.S. Appl. No. 13/615,547, Apr. 12, 2013, Notice of Allowance.
U.S. Appl. No. 13/725,589, Sep. 17, 2015, Office Action.
U.S. Appl. No. 13/725,589, Mar. 18, 2016, Notice of Allowance.
U.S. Appl. No. 13/791,829, May 29, 2013, Office Action.
U.S. Appl. No. 13/791,829, Oct. 8, 2013, Notice of Allowance.
U.S. Appl. No. 13/791,846, Jun. 4, 2015, Office Action.
U.S. Appl. No. 13/791,846, Oct. 27, 2015, Notice of Allowance.
U.S. Appl. No. 13/837,801, Dec. 16, 2015, Office Action.
U.S. Appl. No. 13/837,801, Jun. 9, 2016, Office Action.
U.S. Appl. No. 13/837,801, Feb. 9, 2017, Office Action.
U.S. Appl. No. 13/898,202, Jan. 3, 2014, Office Action.
U.S. Appl. No. 13/898,202, Aug. 21, 2014, Office Action.
U.S. Appl. No. 13/898,202, Feb. 10, 2015, Notice of Allowance.
U.S. Appl. No. 13/908,796, Jul. 21, 2015, Office Action.
U.S. Appl. No. 13/908,796, Nov. 6, 2015, Notice of Allowance.
U.S. Appl. No. 14/017,039, Jan. 23, 2015, Office Action.
U.S. Appl. No. 14/017,039, Jun. 10, 2015, Office Action.
U.S. Appl. No. 14/017,039, Oct. 27, 2015, Office Action.
U.S. Appl. No. 14/017,039, Apr. 4, 2016, Notice of Allowance.
U.S. Appl. No. 14/023,428, Jul. 27, 2015, Office Action.
U.S. Appl. No. 14/023,428, Feb. 9, 2016, Office Action.
U.S. Appl. No. 14/023,428, Jun. 13, 2016, Office Action.
U.S. Appl. No. 14/023,428, Dec. 20, 2016, Office Action.
U.S. Appl. No. 14/077,007, Jul. 27, 2015, Office Action.
U.S. Appl. No. 14/077,007, Jan. 29, 2016, Office Action.
U.S. Appl. No. 14/077,007, Aug. 12, 2016, Notice of Allowance.
U.S. Appl. No. 14/246,926, Aug. 5, 2015, Office Action.
U.S. Appl. No. 14/246,926, Nov. 23, 2015, Office Action.
U.S. Appl. No. 14/246,926, Jun. 15, 2016, Office Action.
U.S. Appl. No. 14/246,926, Oct. 3, 2016, Notice of Allowance.
U.S. Appl. No. 14/246,973, Aug. 3, 2015, Office Action.
U.S. Appl. No. 14/246,973, Nov. 24, 2015, Office Action.
U.S. Appl. No. 14/246,973, Jul. 7, 2016, Office Action.
U.S. Appl. No. 14/246,973, Nov. 9, 2016, Notice of Allowance.
U.S. Appl. No. 14/312,339, Jan. 22, 2016, Office Action.
U.S. Appl. No. 14/312,339, May 3, 2016, Office Action.
U.S. Appl. No. 14/312,339, Jan. 31, 2017, Office Action.
U.S. Appl. No. 14/323,753, Nov. 3, 2015, Office Action.
U.S. Appl. No. 14/323,753, Apr. 15, 2016, Notice of Allowance.
U.S. Appl. No. 14/466,576, Jul. 8, 2015, Office Action.
U.S. Appl. No. 14/466,576, Dec. 15, 2015, Notice of Allowance.
U.S. Appl. No. 14/539,830, Jan. 29, 2016, Office Action.
U.S. Appl. No. 14/539,830, Jul. 26, 2016, Office Action.
U.S. Appl. No. 14/539,830, Nov. 18, 2016, Notice of Allowance.
U.S. Appl. No. 15/222,397, Jan. 23, 2017, Office Action.
U.S. Appl. No. 29/296,370, Aug. 18, 2008, Office Action.
U.S. Appl. No. 29/296,370, Dec. 2, 2008, Notice of Allowance.
U.S. Appl. No. 29/296,370, Apr. 1, 2009, Notice of Allowance.
U.S. Appl. No. 14/312,339, Jul. 19, 2018, Notice of Allowance.
U.S. Appl. No. 15/069,230, Aug. 7, 2018, Office Action.
https://www.thefreedictionary.com/flex, retrieved Sep. 2, 2018, definition of the term flex.
https://www.thefreedictionary.com/integral, retrieved Aug. 20, 2018, definition of the term integral.
U.S. Appl. No. 16/144,195, filed Sep. 27, 2018, Walberg et al.
U.S. Appl. No. 14/312,339, Oct. 10, 2018, Issue Notification.
U.S. Appl. No. 14/855,080, Sep. 21, 2018, Office Action.
U.S. Appl. No. 15/056,281, Aug. 27, 2018, Advisory Action.
U.S. Appl. No. 15/056,281, Sep. 19, 2018, Office Action.
U.S. Appl. No. 15/069,230, Oct. 22, 2018, Advisory Action.
U.S. Appl. No. 15/142,106, Sep. 7, 2018, Office Action.
U.S. Appl. No. 15/356,028, Aug. 29, 2018, Office Action.

Related Publications (1)

	Number	Date	Country
	20170135684 A1	May 2017	US

Divisions (1)

	Number	Date	Country
Parent	10081726	Feb 2002	US
Child	10435104		US

Continuations (2)

	Number	Date	Country
Parent	14246926	Apr 2014	US
Child	15419335		US
Parent	11396141	Mar 2006	US
Child	14246926		US

Continuation in Parts (6)

	Number	Date	Country
Parent	10787073	Feb 2004	US
Child	11396141		US
Parent	10435104	May 2003	US
Child	10787073		US
Parent	09732178	Dec 2000	US
Child	10081726		US
Parent	10335075	Dec 2002	US
Child	11396141		US
Parent	10081726	Feb 2002	US
Child	10335075		US
Parent	09732178	Dec 2000	US
Child	10081726		US

Closure device and methods for making and using them

Information

Patent Number

Date Filed

Date Issued

Inventors

Original Assignees

Examiners

Agents

CPC

Field of Search

US

CPC

International Classifications

Disclaimer

Term Extension

Abstract